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Abstract
Spinal cord contains different types of neurons. A vast majority of these neurons are
interneurons. Therefore, a better understanding of how interneurons in the spinal cord
develop is particularly important, as it will hopefully enable researchers to establish better
treatments for spinal cord injury patients. In this thesis, I used zebrafish to study
development of two classes of spinal cord neurons – KA cells (which correspond to
cerebrospinal fluid-contacting neurons, CSF-cNs) and V2b cells. Both KA and V2b neurons
are functionally important in vertebrate locomotor circuitry.
Development of functional neurons involves progression of genetic cascades that
lead to correct cell specification. Some of the most important genes expressed during cell
development encode for transcription factors, which are regulatory proteins that can either
activate or repress expression of downstream genes. Both V2b and KA neurons in
zebrafish express a common set of transcription factors – Tal1, Gata2a, and Gata3. These
proteins are not present in any other spinal cord cell type. Previous work used a
knockdown approach (morpholinos) to show that gata2a and gata3 have different
functions in specification of KA cell types – KA” cells require gata2a and KA’ cells require
gata3 to develop correctly. In this thesis, I test whether the same phenotypes occur in null
mutants. Also, I investigate the role of tal1 in specification of KA cells, and the role of all
three (gata2a, gata3, tal1) genes in V2b specification. To do this, I used tal1, gata2a and
gata3 zebrafish mutants.

KA and V2b neurons also share another characteristic – all these cells are
GABAergic. Therefore, I investigate whether tal1, gata2a and gata3 genes are required for
correct specification of V2b and/or KA global cell fate and/or GABAergic phenotypes of
these cells. In addition, I identify a subset of genes expressed by either KA”, KA’ and/or V2b
cells and analyze the expression of some of these in these mutants.
My results show that tal1, gata2a, and gata3 have distinct functions in each neuron
type. In KA” cells, gata2a is required for correct expression of the majority of KA” markers
and the GABAergic phenotype of these cells. Interestingly, both tal1 and gata3 are not
required for correct specification of KA” cells. In KA’ cells, the situation seems to be
reversed – tal1 and gata3 are required for correct expression of all KA’ markers, but gata2a
is required for only some aspects of the KA’ cell fate in a subset of KA’ cells. In V2b cells, the
phenotypic effects of these mutations are more complicated – neither tal1, gata2a nor
gata3 are required for correct expression of all V2b genes. However, tal1 is required for
expression of a subset of these genes, and for the GABAergic phenotype of V2b cells.
This thesis contributes to better understanding of KA”, KA’ and V2b neuron
specification. Also, the presented results have broader implications, as they underlie the
importance of cell type specificity of genetic cascades that lead to correct development of
spinal cord neurons.
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1. Introduction
The spinal cord consists of nerve cells (neurons) and glia, and together with the
brain constitutes the central nervous system (CNS). Nerve cells in the CNS consist mainly of
motoneurons (MNs) and interneurons (INs), while most sensory neurons belong to the
peripheral nervous system (PNS). Together, these cell types form functional neuronal
circuitry (see Fig. 1). Sensory neurons have cell bodies outside of the spinal cord, but their
axons terminate in the spinal cord and they primarily function to convey sensory
information from the body towards the spinal cord and brain. Motoneurons have their cell
bodies in the spinal cord, but their axons project away from the spinal cord to connect to
the muscles of the body. They play a primary role in conveying locomotory information to
muscles and are the most broadly studied group of spinal cord cells, as they have been
easiest to identify so far (Lewis and Eisen, 2003). However, most spinal cord neurons are
interneurons – cells that have their cell bodies and axons within the CNS, and are crucial for
processing and conveying information between the brain and rest of the body, as well as
within the spinal cord as part of oscillatory networks known as central pattern generators
(CPGs) (as reviewed in: Frigon, 2002). CPGs are neuronal networks that create timing and
patterns of rhythmic muscle movements, without a need for sensory input (for reviews see:
Marder and Bucher, 2001; Grillner et al., 2007). Interneurons in the dorsal part of the
spinal cord are important for receiving and processing sensory information, while cells in
the ventral part of spinal cord regulate locomotion (for review see: Goulding, 2009). In the
case of some ventral cell populations, we already know their specific functions in
locomotor circuits. For example, V0 cells regulate right-left alternation in mouse (Lanuza et
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al., 2004; Griener et al., 2015). Also, V1 cells are important for fast movements (Gosgnach et
al., 2006), and together with V2b cells regulate flexor/extensor muscle output in mouse
(Zhang et al., 2014; Britz et al., 2015).
The physiological functions of many spinal interneuron populations are already
known, but we still don’t understand the processes by which these cells form. This
knowledge could help develop therapeutic applications, particularly for spinal cord
injuries. For example, understanding the genetic networks that lead to distinct, fully
functional neurons should help researchers develop stem-cell based therapies to replace
damaged neurons and/or circuits. In one case, expression of developmentallycharacterized morphogens at specific concentrations in cell culture has already led to the
generation of electrophysiologically functional V2a cells (Brown et al., 2014). Another
recent study demonstrated that expression of specific genes in stem cells led to
development of neurons from glia that once grafted, improved the locomotion of paraplegic
rats (Hong et al., 2014).
Some of the most important molecules for understanding development of particular
cell types are transcription factors. Transcription factors are proteins that bind to DNA and
regulate expression of other genes. Due to their regulatory role, they are crucially
important in developmental processes and often act as ‘master regulators’, sitting at the
top of genetic networks that lead to the development of functional cell types.
Understanding the roles that transcription factors play in spinal cord development, is key
to understanding how mature, fully functional neurons arise. The hypothesis that underlies
my research is that the combinatorial code of transcription factors and the temporal
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sequence in which they are expressed, is what specifies the development of particular
neuronal subpopulations (Lewis, 2006). My study concentrates on V2b and KA
(Kolmer-Agduhr) neurons that are located in the ventral part of the spinal cord. V2b and
KA neurons share a GABAergic neurotransmitter phenotype, and several transcription
factor genes are co-expressed by both of these cell types: gata3, gata2a and tal1 are
expressed by both KA and V2b cells, while tal2 is expressed by KA cells and a subset of V2b
cells (Batista et al., 2008; Yang et al., 2010). In this thesis, I will describe the expression
patterns of additional transcription factor genes in these cells and I will also investigate the
functions of gata3, gata2a and tal1 in development of V2b and KA cells. Finally, I will also
briefly examine the expression of additional genes that are good candidates for being
expressed by either V2b and/or KA cells. As my work is informed by the findings from
other model organisms, I will use the nomenclature that is specified in section 2.10 of the
methods chapter.

1.1 Zebrafish as a model organism for understanding spinal
cord development
Zebrafish (Danio rerio) is an excellent organism to study spinal cord development.
The animals develop fast, gaining a heart, brain and spinal cord by 24 hours
post-fertilization (24hpf). Importantly, external fertilization allows for easy observation of
the embryos without the need to sacrifice adults. Also, compared to most other animals
that are opaque, the optical transparency of zebrafish embryos makes it especially easy to
visualize tissues deep inside the animal, such as the spinal cord. In addition, one pair of fish
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can potentially lay several hundred embryos at one time. This facilitates working with
double mutant animals and genetic analyses.
The translucent nature of zebrafish has enabled very detailed descriptions of
individual cells in the spinal cord (e.g. Bernhardt et al., 1990) and as of now, all of the
zebrafish spinal cord neuron types have been described based on their morphology (size
and shape of the cell body and axon projections) and dorsoventral position in spinal cord
(Fig. 2, adapted from: Lewis and Eisen, 2003). This is in contrast with the amniote spinal
cord, which is more complicated and where individual cell types are more difficult to
identify on the basis of morphology. Despite the zebrafish spinal cord being much smaller
than that of mammals or birds, the distinct subtypes of interneurons found in amniotes
seem to have corresponding cells in zebrafish: at least most of the currently known genes
expressed by amniote spinal cord are also expressed in zebrafish spinal cord, and the
dorsoventral position of those cells corresponds to that of amniote cell populations (as
reviewed in: Lewis, 2006 and in Goulding, 2009). Therefore, it seems likely that the
mechanism of spinal cord development is highly conserved between zebrafish, birds, and
mammals.
The main differences between gene expression in amniote and zebrafish spinal cord
result from a particular evolutionary event - in the course of evolution, zebrafish (together
with all other teleosts) underwent an additional whole genome duplication (Postlethwait et
al., 1998). As a consequence, some genes have duplicate copies in zebrafish, as compared to
most other vertebrates. Most often, after genome duplication one copy of the gene would
become nonfunctional (as reviewed in: Glasauer and Neuhauss, 2014). However,

5
sometimes both copies are retained either because one of the copies acquires a novel
function (neofunctionalization), or the functions of the gene become split between both
copies (subfunctionalization) (as reviewed in: Glasauer and Neuhauss, 2014). Nevertheless,
the processes of spinal cord development in zebrafish and other animals are highly
homologous (Goulding et al., 2009, Lewis, 2006), so the results of my research are likely to
be highly relevant to other vertebrates, including mammals.

1.2 Overview of spinal cord development
The spinal cord of most vertebrate animals can be divided into two regions mediallaterally: ventricular zone/proliferating zone (medially) and post-mitotic domain
(laterally), with floor plate and roof plate delineating the most distant boundaries of the
spinal cord along the dorsoventral axis (Fig. 1). The most ventral part of the spinal cord, the
floor plate, secretes sonic hedgehog (Shh), while the dorsally located roof plate and neural
tube secrete bone morphogenetic protein (BMP) and Wnt signaling molecules (as
described in: Lewis, 2006). In addition, retinoic acid plays an important role in both
anterior-posterior and dorso-ventral neural tube patterning (Lupo et al., 2006; Maden,
2002). Combined gradients of these morphogens across the spinal cord lead to the
existence of molecularly distinct cell domains (progenitor domains) within the ventricular
zone of the spinal cord (Briscoe et al., 2000; Lewis, 2006).
In mouse, at least 5 types of ventral progenitor domains (p3, pMN, p2, p1, p0) and 6
types of dorsal progenitor domains (dP6, dP5, dP4, dP3, dP2, dP1) have been identified
based on their dorsoventral position and the specific set of genes that they express (see Fig.
1B; also for review, see: Jessell, 2000 or Goulding and Pfaff, 2005). Progenitor cells in the
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ventricular zone have potential to undergo mitosis (divide) and give rise to differentiated
post-mitotic cells. When cells become post-mitotic, they exit the cell cycle, move laterally
and begin to express a different combination of transcription factors that will lead to the
formation of fully differentiated, functional neurons (as described in: Lewis, 2006). Specific
progenitor domains have potential to give rise to at least one (usually more) post-mitotic
cell types (as described in: Lewis, 2006; see Fig. 1B). In each case, these related populations
of cells share at least a subset of transcription factors, and often share one or more
functional characteristics (as described in: Lewis, 2006 and in: Goulding, 2009).
The post-mitotic interneuron subpopulations on the dorsal side are designated dI1d-6, while on the ventral side they include V0, V1, V2 and V3 cells. In addition, ventral
spinal cord contains motoneurons that are located between the V3 and V2 subpopulations
(as described in: Lewis, 2006; see Fig. 1). So far, homologous cells for all of the ventral
post-mitotic cells and most of the dorsal ones have been described in zebrafish (as
reviewed in: Lewis, 2006 and Goulding, 2009, unpublished data Lewis Lab). In addition, as
mentioned above the zebrafish spinal cord contains KA cells, which form in the most
ventral part of the spinal cord and contact the central canal (Bernhardt et al., 1992). While
similar cerebrospinal-fluid contacting neurons (CSF-cNs) have been described in mouse
and other species (as desribed in: Djenoune et al., 2014), it is not clear where they form in
these animals. I will discuss both V2 cells and KA cells in more detail below.
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Figure 1. Schematic representation of cross-section through the spinal cord. Dorsal
up, ventral down. (A) shows relative position of neuron types in the cross-section through
the spinal cord. Blue neurons are sensory neurons (dorsal) and motoneurons (ventral).
Green neurons represent interneurons, which do not leave the central nervous system. (B)
shows position of individual neuron subpopulations in vertebrate spinal cord. The
positions of V2 (V2a and V2b) cells and KA (KA” and KA’) cells in ventral spinal cord are
indicated in green. (B) is adapted from: Lewis et al., 2006.
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1.3 Specification of functional characteristics of post-mitotic
spinal cord interneurons
Spinal cord cells can exhibit a variety of functional characteristics, including a
specific axon trajectory, neurotransmitter chemical messenger, and specific
electrophysiological properties like firing intensity and duration (as reviewed in: Goulding,
2009). Each of those characteristics is important for neurons to function correctly in
circuitry, and therefore crucial for a correctly functioning neuronal network. In my
research, I am interested in determining whether the transcription factors I examine are
required for specification of global cell fate, or whether they just specify a subset of the
functional characteristics of these cells. In terms of specific aspects of cell fate, I am
particularly interested in identifying transcription factors that are required for the
neurotransmitter phenotype of KA and V2b cells. However, I am also interested in
determining whether the transcription factors I examine are required for specification of
global cell fate, or whether they just specify a subset of the functional characteristics of
these cells.
Neurotransmitters are small molecules that are synthesized and released by
neurons into the synaptic cleft to elicit a response in the postsynaptic neuron or another
cell. Neurotransmitters can be either inhibitory or excitatory in nature, depending on the
receptors that they bind. An inhibitory effect decreases the likelihood of the postsynaptic
cell firing an action potential, and an excitatory effect increases the chances of firing in
postsynaptic cells. Out of over 20 types of neurotransmitters currently known to be
synthesized by cells, the most abundant ones in the spinal cord are GABA
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(gamma-Aminobutyric acid), glycine and glutamate (reviewed in: Goulding, 2009). GABA
and glycine are usually inhibitory, while glutamate is excitatory. Enzymes that limit the
synthesis of any given neurotransmitter are usually characteristic of cells with that
fate/phenotype and can be used to identify cells, e.g. GABA is formed by decarboxylation of
glutamate by the enzyme glutamate decarboxylase (GAD), and GAD is therefore expressed
in all GABAergic neurons (as reviewed in: Erlander and Tobin, 1991). Markers of
GABAergic cells used in this thesis include gad1b (previously known as gad65; described in
methods section 2.5), and gad2 (previously known as gad67; described in the methods
section 2.5), and encode for GAD enzyme in zebrafish (Higashijima et al., 2004a, b).
In addition, it is important to remember that, even though usually mature cells use
predominantly one neurotransmitter as their primary signaling molecule, a cell can use
more than one neurotransmitter - for example, GABA and glycine are sometimes coexpressed by the same neurons in the spinal cord (Jonas et al., 1998; Batista and Lewis,
2008). The inhibitory action of GABA is due to hyperpolarization of the neuron membrane
mediated by reduction of calcium levels in the postsynaptic neuron, which depends on the
influx of chloride into the cell (as reviewed in: Li and Xu, 2008). However, GABA can also be
excitatory very early in development, when the concentration of chloride ions inside the
cells is higher than outside, and GABA-mediated opening of the channels causes a chloride
efflux, which leads to the elevation of calcium concentration and depolarization of
postsynaptic neuron membranes (as reviewed in: Ben-Ari, 2002).
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Figure 2. Cell trajectory and neurotransmitter phenotype of neurons found in
zebrafish spinal cord. Schematic showing morphologies and positions of cell somas and
axon trajectories of interneurons in zebrafish spinal cord (lateral view). Full lines indicate
axons that are ipsilateral, and dashed lines show axons that cross the midline of spinal
cord, becoming contralateral. Neurons that synthesize inhibitory neurotransmitters (GABA,
glycine) are shown in orange and red respectively, while excitatory (glutamatergic)
neurons are blue. Note that some morphological classes of neurons contain cells that utilize
different neurotransmitters. KA and V2b (VeLD) cells both use GABA. Figure adapted from:
Lewis and Eisen, 2003.
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Both cell populations that I am interested in, KA cells (called Cerebral Spinal Fluid
Contacting Neurons, or CSF-cNs in most other species) and V2b cells, are GABAergic in
mouse (Orts-Del’Immagine et al., 2014) and in zebrafish (Bernhardt et al., 1992). These are,
however, only two of several populations of spinal cord GABAergic neurons. In amniotes,
other GABAergic subpopulations include dI4 and dI6 and late-born dILA neurons in the
dorsal spinal cord, and V1 neurons in the ventral spinal cord (Hori and Hoshino, 2012). In
mouse, all of these dorsal populations express Pax2, Pax5 and Pax8, but Pax2 is required for
the inhibitory phenotype of only the most dorsal spinal cord cells (Pillai et al., 2007).
Similarly, in zebrafish pax2a and pax2b (orthologs of mouse Pax2), and pax8, are expressed
in most inhibitory cells within the V1 and dorsal spinal cord region (Batista and Lewis,
2008), and act redundantly in those inhibitory cells to specify the inhibitory phenotype
(Batista and Lewis, 2008). At the same time, in zebrafish pax5 is not expressed in the spinal
cord (Batista and Lewis, 2008). However, inhibitory KA and V2b cells in zebrafish do not
express the pax2a, pax2b or pax8, which suggests that a different mechanism must specify
the inhibitory phenotype of those cells. In this thesis, I will investigate whether any of three
genes expressed by V2b and KA cells, tal1, gata2a and gata3, are required for specification
of the neurotransmitter fates of these cells.
Another functional property of a neuron is its axon trajectory. Neurons can send
their axons either rostrally, which is also called an ‘ascending’ phenotype, or caudally,
which is also called a ‘descending’ phenotype (see Fig. 2, adapted from: Lewis and Eisen,
2003). Also, the axon can cross the midline of spinal cord (contralateral), or can stay on the
same side of the spinal cord, (ipsilateral). Axon trajectory is especially tractable in optically
clear zebrafish. Since the cell populations that I’m investigating have different axonal
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trajectories (KA axons are ipsilateral ascending, and V2b axons are ventral lateral
descending), it is highly unlikely that the shared transcription factors expressed by those
cells are responsible for specifying particular axon trajectories of either V2b or KA cells.
Other functional properties, such as electrophysiological properties of the cell, or
correct synapse-formation require more specialized assays and are not properties that I’m
going to investigate. Nevertheless, they are important for a neuron to become a part of a
fully functional neuronal circuit.

1.4 V2 cells
V2 cells are born from p2 progenitor domain cells. When a p2 cell divides for the last
time, it gives rise to two immature V2 cells, which then usually develop into one V2a and
one V2b cell (Kimura et al., 2008). In amniotes, immature V2 cells are characterized by the
expression of transcription factor genes gata2a and lhx3, which begin to be expressed by
late progenitor p2 cells and persist into early post-mitotic V2 cells (Zhou et al., 2000; AlMosawie et al., 2007). However, after the V2 cells begin to diversify, the binary choice
between becoming either a V2a or V2b cell is regulated by Delta-Notch signaling in both
zebrafish (Kimura et al., 2008; Batista et al., 2008) and in amniotes (Peng et al., 2007; Del
Barrio et al., 2007; Joshi et al., 2009). In amniotes, the mechanism that leads to asymmetric
activation of Delta-Notch signaling is mediated via direct binding of FOXN4 and ASCL1 to
the enhancer of Delta-like 4 (Dll4) receptor (Fig. 3, Misra et al., 2014). In amniotes, high
levels of Delta expression (and low levels of Notch) in V2a cells leads to downregulation of
Gata2 while high levels of Lhx3, and high levels of Notch in V2b cells results in upregulation
of Gata2, followed by expression of Tal1 and concurrent suppression of Lhx3 (Del Barrio et
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al., 2007; Peng et al., 2007). This leads to specification of V2a versus V2b cell fates, and a
similar mechanism is likely to exist in zebrafish as in both amniote and zebrafish spinal
cord attenuation of Delta-Notch signaling leads to overproduction of V2a cells at the
expense of V2b cells (Kimura et al., 2008; Batista et al., 2008a; Joshi et al., 2009).
Mature V2a cells are vsx1+/vsx2+/lhx3+ excitatory interneurons (Karunaratne et al.,
2002; Kimura et al., 2006). Their sister cells, V2bs are gata2a+/gata3+/tal1+ inhibitory
interneurons (Batista et al., 2008; Kimura et al., 2008; Joshi et al., 2009). While differing in
their neurotransmitter phenotype, post-mitotic mature V2a and V2b cells share a similar
ipsilateral descending axon trajectory, at least in zebrafish, in which V2a cells develop into
excitatory Circumferential Descending (CiD) interneurons (Kimura et al., 2006b), while
V2b cells develop into Ventral Lateral Descending (VeLD) interneurons (Batista et al.,
2008). In their mature form, fully developed V2a and V2b cells are intermingled in a ‘salt
and pepper’ manner and located adjacent to the p2 progenitor domain along the
dorso-ventral axis in both amniotes (Li et al., 2005) and zebrafish (Batista et al., 2008).
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Figure 3. Schematic representation of potential genetic hierarchy in amniote V2b
cells. Schematic was constructed based on interpretation of results published so far in
mouse and chicken. Arrows indicate genes that appear to be downstream of each other.
Black color represents loss-of-function experiments, and orange arrows represents
gain-of-function experiments. Pointed arrow indicates the activation of downstream genes,
and line with a circle indicates downstream gene repression. Numbers indicate studies
that are referenced by first author on the left.
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Interestingly, experiments using a Tg(vsx2:Kaede) transgenic line that labels V2a
cells show that in zebrafish these cells migrate dorsally after they form (Kimura et al.,
2006). Kaede is a protein that can be converted from green to red by a particular
wavelength of light. This can be performed at a specific time point, so cells born before the
conversion become red, while cells born after conversion time remain green (Kimura et al.,
2006). Conversion of the Kaede chromophore at 32hpf shows that cells labeled with
Tg(vsx2:Kaede) that are green are located more ventrally, while red cells are more dorsal
(Kimura et al., 2006). Therefore, older V2a cells are positioned more dorsally than younger
ones (Kimura et al., 2006). So far, it is not known whether V2b cells might also migrate
along the dorso-ventral axis once specified.
In addition, in some vertebrates additional V2 subpopulations have been described.
V2c cells in mouse are born from the p2 progenitor domain, as are V2a and V2b cells, but
they do not express Vsx2 (V2a marker) or Gata3 (V2b marker); instead, they express Sox1
(Panayi et al., 2010). V2c cells are likely derived from V2b cells, as Sox1 is upregulated
while Gata3 is downregulated in a subset of V2b cells (Panayi et al., 2010). In the absence
of Sox1 the number of Gata3+ V2b cells increases, while the number of V2a cells remains
unchanged, further suggesting that V2c cells are specified from post-mitotic V2b cells and
that Sox1 is required for their specification (Panayi et al., 2010). However, the precise
mechanism by which V2c cells are specified remains to be elucidated. Also, whether V2c
cells exist in zebrafish is currently unknown. To address this, I will investigate the
expression patterns of sox1a and sox1b, the orthologs of Sox1 in zebrafish, in this thesis.
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In addition, at least in mouse, yet another V2 population exists. V2d cells are also
born from the p2 domain, express Shox2 and contribute to central pattern generator (CPG)
activity (Dougherty et al., 2013). V2d neurons are similar to V2a neurons in that they are
also excitatory and project axons ipsilaterally (Dougherty et al., 2013). Even though some
Shox2-expressing cells express V2a marker Vsx2, about a quarter of Shox2-positive cells do
not express Vsx2 (Dougherty et al., 2013). So far, there is no evidence for presence of V2d
interneurons in other species.

1.5 KA cells
A special class of spinal cord cells that contact cerebrospinal fluid was first
described by W. Kolmer and E. Agduhr in the early 1920s and 1930s and shown to exist in
over 200 vertebrate species (as described in (Djenoune et al., 2014). The cell bodies of KA
neurons are contained within the spinal cord but they project their sensory cell tuft
(dendrites) to directly contact the cerebrospinal fluid in the central canal (Bernhardt et al.,
1990). In zebrafish, as well as in frog (Dale et al., 1987), these cerebrospinal-fluid
contacting cells are named Kolmer-Agduhr (KA) cells, after the researchers that initially
described them. In those species at least, KA cells are ciliated GABAergic cells that and have
ventrally projecting ipsilateral ascending axons (Dale et al., 1987; Bernhardt et al., 1992).
KA cells are important in locomotor behaviors. In zebrafish larva they can contribute to
central pattern generator (CPG) activity and swimming behavior, as optical stimulation of
those cells is sufficient to induce spontaneous swim-like behavior (Wyart et al., 2009).
KAs are derived from two distinct progenitor domains (p3 and pMN) and
consequently occupy distinct dorsoventral positions (Park et al., 2004). Based on those
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differences, they have been subdivided into KA” and KA’ subpopulations (Park et al., 2004).
Cell lineage tracing experiments show that more dorsally located KA’ cells originate from
the olig2-expressing pMN domain, while KA” originate ventral to this domain (Park et al.,
2004). Notch signaling is important for specification of KA’ cells – in absence of Notch
signaling primary MNs form at the expense of KA’ cells, and when there is an excess of
Notch signaling, KA’s form at expense of primary MNs in zebrafish (Shin et al., 2007). KA”
cells differentiate in the lateral floorplate (LFP) region (Schafer et al., 2007) and are
intermingled with V3 (and potentially other) interneurons. KA” differentiation is also
dependent on Notch signaling, as KA” cells are reduced in mindbomb(mib) mutants that are
deficient in Notch signaling (Kang et al., 2013), and also after early (7hpf) heatshockmediated Notch signaling ablation (Yeo and Chitnis, 2007). However, heatshock-mediated
Notch signaling ablation at later stages (10-14hpf), as well as morpholino-induced
knockdown of Notch receptor jagged2, both result in an increase of KA” and other cells
including secondary MNs (Yeo and Chitnis, 2007). Interestingly, heatshock-mediated Notch
signaling ablation at 17hpf has no effect on number of KA” cells (Yeo and Chitnis, 2007).
This suggests that the timing of Notch signaling plays a pivotal role in specifying KA” cells
from p3 cells (Yeo and Chitnis, 2007).
Even though KA” and KA’ cells differ in their dorsoventral position, many of their
properties (morphology, electrophysiological properties and molecular markers) are
similar (Yang et al., 2010; Djenoune et al., 2014). In addition, most genes that are expressed
by these cell types are expressed by both KA and V2b cells.

18

1.6 Expression profiles of known markers of V2b and/or KA
cells
Both KA and V2b cells express gata2a, gata3 and tal1 transcription factor genes in
zebrafish (Batista et al., 2008). As I analyze mutations in all three of these genes in this
thesis, here I will describe what is known about these genes in zebrafish and other
vertebrate species. Since my project investigates role of those genes in the spinal cord
development, in this introduction I will focus primarily on studies of the spinal cord and
brain. When relevant, I will also describe briefly evidence from other tissues. In addition, I
will describe tal2 as this is a homologue of tal1 (also called tal1) that is also expressed by
both V2b and KA cells. Also, Table 1 outlines known genes expressed by V2b and/or KA
cells, as well as transgenic lines used in my experiments to visualize V2b/KA cells as well as
V2a cells.
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Table 1. Genes expressed by V2b and/or KA cells. Summary of the reference genes and
transgenic lines used in this thesis to visualize V2 and KA cells. All of these genes are
expressed by the known cell populations, as described in the published literature. Note that
Tg(gata1:GFP) might not label all of the V2b cells at 24hpf, a stage at which I performed my
experiments. Also, I do not see clear labeling by the transgenic lines that label V2a cells
(Tg(vsx2:GFP), Tg(vsx2:RFP), Tg(vsx2:Kaede)) before 27hpf.
Gene name
gata3
gata2a
tal1

Cells in which expressed
KA and V2b cells
KA and V2b cells
KA and V2b cells

tal2

KA cells

gads

KA and V2b cells

Tg(gata1:GFP)

KA and V2b

Tg(vsx2:GFP)
Tg(vsx2:RFP)
Tg(vsx2:Kaede)

V2a cells
V2a cells
V2a cells

Reference
Comments
Batista et al., 2008
Batista et al., 2008
Batista et al., 2008
Pinheiro et al., 2004, Not in all V2b cells
Schafer et al., 2007
at 24hpf
Higahsijma et al.,
In a few additional
2004a, 2004b
cells at 24hpf
Not in all V2b cells
Batista et al., 2008
at 24hpf
Kimura et al., 2006
I don’t see cells
Kimura et al., 2006
labeled before
27hpf
Kimura et al., 2006
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1.6.1 Gata2a
Gata2a (GATA-binding protein 2) is a C4 finger transcription factor from the GATA
family of proteins which normally bind to a WGATAR (W = A or T and R = A or G)
consensus sequences (Merika and Orkin, 1993). It was originally found as a regulatory
sequence important in erythroid development (Yamamoto et al., 1990). It is expressed in a
variety of cell lines and tissues, including pluripotent mouse progenitor cells, mast and
megakaryocytic mouse cell lineages, endothelial cells, chicken early hematopoietic cells,
and many other animal and human cell types and tissues (as reviewed in: Orkin, 1992 and
in Burch, 2005). Gata2 has been especially widely studied in hematopoiesis, where it is
important not only in proliferation of blood-forming cells, but also in specification of blood
lineages as shown by cell culture experiments (Leonard et al., 1993; Briegel et al., 1993). It
is also important for mouse urogenital development (Zhou et al., 1998) and for specifying
mouse ventral pituitary cell types (Dasen et al., 1999). In neuroepithelial mouse cell
culture, Gata2 acts in suppressing cell proliferation and promoting exit of the cell cycle (El
Wakil et al., 1996). In mouse nervous system, Gata2 is expressed in both developing brain
and spinal cord (Zhou et al., 1998). At first, it is expressed in rhombomeres 2 and 4 of the
hindbrain, where it can be detected at day 9, and the expression in the remaining brain
parts and in the spinal cord follows soon after that (Zhou et al., 1998).
In mouse neural tube, Gata2 expression begins between 10 and 12 dpc in both brain
and spinal cord (Zhou at al., 1998). In the spinal cord, the gata2 expressing cells are
located near the ventricular zone, but the labeling with BrdU shows that very few cells that
express Gata2 are still dividing: the majority of Gata2-expressing cells are located more
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laterally than the BrdU-positive cells of the ventricular zone (Zhou et al., 2000). At the early
stage at which it was investigated (E10.5), Gata2 expression does not overlap with Nkx2.2,
but it does overlap with dorsal Lim3- positive cells (expressed dorsally by V2 and more
ventrally by MNs), and with Vsx2-expressing cells (Zhou et al., 2000), which were the only
known V2 markers at the time.
In chick spinal cord, GATA2 is present in cells located within the V2 domain, with
some of the GATA2-positive cells co-labeled with GATA3, but not by VSX2 (also known as
CHX10) (Karunaratne et al., 2002). Interestingly, the GATA2-positive cells that are not
labeled with GATA3 are localized to the more medial part of the chicken spinal cord,
especially at earlier stages, suggesting that GATA2 could potentially be expressed before
GATA3 (Karunaratne et al., 2002). A similar expression pattern is found in mouse, where
Gata2 is expressed closer to ventricular zone than Gata3 is (Nardelli et al., 1999).
In zebrafish, the teleost genome duplication led to the existence of two Gata2
paralog genes, gata2a and gata2b (Gillis et al., 2009). gata2a used to be previously known
as gata2a, and gata2b had the name zgc:91840 (ZFIN.org). These genes share only 57%
identity and 67% similarity, and they play different functions in tissues in which they’re
expressed (Butko et al., 2015). Transcription of gata2b is first detected in zebrafish at
16hpf, where it is expressed first in the posterior plate mesoderm (Butko et al., 2015).
Later gata2b expression can be detected in dorsal aorta and branchimotor neurons (at
20hpf) and in hematopoietic cells (at 50hpf and 72hpf), but at any of the investigated
stages it does not appear to be expressed in spinal cord cells (Butko et al., 2015; Lewis lab
observations). This is in contrast to gata2a, which is transcribed earlier – it is already
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expressed at 75% epiboly in ventral ectoderm (Detrich et al., 1995), and in presumptive
hematopoietic progenitors by around 3-somite stage (approx. 10.3hpf) (Detrich et al.,
1995; Li et al., 2009). gata2a is detected in posterior plate mesoderm earlier than gata2b,
at 8 somite stage (13dpf) (Li et al., 2009). Later, gata2a is also expressed in hematopoietic
and endothelial stem cells, as well as in brain and the spinal cord (Yang et al., 2007; Batista
et al., 2008; Kobayashi et al., 2010). Expression patterns of gata2a and gata2b are therefore
different – for example, gata2a is expressed throughout dorsal aorta, and gata2b
expression is limited to only the hematopoietic part of the dorsal aorta, and gata2b is not
present in the spinal cord (Butko et al., 2015). Functions of gata2a and gata2b are also
different in the circulatory system – loss of gata2a results in lack of trunk circulation and
pooling of red blood cells in the trunk (Zhu et al., 2011; Butko et al., 2015), while gata2b
morphants show normal expression of several blood cell markers, including tal1 (which is
also expressed in spinal cord cells) and gata2a (Butko et al., 2015). gata2a and gata2b may
represent a subfunctionalization of mammalian Gata2 gene functions, with gata2a being
required for vascular development, and gata2b required for correct development of
hematopoietic stem cells (HSCs) (Butko et al., 2015). Given the different expression
patterns and functions of gata2a and gata2b in zebrafish, and no apparent expression of
gata2b in zebrafish spinal cord, in this thesis I will only look at expression of gata2a and its
role in the spinal cord.

1.6.2 Gata3
GATA3 (GATA-binding protein 3) also belongs to the GATA family of transcription
factors that bind WGATAR (W = A or T and R = A or G) consensus sequences (Merika and
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Orkin, 1993). GATA3 was first identified as a protein that binds to an enhancer of Delta
gene of human T-cell receptor (Ho et al., 1991; Ko et al., 1991; Joulin et al., 1991). Since
then, it was described to play multiple roles in development, proliferation and maintenance
of T-cells, as well as innate lymphoid cells, with its important role in innate and adaptive
immunity highly dependent on the dose, developmental stage, and cell lineage (reviewed
in: Heicklen-Klein et al., 2005, in Wan et al., 2014, and in Tindemans et al., 2014).
In mouse spinal cord, Gata3 is expressed dorsally to motoneurons and ventrally to
V1 cells, by the same cells as Lhx3 and Gata2 which are markers of V2 cells (Ericson 1997,
Zhou et al., 2000). Later experiments in chicken show that GATA3 labels GATA2-positive
cells that are intermingled with cells that express VSX2, and VSX2 and GATA3 are never coexpressed in the same cells of spinal cord (Karunaratne et al., 2002). In mouse spinal cord,
GATA3 expression partially overlaps with TAL1 expression, with cells that express both
markers located more medially than GATA3+/TAL1- cells (Smith et al., 2002). Similar to
what was found in chicken, in mouse GATA3 and VSX2 expression are mutually exclusive
but cells that express those two markers are intermingled with each other (Smith et al.,
2002). Also, at least some gata3-expressing cells co-express gata2a and tal1 in zebrafish,
and these cells are intermingled with vsx2-positive V2a cells (Batista et al., 2008). In
conclusion, Gata3 is a well-established marker of inhibitory V2b cells in chicken, mouse and
zebrafish (Karunaratne et al., 2002, Smith et al., 2002, Kimura et al., 2008; Batista et al.,
2008)
In zebrafish gata3 is first expressed at 4hpf (Neave et al., 1995). During epiboly,
gata3 expression is restricted mainly to the yolk syncytial layer, deep cell blastomeres, and
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later to part of the blastula in a pattern resembling baseball stitching (Neave et al., 1995).
Later, the expression is also detected in the intermediate mesoderm that will form
pronephros, and in the pronephral ducts (Neave et al., 1995). In zebrafish central nervous
system (CNS), gata3 expression can be detected in brain and spinal cord. By 15hpf gata3 is
present in ventral spinal cord (Neave et al., 1995). At 16-somite stage gata3 is already
present in KA domains (together with tal1 but before gata2a), begins only between 18hpf24hpf (after tal1 and gata2a; Batista et al, 2008). Expression in spinal cord persists until
later stages but starts to diminish by 36hpf (Neave et al., 1995). gata3 is also expressed in
zebrafish brain, where it can be detected in ventral midbrain and diencephalon at 20hpf, as
well as in optic tectum by 48hpf (Neave et al., 1995). gata3 is also expressed in both newly
formed neurons and glia of the telencephalon after injury, where it is required for both
migration of newly born neurons and cell proliferation (Kizil et al., 2012).

1.6.3 Tal1
Tal1, (stem cell leukemia; also known as Scl or Tcl5), is a basic helix-loop-helix
(bHLH) protein that was first discovered through its important role in T-cell acute
lymphoblastic leukemia (Begley et al., 1989; Finger et al., 1989; Chen et al., 1990). Even
though the protein contains a DNA binding domain, TAL1 has been shown in zebrafish, in
embryonic stem cells and in human hematopoietic cell culture to be able to exert
transcriptional activity without necessarily binding DNA (Porcher et al., 1999; Ravet et al.,
2004). Also, in mouse TAL1 DNA-binding activity is dispensable for specification of
hematopoietic cells, but is necessary for red cell maturation, suggesting that the
mechanisms that TAL1 uses to mediate regulation of gene expression are dependent on cell

25
type and developmental process (Kassouf et al., 2008). Mechanisms that might contribute
to a DNA-binding independent action of TAL1 involve protein-protein interactions and/or
sequestration of other regulators that would otherwise inhibit developmental processes
(Kassouf et al., 2008). It is possible that TAL1 is recruited to the enhancers of the target
genes as part of a larger complex, and that the complex can not bind to DNA in absence of
TAL1. Such a mechanism is in place in erythroid cell formation, where the TAL1-FOGGATA1 complex enables expression of downstream genes (Wadman et al., 1997). Also,
another possibility is that the proteins that would normally inhibit expression of
downstream genes bind to TAL1 and are thus prevented from inhibiting gene expression.
Tal1 is essential for correct specification of all haematopoietic lineages and for
differentiation of megakaryocytes from mesoderm (Porcher et al., 1996; Gering et al.,
1998). Tal1 is also expressed in the developing nervous system, including midbrain,
hindbrain, and spinal cord (Smith et al., 2002). In mouse spinal cord, tal1 is expressed in
very late p2/early V2 cells, with the expression beginning at 10.5dpc in mouse, and fading
by 14dpc (Smith et al., 2002; Muroyama et al., 2005).
In zebrafish, tal1 is expressed in the same cells as gata2a and gata3, which includes
V2 cells but also the KA cells that are located more ventrally (Batista et al., 2008). tal1
mRNA is already present in zebrafish spinal cord at 16-somites in KA cells, but expression
doesn’t begin in the V2 domain until 18-somites (Batista et al., 2008).

1.6.4 Tal2
TAL2, like TAL1 (TAL1), is a bHLH transcription factor and it is also implicated in
T cell acute lymphoblastic leukemia (T-ALL) (Baer, 1993). It was first identified as another
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protein that is activated by the common chromosomal translocation implicated in human
T-ALL, and it is highly homologous to TAL1 (Xia et al., 1991). In mouse, Tal2 is expressed in
testes (Xia et al., 1991), as well as in developing brain tissue including midbrain,
diencephalon and anterior pons (Mori et al., 1999). Even though TAL2 mutations are
associated with T-cell tumors, Tal2 is not normally expressed in blood and mouse TAL2
mutants do not display any obvious changes in blood formation (Bucher et al., 2000).
However, mutants display widespread malformations in CNS development including
midbrain malformations, and do not survive longer than 32 days after birth (Bucher et al.,
2000).
Brain expression of Tal2 in mouse partly overlaps with expression of Gata2, Gata3
and Tal1/Tal1 (Achim et al., 2013). Interestingly, all those genes are expressed by
GABAergic neurons of the brain, but the overlap in their expression patterns differs
between specific areas of the brain. In the midbrain area, Tal2 is expressed more broadly
than Tal1 (Achim et al., 2013). The opposite is true for the neighboring rhombomere 1
region, where Tal1 is expressed more broadly than Tal2 (Achim et al., 2013). Also, in the
midbrain almost all Tal2-expressing cells are labeled by GATA2 antibody, but only very few
Tal2-expressing cells coincide with GATA3-positive cells (Achim et al., 2013). As will be
described later, those differences result in different functions of those transcription factor
genes in GABAergic neurogenesis of mouse brain (Achim et al., 2013).
In zebrafish, tal2 is also expressed in brain, but it is also present in developing spinal
cord (Pinheiro et al., 2004). So far spinal cord expression has not been reported in any
other organism. It is first detected in a few cells of head and spinal cord at 13 somite
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(15.5hpf) stage (Pinheiro et al., 2004). Expression in head proceeds from the developing
midbrain (at 22hpf), to diencephalon of the forebrain, tectum of the midbrain and
hindbrain structures (at 47hpf) (Pinheiro et al., 2004). The diencephalon and tectum
expression resemble that of tal1 (tal1) (Pinheiro et al., 2004, Sinclair et al., 1999), and are
conserved between mouse and zebrafish (Pinheiro et al., 2004; Bucher et al., 2000). Tal2 is
visible throughout the entire length of the spinal cord at 22hpf, in lateral floor plate cells,
and in more dorsal sonic hedgehog-dependent cells that are located approximately in the
V2/V1 domain (Pinheiro et al., 2004). By 44hpf, tal2 expression is already significantly
reduced in the spinal cord (Schafer et al., 2007), and no expression of tal2 in spinal cord
was detected at 47hpf (Pinheiro et al., 2004). tal2-expressing cells at 18-20 hpf do not
divide, as detected by M-phase marker PhH3, suggesting that those cells may already be
post-mitotic at this stage (Schafer et al., 2007). In addition, at 24hpf, tal2 at least partly
co-localizes with the neuronal marker Elavl3 (previously known as HuC), indicating that
some of the tal2-expressing cells are already post-mitotic neurons (Schafer et al., 2007). At
24hpf, two-thirds of the cells that express tal2 also express nkx2.9 (Yang et al., 2010). Some
of the tal2-positive cells express p3 marker nkx2.2b, which suggests that tal2 is expressed
by some p3 progenitor cells (Schafer et al., 2007). However, other researchers also show
that at 24hpf all of the tal2-expressing cells are already GABAergic (Yang et al., 2010),
which would argue against the tal2-expressing cells being progenitor cells. In addition, at
least a subset of the tal2-expressing cells develop later into V3 cells (Schafer et al., 2007). In
fact, at 44hpf a subset of tal2-expressing cells co-expresses sim1a (previously known as
sim1). sim1a is an ortholog of mouse Sim1 gene, which is a marker of V3 cells (Borowska et
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al., 2013) required for correct V3 specification (Blacklaws et al., 2015). Also, earlier at
36hpf about 25% of the tal2-positive cells also express sim1a (Yang et al., 2010).
However, the majority of cells that express tal2 in the floor plate region seem to
correspond to KA” cells, and more dorsally located cells correspond to KA’ cells (Yang et al.,
2010) and possibly other unidentified cell types. As mentioned before, all of the tal2expressing cells are GABAergic at 24hpf (Yang et al., 2010). Also, tal2 expression colocalizes with gata2a, with the majority of cells in the floor plate region expressing both
markers, but only a fraction of more dorsally-located gata2a+ cells expressing tal2 (Yang et
al., 2010). Similarly, tal2 is expressed in a number of gata3-expressing cells (Yang et al.,
2010), but it is not clear whether it’s present in all or only a subset of them. Overall, these
results suggest that tal2 is expressed in at least a subset of p3 cells, KA” and KA’ cells,
possibly other GABAergic cells, and later in V3 cells in the floor plate region.

1.7.1 Interactions between TAL1, GATA2, GATA3, and TAL2 in the CNS
The role of TAL1 in amniotic spinal cord was extensively tested in mouse and chick,
but has not been investigated in zebrafish spinal cord prior to this thesis research. In
amniotes, TAL1 is expressed at the same time as GATA3 in a subset of mouse spinal cord
cells (Smith et al., 2002), which raises possibility that those two proteins might interact in
those cells. At 11.5dpc, TAL1+/GATA3+ cells are located more medially, while TAL1/GATA3+ cells are restricted to the more lateral edges of the spinal cord (Smith et al.,
2002), which suggests that Tal1 may stop being expressed by V2b cells earlier than Gata3
and may be upstream of Gata3. Since TAL1 null mutant mice lack blood cells and die early
at E8.5 (Porcher et al., 1996), a special nerve-tissue specific knockout line was constructed
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to test the function of TAL1 in mouse spinal cord (Muroyama et al., 2005). The resulting
experiments show that nerve tissue-specific ablation of Tal1 results in loss of Gata3
expression in V2 cells (which was not associated with cell death), and significant
attenuation of Gata2 expression (Muroyama et al., 2005). It’s important to note that gata2a
attenuation in mouse could result from the mosaic nature of tissue-specific tal1 ablation,
and gata2a might be completely lost if non-mosaic V2 cell Tal1 deletion was possible. In
addition, the same study revealed that Tal1 ablation results in dorsal expansion of Olig2expressing pMN cells, and Olig2 mutation results in expansion of Tal1, Gata2 and Gata3,
suggesting that Tal1 and Olig2 cross-repress each other (Muroyama et al., 2005).
Also, in chicken spinal cord overexpression of full length mouse TAL1 results in
suppression of endogenous VSX2-expresion by V2 cells, and ectopic expression of GATA3
(Fig. 3; Muroyama et al., 2005). This suggests that TAL1 may be sufficient to potentially
change V2a cells to V2b cells in chicken embryos (Muroyama et al., 2005). Taken together,
these results suggest that with respect to V2b cells in amniote spinal cord, Tal1 is both
sufficient and required for Gata3+ V2b development, and is required for maintenance of
normal levels of Gata2 expression (Muroyama et al., 2005).
Mutant Gata2 mice investigated at the early (E10.5) stage show a reduction in both
Vsx2 and more dorsal Lim3, suggesting that Gata2 is required for formation of V2 cells (Fig.
3; Zhou et al., 2000). Also, in mouse Gata3 is expressed outside of the ventricular zone (as
opposed to Gata2 which is present closer to ventricular zone), and its expression might
depend on presence of Gata2, as in Gata2 mutants Gata3 cannot be detected, at least in
whole mount embryos that were analyzed (Fig. 3; Nardelli et al., 1999). In addition, a very
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recent study performed in mouse (Fig. 3; Francius et al., 2014), confirms that Gata2 is
required for formation of normal numbers of both V2a (Vsx2-positive) and V2b (Gata3positive) cells in mouse spinal cord, as the expression of each of these markers is reduced
by about 60% in Gata2 mutant embryos. In addition, use of conditional Cre-induced
knockdown in a Gata2loxp/loxp mouse, which removes the start codon of Gata2, shows that
Gata2 is crucial for consolidation of the V2a/V2b fate, as many cells express both Vsx2 and
Gata3 simultaneously in the spinal cord of E12.5 mouse when Gata2 is knocked down at
E9.5 (Francius et al., 2014). However, it seems that Gata3-expressing neurons still form in
large numbers in Gata2 conditional knockout mice, which is a different result to the Gata2
complete knockout mouse reported earlier (Zhu et al., 2000), and the above study
(Francius et al., 2014). Unfortunately, Gata3-expresing cells in the conditional knockout
were not counted, and it is not clear how many cells still express this marker (Francius et
al., 2014). Overall, this suggests however that Gata2 is required for correct development of
both V2a cells and V2b cells in mouse, and that Gata2 is upstream of Gata3 in mouse spinal
cord. The function of Gata3 in the mouse mutant spinal cord has not been investigated so
far.
Overexpression experiments in chicken also show that ectopic GATA2 expression is
sufficient to induce GATA3 expression while reducing the expression of VSX2 by V2 cells, as
well as reducing the number of ISLET1-expressing MNs in the chicken spinal cord (Fig. 3,
Karunaratne et al., 2002). In addition, the same study shows that overexpression of GATA3
can result in ectopic expression of GATA2, this effect is, however, less prominent. The
expression patterns of GATA2 and GATA3, together with these overexpression experiments,
suggest that in chicken GATA2 is upstream of GATA3 in the V2 cell domain and that once
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expressed, GATA3 can either induce or maintain the expression of GATA2 in vivo
(Karunaratne et al., 2002). Interestingly, both Gata2 and Gata3 have 5’ sequences that
would potentially be able to bind proteins of the GATA family, supporting the idea of a
possible ‘feedback loop’(Karunaratne et al., 2002).
During brain development in mouse, Gata2 is required for specification of
GABAergic neurons in the midbrain (Kala et al., 2009), and both required and sufficient for
specification of serotonergic neurons in rhombomere 1 of the hindbrain (Craven et al.,
2004). It is also required for normal development and correct migration of optic tectum
cells in rat brain (Willett and Greene, 2011). In chick midbrain and hindbrain, Gata2
expression precedes that of Tal1 and Gata3, suggesting that Gata2 might be upstream of the
other two genes in chick brain (Herberth et al., 2005). This suggests that the hierarchies of
those transcription factors differ between the amniote spinal cord and brain. In fact, recent
research shows that interactions between GATA- family transcription factors and TALtranscription factors within mouse brain may be tissue-dependent. Formation of midbrain
GABAergic neurons seems to be differently regulated between specific subpopulations of
cells (Achim et al., 2013).
In midbrain, Tal2 expression seems to be Gata2a-independent, while Tal1expression is affected by loss of Gata2 in midbrain (and not affected in the rhombomere 1),
as shown in gata2flox/flox conditional knockout (Achim et al., 2013). In Tal2 knockout mouse
midbrains, Gata3 and Gad1 are still present but downregulated, whereas Gata2 expression
persists fully (Achim et al., 2013). This expression of Gata2 remains unaffected even in
Tal2/Tal1 double knockout embryos, but in those embryos expression of Gad1 and Gata3 is
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completely gone (Achim et al., 2013). In addition, expression of glutamatergic markers
PAX6 and Slc17a6 are upregulated in Tal2 single knockout, and Tal2/Tal1 double knockout
embryos, suggesting that TAL-factors, especially TAL2, are crucial for the correct
specification of GABAergic cells in mouse midbrain (Achim et al., 2013). Overall, in the
mouse midbrain, where Gata2 seems to be required for formation of all GABAergic neurons
in that region, requirement for Tal2 in specification of GABAergic cells seem to be varied
between different midbrain sub-regions, and it could be potentially explained by partial
redundancy with Tal1 (Achim et al., 2013). Since the expression patterns vary between
different regions of the brain, it remains to be elucidated whether Tal2 is required for
formation of other GABAergic cells in the brain, and in the spinal cord.
In zebrafish, roles of gata2a, gata3 and tal1 in V2b cells of spinal cord remain
unclear. Preliminary data in zebrafish gathered by a previous student in the lab, Jeffrey
Jacobstein, suggests that tal1 might be upstream of gata3, but not of gata2a, in zebrafish
spinal cord (Jeffrey Jacobstein, MSc dissertation, 2008). He observed that in tal1 mutant
fish, gata3 is significantly reduced, while gata2a expression remains unaffected. However,
when I started my research, this result still needed to be confirmed, and it was not known
whether loss of tal1 affects gata3 in all of the cells that express it, or just a subset of them.
In my research, I repeat these experiments, and test the functions of tal1 in V2b and KA
cells using tal1 mutant zebrafish.
In addition, I also test the functions of gata2a and gata3 in specifying KA and V2b
cells. Functional analysis of those transcription factor genes was previously investigated by
a different lab using morpholino antisense knockdown experiments, as discussed below.
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However, since the results were surprising and using morpholinos can produce nonspecific effects, I decided to further test the functions of these genes in mutant embryos.
The function of tal2 was also tested by this other group using a knockdown morpholino
approach (as discussed below), but currently there is no zebrafish mutant available to
confirm these results.

1.7.2 Functional analyses of gata2a, gata3 and tal2
Surprisingly, evidence from another study performed in zebrafish suggests that
gata2a and gata3 act differently in KA” cells versus KA’ cells (Yang et al., 2010).
Knockdown of gata2a using morpholinos resulted in a loss of KA” cells and what appeared
to be normal numbers of KA’ cells, while the opposite was true for gata3 morphants, in
which KA’ cells did not form and KA” cells formed in what appeared to be normal numbers
(as detected with tal2 and gad67 at 24hpf in both cases; cells were not counted in either
case) (Yang et al., 2010). In contrast, knockdown of tal2 had no effect on expression of
either gata2a or gata3 in KA cells (Yang et al., 2010).
Interestingly though, tal2 knockdown via morpholino injections resulted in a loss of
the GABAergic phenotype in KA” cells, with the KA’ and V2b GABAergic phenotype
remaining unaffected (Yang et al., 2010). Given that, as mentioned above, injections with
this morpholino do not affect gata2a (and gata3) expression in any of the cells (Yang et al.,
2010), but injections with gata2a abolish tal2 expression in KA” cells, these results suggest
that tal2 is downstream of gata2a or acts in an independent pathway to specify the
GABAergic phenotype of the cells.
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Since morpholinos are known to sometimes have non-specific binding off-target
effects, or induce apoptosis (Eisen and Smith, 2008), I decided to re-confirm these results
using mutants. In addition, I examined the roles of gata2a and gata3 in V2 cells as this was
not addressed by this previous study. Finally, I also used many more markers of KA and
V2b cells than this previous study, which used only two molecular markers to look at KA
cells, tal2 and gad. These additional markers enable me to assess whether KA cells require
either gata2a or gata3 for either their global fate specification or for their GABAergic
phenotype.

1.7.3 Mutant alleles
The tal1 mutant used in this study, tal1t21384 (Bussmann et al., 2007; kindly provided
by Dr. Varga at University College of London, UK) carries a nonsense mutation at amino
acid 183, leading to deletion of the C-terminus of the protein, including the entire bHLH
domain (also see Fig. 4). This suggests that it might be a null mutant. The mutation results
in abnormal vessel formation between somites, loss of tal1 expression in erythroid cells
and reduction in tal1 spinal cord expression; all abnormal phenotypes can be rescued by
injecting wild-type tal1 mRNA (Bussmann et al., 2007).
The gata2um27 mutant used in this study was kindly provided by Dr. Lawson at
University of Massachusetts Medical School, MA, US. It was created with zinc-finger
nucleases and results in a 10bp deletion that leads to a protein truncation upstream of both
zinc finger domains (Zhu et al., 2011; also see Fig. 4). The mutant phenotype includes
defects in morphogenesis of dorsal aorta, and loss of trunk blood circulation (Zhu et al.,
2011).
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The gata3sa0234 mutant used in this study was generated using zinc-finger-nucleases,
and kindly provided by Dr. Steven Harvey at Wellcome Trust Sanger Institute, UK. The
mutation causes deletion followed by an insertion at position 264aa, which leads to
addition of 13 extra amino acids before reaching the stop codon (personal communication
and my sequencing results). This causes only 8 amino acids of the first zinc finger domain
to remain intact, and completely removes the second zinc finger from the truncated
protein.
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Figure 4.
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Figure 4. Schematics showing location of gata2aum27, tal1t21384 and gata3sa0234
mutations. Numbers indicate amino acid positions of particular protein domains. DNAbinding domains are indicated in red (zinc finger domains) or yellow (bHLH domain). (A)
gata2aum27 mutation is a 10bp deletion that leads to a premature stop codon. If a protein is
still made it will not contain either of the two zinc finger domains normally present in
Gata2a (Zhu et al., 2011). (B) tal1t21384 mutation is an AT change that leads to formation
of premature stop codon. If the protein is still made, it will not contain the bHLH DNAbinding domain (Bussmann et al., 2007). (C) gata3sa0234 is a small deletion and insertion
that leads to formation of a premature stop codon before the two zinc finger domains
(unpublished, courtesy of Dr. Harvey and Dr. Stemple at Wellcome Trust Sanger Institute,
UK).
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1.8 Discovering novel candidates that may be expressed by V2
and/or KA cells
In addition to analyzing the functions of tal1, gata2a and gata3 in V2b and KA cells, I
was also interested in finding new potential markers of these cells. I was particularly
interested in finding genes that are expressed solely by either V2b or KA cells, because at
least when I started my project there were only a few transcription factor genes known to
be expressed by these cells, and all of them were shared between both populations.
Literature in other organisms suggested that foxn4 and sox1a/sox1b are expressed by V2
cells, but it was not known whether KA cells and V2b cells in zebrafish also express these
genes. In the following sections, I will outline the current knowledge about expression
patterns of these genes and about their role in the spinal cord development.

1.8.1 foxn4
Foxn4 (Forkead box N4) is a forkhead helix-loop-helix transcription factor that is
expressed in mouse eye and spinal cord during embryonic development (Gouge et al.,
2001). It is required for correct specification of particular cell types in the eye (Li et al.,
2004). In mouse spinal cord, Foxn4 is expressed in a subset of p2 progenitor cells, and a
small subset of Foxn4 cells also co-expresses Gata2 and Tal1 (Li et al., 2005; delBarrio et al.,
2007). Later, it was also shown that Foxn4-expressing cells give rise to all V2 cells in mouse
spinal cord (Li et al., 2010; Misra et al., 2014; Panayi et al., 2010). In mouse spinal cord,
Foxn4 acts upstream of Tal1, as Foxn4 null mutants show loss of Tal1 expression, while
Tal1 knockout mice have normal Foxn4 expression (Li et al., 2005; Del Barrio et al., 2007).
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Also, early studies in chicken indicated that foxn4 on its own may not be sufficient to
specify V2b cells (Li et al., 2005), but later experiments show that overexpression of Foxn4
is sufficient to induce Gata3, Gata2 and Tal1 in chicken embryos, while suppressing Vsx2
expression, suggesting that Foxn4 is sufficient for V2b formation, at the expense of V2a cells
(Del Barrio et al., 2007). This study suggests that Foxn4 is both sufficient and required for
V2b formation in amniotes (Li et al., 2005; Del Barrio et al., 2007).
In addition, Foxn4 is expressed in mitotically active cells that express Notch ligand
delta-like 4 (Dll4) in mouse, and is often found in pairs of cells that presumably have
recently undergone division (Del Barrio et al., 2007). A Foxn4 null mutation in mouse
causes loss of Dll4 expression, and studies in chicken show that electroporation of Foxn4
causes ectopic expression of Dll4, suggesting that Foxn4 is both required and sufficient for
Dll4 expression (Del Barrio et al., 2007). It is possible that the Foxn4 and Delta-Notch
signaling participate in a regulatory loop that specifies V2b cells, as electroporation of Dll4
in chicken embryos causes an increase in Foxn4 and Gata2 expression, while attenuating
the number of Vsx2-positive cells (Misra et al., 2014). Also, Notch signaling plays a crucial
role in V2a/V2b division in both mouse and zebrafish, with Notch signaling being required
for correct V2b specification (Del Barrio et al., 2007; Peng et al., 2007; Batista et al., 2008).
In absence of Foxn4, more V2a cells form and V2b cells are reduced in number (Del Barrio
et al., 2007; Peng et al., 2007; Misra et al., 2014). Taken together, these results suggest that
FOXN4 may be a ‘master regulator’ of V2b versus V2a cell face in p2 progenitor cells and
that it may exert its influence through Dll4 and Notch/Delta signaling.
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In zebrafish, foxn4 is already expressed at the one cell stage, with early expression
being presumably maternally derived (Danilova et al., 2004). Expression of Foxn4
continues but gradually decreases during early development (Danilova et al., 2004). Later,
at 10hpf foxn4 is expressed in the forebrain, and by 19hpf midbrain structures also express
foxn4 (Danilova et al., 2004). At 22hpf foxn4 continues to be expressed in the retina,
olfactory placode, and various parts of the brain including the area where cranial
motoneurons form (Danilova et al., 2004), but from looking at photographed embryos in
this study I think it might also be in anterior ventral spinal cord neurons at this stage.
Expression in the head continues until at least 7dpf (Danilova et al., 2004). foxn4 is also
expressed in the atrioventricular canal of heart between 24hpf-72hpf, where is required
for correct formation of this structure, as shown by morpholino-induced knockdown
experiments (Chi et al., 2008). In zebrafish spinal cord, expression of foxn4 has only been
described by the one study which indicates that at 18hpf, foxn4 is expressed in spinal cord
cells that express vsx1 corresponding to very late p2 or very early V2a/V2b cells (Kimura et
al., 2008; Supplementary Material). foxn4 is expressed often in neighboring pairs of cells,
and sometimes remains in only one of the cells out of the pair, which is suggested to
become in future a V2a cell (Kimura et al., 2008). However, some of the Tg(Vsx1:GFP) pairs
of cells express vsx1 but do not express foxn4, suggesting that foxn4 expression might be
transient and perhaps it could be downregulated before vsx1 (Kimura et al., 2008).
In this thesis, I will examine the expression of foxn4 in zebrafish spinal cord over
time, and try to identify cells that express this gene. I will also test whether any of the tal1,
gata2a or gata3 mutants affect the expression of foxn4 in zebrafish spinal cord.
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1.8.2 sox1a and sox1b
Zebrafish sox1a and sox1b are orthologs of mouse Sox1, and belong to the SOX family
of transcription factors. Sox genes were first described in the mammalian genome and are
divided into distinct groups based on their sequence similarity (Schepers et al., 2002). SoxB
members share 85% sequence similarity within their DNA-binding domains, and the
evolutionarily conserved SoxB1 group consists of Sox1, Sox2 and Sox3 (Harley et al., 1994;
Bowles et al., 2000). In Drosophila, chicken and Xenopus, orthologs of these genes are
expressed in neural primordium cells and are thought to play important role in
specification and determination of neural cells (as described in Kan et al., 2004). In
chicken, members of the SoxB1 family play an important role in interpretation of the
morphogen signal in both the limb bud and neural tube (Oosterveen et al., 2013). For
example, one of SoxB1 family members (Sox3) appears to be sufficient to give mesodermal
cells the potential to respond to morphogens and later express transcription factor genes
that form neurons (Oosterveen et al., 2013).
In mouse, Sox2 and Sox3 are expressed very early in development and are thought to
contribute to maintenance of neural progenitor cells while inhibiting neurogenesis (Bylund
et al., 2003; Graham et al., 2003). Sox1 is expressed later than other SoxB1 members, at the
beginning of the formation of neural plate, and is required for formation of GABAergic cells
in several mouse brain structures (Malas et al., 2003), as well as being sufficient for
neuronal differentiation of cells from the P19 cell line (Pevny et al., 1998). Also, SOX1 is the
only SoxB1 transcription factor that promotes neurogenesis via several different
mechanisms, including binding inhibition of Notch signaling (binding to Hes1), suppressing
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beta-catenin mediated signaling, promoting pro-neural neurogenin1 expression and
promoting exit from the cell cycle in cell culture (Kan et al., 2004). However, although Sox1
seems to be downregulated in majority of post-mitotic cells, it is still expressed in scattered
cells in several adult brain structures (Malas et al., 2003; Kan et al., 2004).
In mouse spinal cord during early developmental stages (i.e. E9.5), Sox1 is expressed
in the ventricular zone (VZ), and not in post-mitotic differentiated cells (Pevny et al., 1998;
Genethliou et al., 2009). However, at later stages starting from E10.5 and peaking at E12.5,
Sox1-expressing cells are present in the differentiated cell domain (Panayi et al., 2010). The
origin of these cells can be traced to the progenitor p2 domain, as some of the Sox1expressing cells overlap with Foxn4-iCre_Rosa26stopYFP –expressing cells (Panayi et al.,
2010). Furthermore, Sox1-expressing cells seem to have once expressed Gata3 (as
demonstrated by using GATA3-eGFP transgenic mouse) (Panayi et al., 2010). Overall, this
suggests, that in mouse an additional group of V2 cells (V2c cells) might exist, which
derives from V2b cells (Panayi et al., 2010). This remains to be confirmed in other
organisms.
In this thesis, I have investigated expression patterns of Sox1 orthologs, sox1a and
sox1b in zebrafish, and examined whether their expression depends on presence of gata2a,
gata3 and/or tal1.

1.8.3 Other markers (found from microarray & literature)
In this thesis, I will also briefly describe the expression pattern of several
transcription factors that have been identified by other lab members as being potential
candidate markers of either V2b and/or KA cells. Those markers have been found either
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from literature sources or via microarray analyses performed by the lab, which profiled the
expression pattern of V2b/KA cells versus other cells in the spinal cord, using microarrays
that contained at least most transcription factors in the zebrafish genome. Some of these
(sox1a/sox1b/foxn4) are also included as KA and V2b markers in my mutant studies.
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2. Methods
2.1 Fish husbandry
Adult zebrafish (Danio rerio) were maintained on a 14 hours light/10 hours dark
cycle. Embryos were collected and maintained in Embryo Medium (EM: 5mM NaCl, 0.17mM
KCl, 0.33mM CaCl2.2H2O, 0.33mM MgSO4.7H2O + 10g HEPES/liter). For all experiments,
embryos were staged by hours post-fertilization at 28.5°C) or position of lateral line
primordium over the somites (e.g. 24hpf=prim5 (Kimmel et al., 1995)). Occasionally,
embryos were grown at 25°C or 32°C to achieve desired stages at particular times. In these
cases developmental stages were calculated and confirmed with morphological criteria as
described in Kimmel et al., 2005.

2.2 Fish lines
Wild-type embryos were obtained by mating wild type adults (AB, TL, or AB/TL
hybrids). Transgenic embryos were obtained by mating heterozygous carriers of
Tg(8.1kGata1:eGFP) (Kobayashi et al., 2001) and homozygous/heterozygous Tg(vsx2:GFP),
Tg(vsx2:Kaede), Tg(vsx2:RFP) (Kimura et al., 2006) fish. Mutant embryos were obtained
from matings of heterozygous gata2aum27 (Zhu et al., 2011), gata3sa0234 (unpublished fish
line kindly provided by Dr. Steven Harvey at Sanger Institute, Cambridge, UK) or tal1t21384
(Bussmann et al., 2007) mutants. Adult gata2a and gata3 mutant carriers (heterozygous
fish) were identified by fin-clipping and PCR, followed by a restriction enzyme digest
and/or sequencing whenever appropriate. Adult tal1 mutation carriers were identified by
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the above method or by the observation of the morphological phenotype in approximately
25% embryos (assumed to be homozygous mutants). The mutant morphology includes
curved tails, smaller eyes, heart edema and no blood circulation in the trunk of embryos at
around 48hpf (Bussmann et al., 2007).

2.3 Embryo fixation
All embryos were fixed in 4% paraformaldehyde (PFA; Sigma-Aldrich cat. # P6148)
overnight at 4°C or for 4 hours at room temperature with shaking. Embryos that were to be
used for antibody staining were washed out of 4% PFA with PBST (PBS (PBS, SigmaAldrich, cat. # P4417) + 0.1% Tween 20 (Sigma-Aldrich, cat. # P1379)) 2 x 5 minutes and
2 x 10 minutes and stored at 4°C in PBST. Embryos for in situ hybridization (ISH) were
washed out of 4% PFA with PBST 2 x 5 minutes and 2 x 10 minutes, followed by
dehydrating in 100% methanol (Fisher Scientific, cat. # BP1105) for 2 x 5 minutes and 2 x
10 minutes, and stored at -20°C in 100% methanol. Embryos that were used for in situ
hybridization followed by immunohistochemistry (ISH+IHC) were washed 2 x 5 minutes
and 2 x 10 minutes with PBST. Then these embryos were permeabilized with proteinase K
10μg/ml (Roche, cat. # 03115879001) diluted in distilled water for 24 minutes. The
embryos were then fixed in 4% PFA for 20 minutes to inactivate the proteinase K, and 4%
PFA was washed off with PBST for 2 x 5 minutes, 2 x 10 minutes. Finally the embryos were
equilibrated in 50% cheap hybridization buffer/50% PBST. Cheap hybridization buffer is
50% formamide (Sigma-Aldrich, cat. # F9037) plus 50% 5x SSC (from a 20x SSC stock
which is 3M sodium chloride (Sigma- Aldrich, cat. #S5886) + 0.3M tri-sodium citrate
(Sigma- Aldrich, cat. # W302600) and 0.1% Tween 20. The embryos were then equilibrated
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in 100% cheap hybridization buffer and stored -20°C for less than a week in hybridization
buffer (cheap hybridization buffer + 500 μg/ml yeast RNA (Roche, cat. # 10109223001) +
50 μg/ml heparin (Sigma-Aldrich, cat. # H3393), final pH 6.0).

2.4 Plasmid preparation
All plasmids were purified using Qiagen’s QIAfilter Plasmid Midi Kit, (cat. #12243)
according to the manufacturer’s instructions. Cells from a 150 ml (high copy plasmid) or
250 ml (low copy plasmid) culture of an E. coli transformant were lysed by alkaline lysis.
The protein precipitate was separated using the filter provided in the kit.
The cleared filtered solution containing the DNA was then applied to an anion exchange
column. After several wash steps the plasmid DNA was eluted from the column and
precipitated using isopropanol. The pellet, obtained by high speed centrifugation, was
washed with 70% ethanol, air dried, resuspended in dH20 and stored at -20°C.

2.5 Probe preparation
All probes were prepared to recognize genes described in the zebrafish community
database (zfin.org). References to the gene ZFIN identifier number, and to the reference for
each probe can be found in Table 2.
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Table 2. Gene names and ZFIN identifiers. ZFIN identifiers (middle column) are
provided for each of the genes used in this thesis along with common previous names. The
column on the right provides the references for the RNA probes used for in situ
hybridization experiments.
Gene name

ZFIN ID

References for probe

gata2a (previously called gata2) ZDB-GENE-980526-260

This thesis

gata3

ZDB-GENE-990415-82

This thesis

tal1 (previously called scl)

ZDB-GENE-980526-501

(Peng et al., 2007)

tal2

ZDB-GENE-040115-1

(Pinheiro et al., 2004)

foxn4

ZDB-GENE-990415-277

(Danilova et al., 2004)

sox1a

ZDB-GENE-040718-186

(England et al., 2014)

sox1b

ZDB-GENE-060322-5

(England et al., 2014)

gad2 (previously called gad65)

ZDB-GENE-030909-9

(Higashijima et al., 2004)

gad1b (previously called gad67) ZDB-GENE-030909-3

(Higashijima et al., 2004)

slc32a1 (previously called viaat) ZDB-GENE-061201-1

(Kimura et al., 2006)

nkx6.1

ZDB-GENE-040718-178

(Cheesman et al., 2004)

nkx6.2

ZDB-GENE-070626-1

(Hutchinson et al., 2007)

dbx1b

ZDB-GENE-000128-11

(Seo et al., 1999)

dbx2

ZDB-GENE-000128-13

(Seo et al., 1999)

insm1a

ZDB-GENE-040426-1810 (England et al., 2014)

crb1

ZDB-GENE-050208-382

(England et al., 2014)

her6

ZDB-GENE-980526-144

(England et al., 2014)

mnx1

ZDB-GENE-040409-1

(England et al., 2014)

sp8a

ZDB-GENE-030131-9849 (England et al., 2014)
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Probes were synthesized using template from either a Polymerase Chain Reaction
(PCR) product or linearized plasmid DNA (Table 2, Table 3), followed by a probe reaction.
For PCR, primers were designed by myself or other members of the Lewis lab and obtained
from Integrated DNA Technologies, and the following reaction was carried out to obtain the
template:

PCR mix:
dH20

27.25μL

5x Phusion HF Buffer

10μL

cDNA

5μL

dNTPs

1μL

Dimethyl sulfoxide (DMSO) 1.25μL
Forward primer (10mM)

2.5μL

Reverse primer (10mM)

2.5μL

Phusion DNA polymerase

0.5μL

Total volume

50μL

PCR conditions:
94°C

3 minutes

94°C

30seconds

56.5°C

30 seconds

72°C

90 seconds

72°C

10 minutes

x35

2.5μL of the PCR reaction was run on a 1% TAE agarose gel at 125 mV for 45 minutes.
If the PCR resulted in a product was of the correct size, the remaining PCR mix volume was
increased to 200μL with dH2O. DNA was extracted using equal volume of
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Phenol:Chloroform:Isoamyl Alcohol followed by equal volume of Chloroform:Isoamyl
Alcohol. After each step, aqueous layer was removed and transferred to fresh tubes,
vortexed for at least 20 seconds, and centrifuged for 5 minutes at 13500rpm. Finally, the
DNA was precipitated by adding 1/10 volume of 4M sodium chloride and 2 x volume of
ethanol and placing the reaction at -20oC overnight or longer. After spinning the reaction at
13,500 rpm for 30 minutes, the supernatant was removed and the pellet was washed with
70% ice cold ethanol. Finally, I resuspended the DNA in 20μL of dH2O.
When using plasmid DNA to prepare probe template, plasmid DNA in excess of 1μg
of insert DNA was linearized with the appropriate restriction enzyme (Table 3). All
restriction endonucleases were obtained from New England Biolabs or Roche Diagnostics
Ltd. A 20μl reaction included 2μl buffer, DNA to give required concentration, dH20 to make
up the volume and 0.5 μl enzyme (or 1 unit/μg DNA). The reaction mix was put at 37°C for
2 hours then treated with proteinase K (0.05μg/μl) for 30 minutes at 37oC. DNA was
extracted with phenol chloroform followed by chloroform and cut DNA was precipitated
with ethanol and salts (1/10 volume of 4M NaCl + 2 volumes of ethanol) by placing the
solution at –20°C overnight or longer, then centrifuged at maximum speed for 30 minutes
and resuspended in dH2O.
Probe reactions were conducted in 20μl total volume containing linearized DNA
equivalent to 1μg insert DNA, 2μl of 10X digoxigenin-UTP from DIG RNA Labeling
Mix (Roche cat. # 11277073910) or 2μl of 10X fluorescein-UTP from Fluorescein RNA
Labeling mix (Roche cat. # 11685619910) nucleotide mix, 2μl transcription buffer (40
units of the appropriate RNA polymerase (see Table 3), T7 RNA Polymerase (New England
Biolabs, cat. # M0251S), T3 RNA Polymerase (Roche cat. # 11031171001), SP6 RNA
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Polymerase (Roche cat. # 10810274001) and RNAse free dH2O. The reaction mixtures were
put at 37°C for 2 hours, then 40 units DNAse I (Roche, cat. # 04716728001) were added
and incubated for 15 minutes. This reaction was stopped with 2μl of 200 mM EDTA pH 8.0
(Sigma-Aldrich, cat # E5134). RNA was precipitated with 2.5μl 4M LiCl (Sigma-Aldrich,
L9650) and 75μl pre-chilled ethanol at –20°C overnight. The solution was then centrifuged
at maximum speed for 30 minutes at 4°C and re-suspended in 100μl RNAse free water
containing 40 units RNAse inhibitor. 2.5 μl of this was electrophoresed in 1x TAE buffer at
180 mV for 7 minutes to check that a reasonable quantity of RNA had been synthesized and
had not degraded. Then 400μl of hybridization buffer (50% formamide; 50% 5x SSC; 0.1%
Tween 20; 500 μg/ml yeast tRNA + 50 μg/ml heparin final pH 6.0) was added to the rest of
the RNA solution (probe) before storing at –20°C.
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Table 3. Restriction enzymes, primer sequences and RNA polymerases used to
prepare in situ hybridization probes used in this thesis. Reagents that were used for
making each of the in situ hybridization probes used in this thesis are listed. RNA
polymerases are listed in each case. When PCR primers were used for making in situ
hybridization probes, each forward and reverse primers are shown. Whenever plasmid
constructs were used, restriction enzymes used to linearize the plasmid are provided.
Gene name

Polymerase

PCR primers

gata2a

T3

gata3

T3

insm1a

T3

crb1

T3

her6

T3

mnx1

T3

sp8a

T3

Gene name

Polymerase

Restriction enzyme

tal1

T7

SalI

tal2

T3

EcoRI

foxn4

T3

XhoI

sox1a

T3

XhoI

sox1b

T3

HindIII

gad2

T3

EcoRI

gad1b

T3

EcoRI

slc32a1

T3

XhoI

nkx6.1

T7

XbaI

nkx6.2

T7

NotI

dbx1b

T7

BamHI

dbx2

T7

BamHI

GTGAGGGTTTCGAGGAGCTC
AATTAACCCTCACTAAAGGGAAGCAACATCGCCTTGGCTAG
CTGCTACCTCCAATCTCCCAC
AATTAACCCTCACTAAAGGGACAACCATTCAGTCTGCATTACATAAAG
GCGAAATAAGAAAGCGACACCTG
AATTAACCCTCACTAAAGGGATAAGTCCCGGCGAGCTATAAAAC
TACTCAAGACCTCAACACTCTGC
AATTAACCCTCACTAAAGGGAACATTCACTGACGTCTACCTCAC
ACCAGTTGAACTCGGGACAC
AATTAACCCTCACTAAAGGGAGGAATCAAAAAGGCGAACTG
TCCATATCCTCCTCTTCCGACAG
AATTAACCCTCACTAAAGGGATGTCATTGGTTCGTTCATCCTCAG
ACACAGAACCCGTCCAGAAC
AATTAACCCTCACTAAAGGGAGCGCTTTTAACCTCCAGATG
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2.6 in situ hybridization and immunohistochemistry
procedures
2.6.1 Single in situ hybridization
Embryos (including some for antibody pre-absorption) were rehydrated through a
MeOH/PBS series: 5-10 minutes each in 75:25 50:50 25:75 and 100% PBST. Embryos
fixed at 24 h or older stages were treated with proteinase K at 10μg/ml for the length of
time that was pre-determined as most suitable by other lab members (our Proteinase K
stock solutions are calibrated each time a new stock is made), or for 1-2 minutes longer in
cases where staining had been weak in previous experiments and I wanted to check if more
permeabilization would improve probe penetrance. The following times were normally
used: 22hpf embryos 12 minutes, 24hpf embryos 24 minutes, 27hpf embryos 27 minutes,
72hpf embryos (for preabsorption of antibody) 1 hour (also see Table 4). Then all embryos
were re-fixed in 4% PFA for 20 minutes and washed 2 times for 5 minutes and 1 time for
10 minutes in PBST. All embryos were equilibrated in 50% cheap hybridization buffer
(50% formamide; 5x SSC; 0.1% Tween 20): 50% PBST. They were then equilibrated in
100% cheap hybridization buffer. This was replaced with fish hybridization buffer (cheap
hybridization buffer + 500 μg/ml yeast tRNA + 50 μg/ml heparin, final pH 6.0) in which
embryos were pre-hybridized at 70°C for at least 4 hours. Embryos were hybridized with
RNA probes (1:20000 dilution of the synthesized probe) in hybridization buffer overnight.
Probes in hybridization buffer solution were placed at 70°C for at least one hour before use.
Washes were also prepared and placed at 70°C overnight to equilibrate to temperature
(70°C). On the next day the embryos were washed at 70°C with 1 ml of the following
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solutions: 2 times with cheap hybridization buffer for 5 minutes each; 1 time with 50%
cheap hybridization buffer: 50% 2x SSC for 5 minutes; 3 times with 2x SSC for 20 minutes
each; 2 times with 0.2x SSC for 20 minutes each; 1 time with 0.1x SSC for 20 minutes; 3
times with PBST 5 minutes each. The embryos were then washed with 1 ml of PBST at
room temperature and incubated with sheep in situ block (PBST + 2 mg/ml BSA (SigmaAldrich -Aldrich, cat. # A7906) + 5 % sheep serum (Sigma-Aldrich, cat. # S2263) + 1%
DMSO (Sigma-Aldrich -Aldrich, Cat. # D5879)) for 1 hour at room temperature. Sheep antiDig AP conjugated antibody (Roche, cat # 11093274910), which had previously been
added to permeabilized embryos and preabsorbed over night at 4C in sheep in situ block,
was then added to the experimental embryos at a concentration of 1/2000 and incubated
for two hours at room temperature. The embryos were then washed 8 x 15 minutes with
PBST and left washing over night at 4oC in PBST. Next morning the embryos were washed 3
times in NTMT (0.1 M NaCl + 0.05M MgCl + 0.1M Tris pH 9.5 + 0.1% Tween 20, all diluted
in dH2O) buffer and stained with 20 μl of NBT/BCIP stock solution (Roche, cat. #
11681451001) per ml of NTMT. To stop the staining reaction, embryos were washed twice
for 5 minutes and then twice for a minimum of 10 minutes in NTMT, followed by being
washed twice for 5 minutes and then twice for a minimum of 10 minutes in PBST.
Embryos were then kept in PBST at 4oC for short-term storage and or in PBST+azide
for long-term storage. For photography, embryos were passed through a glycerol series
(30% glycerol in PBS; 50% glycerol in PBS; 70% glycerol in dH2O). However embryos that
needed to be genotyped were kept in PBST and then put straight into 70% glycerol in dH20
after being genotyped, before counting cells and photographing.
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Table 4. Permeabilization times used for in situ hybridization and
immunohistochemistry experiments in this thesis. Permeabilization times at room
temperature with proteinase K (10μg/ml) times are stated for in situ hybridization
experiments. Permeabilization times at -20°C with acetone are stated for
immunohistochemistry experiments. All stages are shown in hours post-fertilization
(hpf), and all times are shown in minutes (mins).
Stage of embryo (hpf)

Incubation with Proteinase K
at 10μg/ml (mins)

less than 24hpf

10 mins

24 hpf

24 mins

27 hpf

27 mins

30 hpf

30 mins

36 hpf

36 mins

72hpf and older
(for preabsorption)

60 mins

Stage of embryo (hpf)

Acetone permeabilization (mins)

24 hpf

12 mins

27 hpf

18 mins

30 hpf

21 mins

36 hpf

25 mins

48 hpf

30 mins
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2.6.2 Double fluorescent in situ hybridization
For double fluorescent in situ hybridization, both RNA probes (one digoxigenin and
the other fluorescein labeled) were hybridized simultaneously and the protocol was
initially the same as for single in situ hybridization (see above). However before incubation
with blocking solution, embryos were treated with Image-iT FX Signal Enhancer
(Invitrogen, cat. # I36933), by removing all PBST from the embryos and adding 2 drops of
Image-iT FX Signal Enhancer and incubating at room temperature for 30 minutes.
The embryos were then washed with PBST twice for 5 minutes, and once for 10 minutes.
Embryos were then incubated with goat in situ blocking solution (1x PBST + 2 mg/ml BSA +
5% goat serum (Sigma-Aldrich, cat. # G6767) + 1% DMSO diluted in PBST) for 1 hour at
room temperature. The embryos were then incubated with the primary antibodies Mouse
anti-Dig (1/5000, Jackson ImmunoResearch, West Grove PA, cat. # 200-002-156) and
Rabbit anti-Flu (1/2500, Molecular Probes, cat # A889) simultaneously for 4 hours at room
temperature. The embryos were washed in PBST 8 x 15 minute intervals and left washing
over night at 4°C in PBST. One of the primary antibodies was detected with Anti-MouseHRP or Anti-Rabbit-HRP (both from Invitrogen TSA kit number 5 cat. # T20922 and kit
number 12 cat. # T20915, respectively) at a concentration of 1/200 in blocking solution
during a 5 hour incubation period at room temperature. The embryos were again washed
in PBST 8 times for 15 minutes and left washing over night at 4°C in PBST.
The next morning embryos were then incubated 10 minutes with amplification
buffer (Invitrogen TSA kits mentioned before) and then incubated for 52 minutes with
Alexa Fluor 488 (Invitrogen TSA kit number 12 cat. # T20915) or Alexa Fluor 594
(Invitrogen TSA kit number 5 cat. # T20922) tyramide reagents at a concentration of 1/100
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diluted in amplification buffer with 0.0015% hydrogen peroxide. The embryos were then
washed with PBST 8 times for 15 minutes. The HRP antibody from the first antibody
staining was then inactivated before starting the second antibody incubation, by treating
the embryos for 30 minutes with 3% hydrogen peroxide in PBST. After the inactivation
step the embryos were washed with PBST 8 times for 15 minutes and left over night at 4°C
in PBST. On the following morning the embryos were incubated with the complementary
antibody to the previous reaction, either Anti-Mouse-HRP or Anti-Rabbit-HRP (both from
Invitrogen TSA kit number 5 cat. # T20922 and kit number 12 cat. # T20915, respectively)
for 2 hours at room temperature. The embryos were washed 8 times for 15 minutes and
then left washing over night at 4°C in PBST. Finally, the next morning the staining
procedure with the tyramide reagent was repeated as described above with the other Alexa
reagent. The embryos were washed for 8 times for 15 minutes with PBST at room
temperature and then all the PBST was removed and 2 drops of DABCO were added to
protect the embryos’ fluorescence from quenching. Embryos were mounted in DABCO for
photography and analysis on a compound microscope and/or confocal microscope. Yolks
were always removed from embryos for further analysis and photography.
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2.6.3 Immunohistochemistry
Embryos stored at 4°C in PBST (or PBST + sodium azide if stored for longer than 2
weeks) and were washed 3 times with PBST. The embryos were then incubated with
distilled water for 5 minutes at room temperature, then incubated with acetone at -20°C for
the time indicated in Table 4, and then incubated again with distilled water for 5 minutes at
room temperature. The embryos were then washed in PBS for 5 minutes and treated with
Image-iT FX Signal Enhancer (Invitrogen, I36933), by removing all PBS from the embryos
and adding 2 drops of Image-iT FX Signal Enhancer to the embryos and incubating at room
temperature for 30 minutes. The embryos were then washed with PBS twice for 5 minutes,
and once for 10 minutes. The embryos were incubated with goat antibody blocking
solution (2% goat serum, 1% BSA, 2% DMSO, 0.2% Triton-X in PBS) for 1 hour at room
temperature. Then a primary antibody diluted in goat antibody block at the appropriate
concentration was added to the embryos and incubated for 5 hours at room temperature.
The embryos were then washed 8 times every 15-20 minutes with PDT (2% DMSO; 0.1%
triton-X in PBS). The embryos were left washing over night at 4°C in PDT. The next
morning, the secondary antibody diluted in goat antibody block at the appropriate
concentration was added to the embryos and incubated for 5 hours at room temperature.
The embryos were then once again washed 8 times every 20 minutes with PDT and finally
all the PDT was removed from the embryos and they were stored in DABCO (Acros
Organics, AC11247-1000).
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2.6.4 Single fluorescent in situ hybridization followed by
immunohistochemistry
This protocol is similar to the double fluorescent in situ hybridization protocol
described above, however, before the first antibody incubation and staining was
inactivated with 3% hydrogen peroxide in PBST, the immunohistochemistry procedure
was started. A primary antibody was added to the embryos (usually chicken anti-GFP
(Abcam, ab13970) diluted 1:1000) in goat antibody block solution (PBS + 2% DMSO + 1%
BSA + 2% goat serum + 0.2%Triton-X (Sigma-Aldrich, cat. # X100)) and incubated for 5
hours at room temperature. The embryos were then washed at least 8 times for 15 minutes
each with PDT (PBS + 2% DMSO + 0.1% Triton X) over a period of two hours. The embryos
were left washing over night at 4°C in PDT. The next morning the secondary antibody was
added to the embryos (usually a Goat Anti-Rabbit Alexa 488 diluted 1:1000 in goat
antibody block solution) and incubated for 5 hours at room temperature. The embryos
were then once again washed 8 times every 15 minutes with PDT and finally all the PDT
was removed from the embryos and they were stored in 2 drops of Vectashield Mounting
Medium (Vector laboratories H-1000).

2.6.5 Use of antibodies in immunohistochemistry
GFP was detected with Rabbit Anti-GFP (Molecular Probes, A-6465), or Chicken
anti-GFP (Abcam, ab13970). Kaede was detected with Rabbit Anti-Kaede (MBL
International Corporation (cat. # PM012), RFP was detected with Living Colors antimCherry antibody (Clontech, 632496). All of the above primary antibodies were used at a
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(1/1000) concentration. The primary antibodies used in this work were revealed using
complementary combinations of the following secondary antibodies:
Alexa-Fluor Goat-Anti-Chicken 488 (1/1000) from Invitrogen Corp., (cat. # A11039);
Alexa-Fluor Goat-Anti-Rabbit 488 (1/1000) from Molecular Probes (cat. # A11034);
Alexa-Fluor Goat-Anti-Mouse 488 (1/1000) from Molecular Probes (cat. # A11029);
Alexa-Fluor Goat-Anti-Rabbit 568 (1/1000) from Molecular Probes (cat. # A11036);
Alexa-Fluor Goat-Anti-Mouse 568 (1/1000) from Molecular Probes (cat. # A11031).

2.7 Genotyping
For the first part of research leading to this thesis I used one DNA isolation method,
and later I used the second method. Both methods are described below, and I have used
the new method since 28th November 2014. I verified that the new method worked as well
as the older method by testing the same samples side by side but since the newer method
was much more reproducible (PCR worked with newer method much more frequently than
with the older one), as well as being more time-efficient, easier and requiring fewer
reagents, I then switched to always using it.

2.7.1 Fin-clipping adult zebrafish
Adult fish were placed into tricaine solution and approximately one-third of the
caudal fin was clipped off.
Older method of DNA isolation: Fins were placed in lysis buffer (10 mM Tris-HCl, pH
8.2, 10 mM EDTA, 200 mM NaCl, 0.5% SDS, 200 µg/ml proteinase K in dH20) + 100 µg/ml
Proteinase K and incubated at 55ºC for 2 hours. The Proteinase K was inactivated by
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heating to 90°C for 10 minutes. The debris was centrifuged for 10 minutes at 13500rpm,
and the supernatant transferred to a new tube. The DNA was precipitated by adding 200μL
isopropanol at -20°C overnight. Next day, the solution was centrifuged at 4°C for 30
minutes. The pellet was washed with 70% ethanol and centrifuged for another 20 minutes
at 4°C. The DNA was resuspended in 100μL dH2O and stored at -20°C. Supernatant was
transferred to fresh tubes, and stored at 4°C (short-term) or at -20°C (long-term) and 3μL
of this was used for a PCR reaction.
New method of DNA isolation: Fins were placed into 100μL 50 mM sodium
hydroxide and incubated at 90°C for 20 minutes. Tubes were cooled by placing them on ice
for 10 minutes, followed by adding 10 μL (1/10 volume) 1M Tris-HCl, pH 7.4 to neutralize
the sodium hydroxide and centrifuged at 13500rpm for 10 minutes at room temperature.
Supernatant was transferred to fresh tubes, and stored at 4°C (short-term) or at -20°C
(long-term) and 0.5-1μL of supernatant was used for a PCR reaction.

2.7.2 Tissue extraction from individual zebrafish embryos
Embryos were placed in 70% glycerol on a glass coverslip and part of the tissue was
carefully removed usually from head, but sometimes from tail region. Procedure to extract
DNA from tissue was very similar to that described above for fin-clipping, with following
exceptions: In the newer method, 20μL of 50 mM sodium hydroxide was used for
incubation at 90°C, and 1M Tris-HCl was reduced to 2μL. As with fin-clips, 3μL of
supernatant extracted with older method, and 0.5-1μL of supernatant from newer method
was used for a PCR reaction.
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2.7.3 PCR protocols
2.7.3.1 gata2a
Primers used:
Forward: 3254- gata2genoFOR: AATTCTGCACAGAGGGGCGTGAATGTGTG

(Tm = 64.2˚C)

Reverse: 3255- gata2genoREV: GTACAGGCCGCACGCGTTGCAGA

(Tm = 66.4˚C)

PCR mix:
10xTaq buffer

2μL

50mM MgCl₂

1μL (old protocol) or 0.6μL (new protocol)

10mM dNTPs

0.5μL

10μM Fwd primer

1μL

10μM Rev primer

1μL

H₂0

to 20 μL

Taq Polymerase

0.1μL

DNA

0.5-3μL (usually 1μL with new protocol)
Total: 20μL

PCR program used:
98˚C 1 minute
94˚C 30 seconds
65˚C 45 seconds

x35

72˚C 45 seconds
72˚C 5 minutes
The resulting PCR product was run on a high resolution 2% SFR gel (Amresco, J234-100G)
for at least 60 minutes at 60 mV, and the resulting bands were 108bp for wild-type, and
98 bp for mutant (Fig. 5; as described in: Zhu et al., 2011).
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Figure 5.
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Figure 5. Genotyping gata2aum27, tal1t21384 and gata3sa0234 mutants. (A) gata2aum27
mutation results in 10bp deletion, which produces a 98bp PCR band (mutant) in
comparison to 108bp PCR band (wild-type). Bands are separated on a 2% SFR agarose gel.
(B) tal1t21384 mutation produces a DdeI restriction site, which after PCR amplification and
restriction enzyme digestion produces 180+20bp cut bands (mutant), in comparison to
180bp uncut band (wild-type). The 20bp fragment is too small to see on a 2.5% agarose gel.
(C) gata3sa0234 ‘method 1’ protocol inserts the BserI restriction enzyme site into the wildtype sequence after a nested PCR. Digestion with BserI enzyme produces 233+300bp bands
(wild-type), as opposed to uncut 533 band (mutant) visible on 1% agarose gel. As shown in
figure, some bands are ambiguous and in these cases PCR products were sequenced to
confirm the genotype. (D) gata3 ‘method 2’ protocol takes advantage of Hinf1 restriction
enzyme site present in the wild-type, but removed after mutation (which is a deletion
followed by an insertion). Digestion results in 159bp+81bp bands (wild-type), as opposed
to uncut 240bp band (mutant). All PCR bands are visible on a 2% SFR agarose gel. (E)
Example of sequencing result after using gata3sa0234 ‘method 1’ protocol. Upper panel
shows the wild-type sequence, in which BserI restriction enzyme cutting site is introduced
by the first primer set of the protocol. Lower panel shows the mutant sequence, in which
the BseRI restriction site is not introduced. Second PCR in this protocol adds M13(-21)
primer site which enables efficient sequencing.
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2.7.3.2 tal1
Primers used:
Forward:

tttcatgcgcatatccaaaa (Tm = 50.7˚C)

Reverse:

gaaaatccgtcgcacaactt (Tm = 53.9˚C)

PCR mix:
10xTaq buffer

2μL

50mM MgCl₂

1μL

10mM dNTPs

0.6μL

10μM Fwd primer

1μL

10μM Rev primer

1μL

H₂0

to 20μL

Taq Polymerase

0.1μL

DNA

0.5μL-3μL (usually 1μL with new protocol)
Total: 20μL

PCR program used:
94˚C 3 minutes
72˚C 5 minutes
94˚C 30 seconds

x35

54˚C 45 seconds
72˚C 30 seconds
Digest:
10xCutsmart buffer

2μL

H₂0

13.6μL

DdeI enzyme (10 000 U/μL)0.3μL
DNA(PCR product)

4μL
Total: 20μL
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The resulting digested product was run on a 2.5% agarose gel for 60 minutes at 80mV, and
the resulting bands were 180bp for wild-type, and 160bp+20bp for mutant (Fig. 5; as
described in: Bussmann et al., 2007).

2.7.3 gata3
gata3 mutants were genotyped using two separate protocols. The first protocol was
developed by Henry Putz, and involved a nested PCR that produces a final product of
533bp, which can be cut into 2 fragments of 233bp and 300bp length (wild-type), or
remain uncut (mutant). However, the BseRI enzyme used in this method is not always
effective, so this method can produce ambiguous results (Fig. 5, details described above). In
these cases, we re-confirmed the results by sequencing the PCR products. The sequencing
method is reliable, but overall it makes the experiment time-consuming and expensive.
To avoid this issue, Dr. Santanu Banerjee developed a method that is faster and does not
need sequencing. The final PCR product is 240bp in length, and it will be cut with Hinf1
enzyme into 159+81bp (wild-type), or will not be cut (mutant). After incubation for at least
6 hours at 37°C, the digest can be easily resolved on gel 2% SFR agarose (run for 60
minutes at 80 mV) in 0.5 x TBE (Fig. 5).
Primers used:
Method 1
10030 Forward 1:

tgtttagatccagcgcattg (Tm = 53.3˚C)

10031 Reverse 1:

tgtccctgatgaatggcata (Tm = 53.6˚C)

10026 Forward 2:

tatgtaaaacgacggccagtagtgcgactcttcagcctgt (Tm = 67.7˚C)

10027 Reverse 2:

tacaggaaacagctatgactgacacctgcgcttggcgag (Tm = 68.5˚C)
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Method 2
11341 Forward 1:

GGTTGTGTAGTTGTGCTTGC (Tm = 53.3˚C)

11342 Reverse 1:

TTCTGTCCGTTCATCTTGTG (Tm = 52.6˚C)

PCR Mix:
Method 1
PCR1:

PCR2:

10xTaq buffer

2μL

10xTaq buffer

2μL

50mM MgCl₂

1μL

10mM dNTPs

0.6μL

10mM dNTPs

0.6μL

10μM Fwd primer

1μL

10μM Fwd primer

1μL

10μM Rev primer

1μL

10μM Rev primer

1μL

H₂0

14.3μL

H₂0

11.3μL (heads)

Taq Polymerase

0.1μL

DNA (1:3 diluted PCR1)

1 μL

OR 14.3 μL (fins)
Taq Polymerase

0.1μL

DNA

3μL (fins) OR 1μL (heads)
Total: 20μL

Total: 20μL
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Method 2
PCR:
10xTaq buffer

2μL

50mM MgCl₂

1μL

10mM dNTPs

0.5μL

10μM Fwd primer

1μL

10μM Rev primer

1μL

H₂0

to 20μL

Taq Polymerase

0.1μL

DNA

3μL (fin) OR 1 μL (heads)
Total: 20μL

PCR programs used:
Method 1
PCR1:
94˚C 3 minutes
94˚C 30 seconds
52˚C 30 seconds

x35

72˚C 75 seconds
72˚C 5 minutes
PCR2:
98˚C 1 minute
94˚C 30 seconds
58˚C 45 seconds
72˚C 30 seconds
72˚C 5 minutes

x35
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Method 2
98˚C 1 minute
94˚C 30 seconds
58˚C 45 seconds

x35

72˚C 30 seconds
72˚C 5 minutes

Digest:
Method 1
For Method 1, the amount of PCR product used in the digest was varied between
experiments to maximize the efficiency of the enzyme. Concentration of DNA was
estimated depending on the brightness of the band in a PCR gel and usually the amount
was chosen to be around 200ng. Ambiguous results were always confirmed with
genotyping (M13(-21) forward primer). Original recommendations from Henry Putz were
to use 10 l of PCR product in a 20l reaction.

Method 2
Hinf1 enzyme

0.3 l

10xCutsmart buffer

3 l

H₂0

21.7 l

DNA (PCR product)

3μL
Total: 30μL

69

2.8 Imaging
Photographs were taken using an Zeiss Axio Imager M1 compound microscope or a Zeiss
LSM 710 confocal microscope and processed using Adobe Photoshop and ImageJ software.
Most images are projections of multiple focal planes, unless otherwise stated.

2.9 Cell counts and row numbers
In all cases, cell counts are for both sides of a 5-somite length of spinal cord adjacent to
somites 6-10. Cell row numbers are assigned ventral to dorsal (e.g. cells directly above the
notochord are in row 1). Error bars show standard error of the mean (SEM). Results were
analyzed using the students’ T test. All statistical analyses was performed using Microsoft
Excel. When appropriate, the following symbols were used to denote significance found
level found by the Student’s t-test (Table 5).
Table 5. Symbols used to indicate different p-values. All p-values were obtained from
the Student’s t-test. NS (not significant) test results are not denoted on graphs. All other
values were represented by the stars as shown here.
NS

p ≥ 0.05

*

p < 0.05

**

p < 0.01

***

p < 0.001
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2.10 Nomenclature for gene, mutant and protein names
The nomenclature for gene and protein names throughout this thesis is consistent
with current guidelines for each organism. The basic nomenclature rules are outlined in
Table 6.
Table 6. Nomenclature guidelines. Summary of nomenclature guidelines for gene and
protein names for specific organisms. Rules are illustrated for a fictional gene/protein ABC.
Gene symbols are always italicized, while protein symbols are not italicized. Rules about
capital letters differ between organisms. When I refer to a protein or gene in more than one
animal, I use just one of these conventions (usually the mouse or human). Current as of
November 2015.
Organism

Gene symbols
(always italicized)

Protein symbols
(not italicized)

Reference

Zebrafish

Lowercase
(e.g. abc)

Only first letter
uppercase (e.g. Abc)

zfin. org

Frog

Lowercase
(e.g. abc)

Only first letter
uppercase (e.g. Abc)

www.xenbase.org

Mouse

Only first letter
uppercase
(e.g. Abc)

All letters uppercase
(e.g. ABC)

www.informatics.jax.org

Rat

Only first letter
uppercase (e.g. Abc)

All letters uppercase
(e.g. ABC)

rgd.mcw.edu

Chicken

All letters uppercase
(e.g. ABC)

All letters uppercase
(e.g. ABC)

birdgenenames.org

Humans

All letters uppercase
(e.g. ABC)

All letters uppercase
(e.g. ABC)

www.genenames.org
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3. Results
3.1 Identifying and characterizing the expression of genes that
label V2 and/or KA cells in zebrafish embryos
3.1.1 Investigating the relative numbers of KA’, KA’’ and V2b cells
3.1.1.1 Expression of gata2a, gata3 and tal1
As mentioned in the introduction, gata2a, gata3 and tal1 are expressed in KA and
V2 cells in zebrafish spinal cord (Batista et al., 2008). To characterize in detail where these
cell types are located dorso-ventrally in the spinal cord, I performed in situ hybridization
with all three of these genes at 24hpf (Fig. 6A-C). I then counted how many cells were
present in the region of the spinal cord adjacent to somites 6-10, on both sides of the spinal
cord, in each dorsal-ventral row from the most ventral row just above the notochord (row
1) until there were no more labeled cells. As shown in Fig. 7, my cell counts show that at
24hpf, tal1, gata2a and gata3 are primarily expressed in rows 1-5, with very occasional
cells found in row 6. This is consistent with these markers being expressed by both of the
KA subpopulations (KA’ and KA’’; probably all cells in rows 1 and 2 and some cells in row 3;
Batista et al., 2008), as well as V2b cells (probably some cells in row 3 and almost all cells
more dorsal; Batista et al., 2008). This established an expression profile that I could then
compare to, to establish whether other genes are also expressed in V2 cells and/or KA cells.
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Figure 6.
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Figure 6. Genes expressed by V2b and/or KA cells in the wild-type embryos at 24hpf.
Lateral views of zebrafish spinal cords at 24hpf. (A-C) show expression of established
genes expressed by both V2b and KA cells, gata3, gata2a and tal1, respectively (D) tal2 is
expressed by KA cells and only some V2b cells (E, F) sox1a and sox1b respectively are
expressed in KA and V2b cell domains (G) gads label GABAergic cells. All panels show the
merged view of several planes from one side of the spinal cord from the compound
microscope. Scale bar: 50μm
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Figure 7. Number of cells that express established V2b and KA genes in wild-type embryos at 24hpf. Graphs shows
average number of cells in each row labeled by in situ hybridization for different genes (represented by different colors). This
data is a compilation of all the genotyped wild-type embryo cell counts from incrosses of heterozygous mutants (from at least
2-3 separate experiments). Lines above the bars indicate the expected positions of KA”, KA’ and V2b cells in the zebrafish
spinal cord based on current knowledge.
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Table 7. Number of cells labeled by in situ hybridization experiments in wild-type embryos. Numbers represent average
values of cells labeled by in situ hybridization experiments in genotyped wild-type embryos. This data is a compilation of all
the genotyped wild-type embryo cell counts from incrosses of heterozygous mutants (from at least 2-3 separate experiments).
Number of embryos counted is indicated in the last column. Numbers represent average ± SEM.
1

2

8

gata3 20.75±0.45 8.75±0.59 15.38±0.42 11.38±0.73 6.13±0.44 1.75±0.31

0

0

64.13±0.67 19.25±0.53

n=8

gata2a 20.4±0.43

0

0

64.2±0.88

n=10

2.17±0.41 0.25±0.13

0

62.83±1.16 21.33±1.1

n=12

0.67±0.25

0

0

50.53±0.89 10.2±0.82

n=15

14.1±0.69

4

12.7±0.56

tal1

20.33±0.45 8.42±0.72

12.75±0.3 11.92±0.34

tal2

21.07±0.46 9.33±0.42

9.87±0.6

5.73±0.45

5

5.5±0.37
7±0.73
3.8±0.37

6

0.8±0.25

TOTAL

19±0.6

sox1a 20.93±0.35 8.57±0.48

12.43±0.5 10.93±0.45 8.07±0.58 3.57±0.44

0.5±0.14

0

sox1b 21.17±0.63

12.67±0.74 9.58±0.51 6.08±0.43 2.33±0.26 0.92±0.34

0

61.75±1.19 18.92±0.89 n=12

3.33±0.47 10.33±0.39 1.93±0.21

0

15.6±0.25 12.27±0.44 n=15

foxn4
gads

0

9±0.66
0

21.3±0.56 10.75±0.51 13.67±0.61 12.58±0.71 7.25±0.43

0
3.83±0.8

0

65±1.23

4+

n
values

7

10.7±0.56

3

23.21±0.91 n=14

1.33±0.48 2.5±0.48 73.42±1.48 27.5±1.11

n=12
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My cell counts in the region of the spinal cord adjacent to somites 6-10 in wild-type
embryos suggest that at 24hpf the largest number of cells that express all three gata3,
gata2a and tal1 genes are located in row 1 (Fig. 7, Table 7, also see Fig 6A-C). gata3 is
expressed by an average of 20.75 cells, gata2a by an average of 20.4 cells, and tal1 by an
average of 20.3 cells (Fig. 7, Table 7). These results show that at 24hpf there are about 21
KA” cells in the region of spinal cord adjacent to somites 6-10. There are fewer labeled cells
in row 2 where KA’ cells are located, with an average of 8.75 cells expressing gata3, 10.75
cells expressing gata2a and 8.4 cells expressing tal1(Fig. 7, Table 7). The slightly larger
number of gata2a-expressing cells in this row compared to other markers suggests that
gata2a might be expressed slightly earlier in KA’ cells than tal1 and gata3. Row 3 probably
corresponds to a mixed population of V2b and KA’ cells, as KA’ cells can also be found in
row 3, although they are still located medially and are in contact with central canal (Dr.
Claire Wyart, personal communication; Djenoune et al., 2014; my cell counts discussed
later and shown in sections 3.2.1.2 and 3.2.1.3). In row 3, more cells express gata3, (15.3
cells), followed by gata2a (14.1 cells), and tal1 (12.7 cells) (Fig. 7, Table 7; also Fig. 6 A-C;
13A-C, 15A-C; 19A-C). Expression of all of these genes is approximately equally distributed
between medially located cells (KA’) and more laterally positioned cells (V2b), suggesting
that KA’ and V2b cells form in similar numbers in this row (As discussed later in chapters
3.2.1.1 and 3.2.1.3). This suggests that the overall number of KA’ cells is slightly smaller
than number of KA”s (approximately 18 versus 21). Alternatively, KA’ cells may be born
later than KA” cells, in which case some KA’ cells may not yet express the investigated
genes at 24hpf. Rows 4 and above contain no KA cells based on our current knowledge, and
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all of the cells labeled by tal1, gata2a and gata3 in these dorsoventral rows should be V2b
cells (Batista et al., 2008). Similar numbers of cells express all three markers in row 4 (Fig
7, Table 7). An average of 11.3 cells express gata3, 12.7 cells express gata2a, and 11.9 cells
express tal1 (Fig. 7, Table 7). Row 5 contains less V2b cells, with gata3 being expressed by
only around 6.1 cells, gata2a by 5.5 and tal1 by 7.25 cells (Fig. 7, Table 7). Only occasional
cells are labeled by these genes in row 6, with no more than 3 cells labeled by either of the
genes (Fig. 7, Table 7). These results provide a reference point for the approximate
numbers of KA and V2b cells present in this region of zebrafish spinal cord at 24hpf
throughout the rest of this thesis.
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3.1.1.2 Expression of tal2
As discussed in the introduction, tal2 is expressed by at least some KA cells and also
by other cells, some of which are likely to be V2b cells, whereas others may be p3 or V3
cells in the lateral floor plate (Pinheiro et al., 2004; Schafer et al., 2007). This data does not
clearly establish whether this gene is expressed by all KA and V2b cells. Therefore, I
performed tal2 in situ hybridizations and compared the number of cells that express this
gene in each dorsal-ventral row with the number of cells labeled with known KA/V2b
markers. My cell counts suggest that at 24hpf tal2 is expressed by a similar number of cells
to those expressing gata3/gata2a/tal1 in row 1 (Fig. 8, Table 7). At this developmental
stage, V3 cells have probably not yet formed (Schafer at al., 2007), which could explain why
there are not more cells that express tal2 in this row. Similarly, in row 2 an equivalent
number of cells express tal2 as express other KA’ markers (Fig. 8, Table 7). However, in
rows 3 and above, tal2 is expressed by far fewer cells than those expressing gata3, gata2a
and tal1. In row 3 around 9.8 cells express tal2, compared to 12.7-15.4 cells labeled by tal1,
gata2a and gata3. The difference is even more prominent dorsal to row 3, with tal2 only
being expressed by around half of the cells that are labeled by other markers (Fig. 8, Table
7). This leads me to conclude that even though tal2 is expressed by both KA cell
populations and probably by all KA cells, it is only expressed by a small subset of V2b cells.
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Figure 8. Number of cells that express tal2 in wild-type embryos at 24hpf. Graph shows average number of cells in each
row labeled by in situ hybridization for different genes (represented by different colors). tal2 is expressed by KA cells and
some V2b cells (Pinheiro et al., 2004; Schafer et al., 2007). This data is a compilation of all the genotyped wild-type embryo
cell counts from incrosses of heterozygous mutants (from at least 2-3 separate experiments). Lines above the bars indicate the
expected positions of KA”, KA’ and V2b cells in the zebrafish spinal cord based on current knowledge.

80

3.1.1.3 Expression of sox1a and sox1b
As mentioned in the introduction, Sox1 is expressed in early spinal cord progenitor
cells (Pevny et al., 1998), but also in post-mitotic spinal cells in mouse (V2c cells, Panayi et
al., 2010). To investigate whether sox1a and sox1b, zebrafish orthologs of mouse Sox1, are
expressed by V2 cells in zebrafish I performed in situ hybridization for each of these genes
at 24h and compared the number and location of labeled cells to the expression patterns of
tal1, gata2a and gata3. Interestingly, I found that sox1a and sox1b are expressed not only in
the V2 domain but also in KA domains (Fig. 9, Table 7). The spinal cord expression patterns
of sox1a and sox1b are very similar to each other, and to that of other KA and V2b markers
(tal1, gata2a and gata3). In rows 1 and 2, similar numbers of cells express each of these
sox1 genes, and similar numbers of cells are labeled by tal1, gata2a and gata3 (Fig. 9, Table
7). In row 3, the average number of cells that express sox1a (12.4), and sox1b (12.6), is
closest to the number of tal1-expressing cells (12.75) than to that of other V2b/KA
established markers which are expressed in more cells (Fig. 9, Table 7). This suggests that
both tal1 and sox1 genes may be expressed later in row 3 cells, or not in all cells. In row 4,
sox1a and sox1b are expressed by only approximately 1-2 cells less than other V2b
markers. Interestingly, in rows 5 and 6, similar number of cells expresses sox1b to the
number expressing tal1, gata2a and gata3, but sox1a is expressed by approximately 1-3
cells more (Fig. 9, Table 7). Occasional sox1a and sox1b-expressing cells can also be found
in row 7, which is more dorsal than expression of the other markers.
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Figure 9. Number of cells that express sox1a and sox1b in wild-type embryos at 24hpf. Graph shows average number of
cells in each row labeled by in situ hybridization for different genes (represented by different colors). This data is a
compilation of all the genotyped wild-type embryo cell counts from incrosses of heterozygous mutants (from at least 2-3
separate experiments). Lines above the bars indicate the expected positions of KA”, KA’ and V2b cells in the zebrafish spinal
cord based on current knowledge. Both sox1a and sox1b appear to be expressed by a similar number of KA and V2b cells as the
established KA and V2b genes, and potentially be a few more V2b cells in most dorsal rows.
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To further confirm that sox1a and sox1b are expressed by KA and V2b cells I
performed double labeling experiments with the Tg(gata1:GFP) line that labels V2bs and
KAs in zebrafish spinal cord (Batista et al, 2008). Even though gata1 is not normally
expressed in zebrafish spinal cord (Detrich et al., 1995), the Tg(gata1:GFP) line used in this
study labels gata3-expressing KA and V2b cells (Batista et al., 2008). Most likely,
Tg(gata1:GFP) is missing a repressor element that would normally prevent gata1 from
being expressed in a similar way to other spinal cord gata genes – gata2a and gata3, or it
could act as an enhancer trap (Batista et al., 2008). However, it seems that at 24hpf, the
stage at which my experiments were performed, Tg(gata1:GFP) labels only a small subset
of V2b cells. This might be due to delay in the labeling of the cells by GFP. In the region of
the spinal cord that I usually analyze I could only identify about 5-10 GFP-expressing V2b
cells on the basis of their dorsoventral position and characteristic axon trajectory.
Therefore, we cannot exclude that additional cells that do not co-localize with
Tg(gata1:GFP)-positive cells are V2b cells not labeled at this stage by this transgenic line.
However, the results of my in situ hybridization followed by GFP immunohistochemistry
staining experiment still help us to understand the identity of the sox1a- and sox1bexpressing cells. As shown in Fig. 10, both sox1a-expressing and sox1b-expressing cells colocalize with Tg(gata1:GFP) cells. In fact, when I analyzed three representative embryos for
each experiment and counted the number of cells that co-localize, I discovered that all of
the GFP-positive Tg(gata1:GFP) most ventral cells (corresponding to rows 1, 2, and to a
lesser extent row 3) also express sox1a (Fig. 7A, Table 7), and sox1b (Fig. 7B, Table 7). This
demonstrates that all KA cells express both sox1a and sox1b at 24hpf.
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However, the identity of the more dorsal sox1-expressing cells is less clear. All of the
more dorsal Tg(gata1:GFP) GFP-positive cells also express sox1a (Fig. 10A), and sox1b (Fig.
10B), showing that at least a subset of the dorsal sox1-expressing cells are V2bs. There are,
however, many sox1a or sox1b-positive cells at a similar dorsoventral position that do no
co-express Tg(gata1:GFP). My analyses show that the number of non GFP-positive cells that
express sox1a is on average 16, while on average 10 cells express sox1b but not GFP (Table
8). The difference in these numbers probably reflects the fact that generally sox1a labels a
few more cells than sox1b at this stage, as indicated by cell counts in single in situ
hybridization experiments on wild-type embryos (Fig. 9; Table 7). These non-GFP cells
could be additional V2b cells (that don’t yet express Tg(gata1:GFP), V2c cells if such cells
exist in zebrafish spinal cord, another spinal cord cell type or a combination of these.
Table 8. Number of co-labeled cells in Tg(gata1:GFP) with sox1a and sox1b. Number of
cells labeled within in a 5 somite length of spinal cord adjacent to somites 6-10. Green
indicates number of Tg(gata1:GFP) cells, and red indicates sox1a or sox1b-labeled cells at
24hpf. Number of embryos counted is indicated at the end of each row. Numbers represent
average ± SEM.
GREEN

GREEN ONLY

RED

RED ONLY

n values

sox1a

43±1.15

0

59.33±0.33

16±1.15

n=3

sox1b

42.33±1.2

0

51.67±1.45

10±0.58

n=3
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Figure 10.
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Figure 10. Expression of sox1a and sox1b in Tg(gata1:GFP) embryos at 24hpf. sox1a
and sox1b label KA cells, a subset of V2b cells and potentially an additional population of
cells. Lateral views of spinal cords of Tg(gata1:GFP) embryos after immunohistochemistry
followed by in situ hybridization labeling sox1a (A), or sox1b (B) mRNA. Anterior left,
dorsal up. Panels in A and B show merged view of multiple confocal planes in half of the
spinal cord. In each case, expression of sox1a or sox1b (red) and Tg(gata1:GFP) (green) are
followed by the merged image of both red and green channels. Panels in A’ and B’ show
single confocal plane of the area marked with white box in panels A and B, respectively.
Stars (*) mark cells that are double labeled by both Tg(gata1:GFP) and sox1a or sox1b
probes. Scale bar: 50μm
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3.1.1.4 Expression of foxn4
As discussed in the introduction, foxn4 is expressed in the V2 domain of zebrafish spinal
cord, possibly early in the differentiation of V2 cells. Co-expression of foxn4 and the V2a
specific gene vsx1 was shown by Kimura et al., (2006). However, the V2b marker gata2a
was also shown to be expressed by Tg(vsx1:GFP) cells (Kimura et al., 2006), so this
transgenic line may label both V2a and V2b cells, making it unclear exactly which cells
express foxn4. Whether foxn4 is co-expressed with any markers of V2b cells has not been
investigated. To further confirm that foxn4 is expressed by V2 cells and to investigate
whether foxn4 is expressed by V2b cells and/or KA cells, I performed in situ hybridization
at 24hpf. My results and cell count data show that foxn4 is not expressed in rows 1 and 2
where KA cells form, but it is expressed in a subset of cells in the usual location of V2b cells
(Fig. 11; Table 7; also photographs in Fig. 12C and in section 3.2). However, cell counts at
24hpf in wild-type embryos (Fig. 11; Table 7) show that foxn4 is expressed primarily in
row 4, with only a few cells in rows 3 and 5. Only about 3 cells in row 3 express foxn4 at
this stage, while an average of 1.7 cells in row 5 express foxn4. In row 4, where the majority
of foxn4-expressing cells are found, the average number of cells (10.3 cells) is comparable
with that of other V2b markers tal1, gata2a and gata3. Given that V2b cells are also found
in other rows, and that foxn4 may also be expressed by V2a cells (Kimura et al., 2006),
foxn4 appears to be expressed only in a small subset of V2 cells.
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Figure 11. Number of cells that express foxn4 in wild-type embryos at 24hpf. Graph shows average number of cells in
each row labeled by in situ hybridization for different genes (represented by different colors). This data is a compilation of all
the genotyped wild-type embryo cell counts from incrosses of heterozygous mutants (from at least 2-3 separate experiments).
Lines above the bars indicate the expected positions of KA”, KA’ and V2b cells in the zebrafish spinal cord based on current
knowledge. Only a subset of cells in V2b domain express foxn4. Note that this panel may be compared to the cell counts in Fig.
12 (Expression of foxn4 in zebrafish wild-type embryos at different stages), but the numbers in this figure and in Fig. 12 come
from separate experiments.
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Figure 12.
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Figure 12. Expression of foxn4 in zebrafish wild-type embryos at different stages. (AE) show lateral views of spinal cords expressing foxn4 at 20hpf (A), 22hpf (B), 24hpf (C),
27hpf (D) and 30hpf (E). Anterior left, dorsal up. (F-H) show examples of cells labeled with
foxn4 that appear to be in the process of division at 24hpf. (I) shows number of cells
labeled with foxn4 in situ hybridization in wild-type embryos at indicated stages. Cell
counts are an average of 4 embryos for each stage. (J) shows the total number of cells that
express foxn4 at any given stage. The only statistically significant difference found by
Student’s t-test is indicated by a bracket and star. Values in (I) and (J) come from the same
cell count data. In both cases, error bars represent SEM. Scale bar: 50μm
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To test whether foxn4 is expressed by V2b cells I performed double labels with
Tg(gata1:GFP). To my surprise, Tg(gata1:GFP) and foxn4-expression did not overlap at 24h
(Fig. 13). In addition, foxn4 was expressed more dorsally than Tg(gata1:GFP) cells,
suggesting that either foxn4-expressing cells are more dorsal than V2b cells, or that the
Tg(gata1:GFP) line labeled only KA cells and a small ventral subset of V2b cells in this
experiment (which is possible – see also earlier discussion in 3.1.1.3 section describing
sox1a and sox1b expression in this transgenic line). To further test whether foxn4 might be
expressed by V2b cells I also performed double labels with slc32a1, which labels all
inhibitory post-mitotic cells (as V2b cells are GABAergic). As shown in Fig. 14F, foxn4 is not
co-expressed with slc32a1. Even though the cells that express slc32a1 are in the same
dorsoventral position as the cells that express foxn4, none of the inhibitory cells co-express
foxn4. Given the results of Kimura at al., 2006 that suggest that foxn4 is expressed by early
forming V2 cells one possible explanation of my results would be that foxn4 is
downregulated in older V2b cells. If this is the case, then zebrafish V2b cells appear be
specified primarily in row 4 at 24hpf.

91

Figure 13. Expression of foxn4 in Tg(gata1:GFP) at 24hpf. Lateral view of
Tg(gata1:GFP) embryo after GFP immunohistochemistry and in situ hybridization for foxn4
mRNA. Panels show a projection of multiple planes taken from half of the spinal cord.
Anterior left, dorsal up. Expression of foxn4 (red) and cells labeled by Tg(gata1:GFP)
(green) are followed by a merged image of both channels. No cells were found to coexpress Tg(gata1:GFP) and foxn4. Scale bar: 50μm
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Figure 14. Expression of foxn4 and other markers of the cell populations in the
zebrafish spinal cord at 24hpf. Lateral views of spinal cords expressing foxn4 in green
and dbx1b (A), dbx2 (B), nkx6.1 (C), nkx6.2 (D), gata2 (E), and slc32a1 (F) in red at 24hpf.
Anterior left, dorsal up. (A-F) show a merge of multiple projections from one side of the
spinal cord followed by a merged image of both green and red channels. White stars
indicate cells that are double-labeled. (C’-E’) show close-up single confocal planes of the
area marked by the white dashed box in (C-E) respectively. Close-ups are shown only in
cases where co-labeled cells were identified in single confocal planes. Scale bar: 50μm
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Since foxn4 is expressed more dorsally than Tg(gata1:GFP) cells, it is also possible
that the V2b cells form more dorsally over time or migrate ventrally once they have
formed. To try and investigate this I examined foxn4 expression and counted the number of
cells at 20hpf, 22hpf, 24hpf, 27hpf and 30hpf (Fig. 12). I predicted that if foxn4 is expressed
only transiently by V2b cells, the total number of foxn4-expressing cells might not change
much over time as “older” cells would be turning it off as “younger” cells are turning it on.
This would be in contrast to other genes that are expressed for longer in these cells, where
the number of cells expressing the gene increases over time (Batista et al., 2008). In
addition, if the dorsal-ventral position at which V2b cells form changes over time, the
location of foxn4-expressing cells should also change. In contrast, if “older” V2b cells
migrate ventrally, the location of foxn4-expressing cells should remain the same at different
stages.
As shown in Fig. 12A, foxn4 is expressed already at 20hpf in cells located mainly in
row 3, with several cells expressed in row 4 (Fig. 12I). A similar pattern of expression is
observed at 22hpf (Fig. 12B), however, more cells are labeled in row 4 at this stage
(Fig. 12I). By 24hpf, foxn4 is expressed mainly in row 4, with some cells still in row 3, and
some cells in row 5 starting to express foxn4 (Fig. 12C, I). Since both post-mitotic V2 cells
and p2 progenitor domain cells are found in row 4 at 24 hpf (Batista et al., 20008; England
et al., 2011), this would be consistent with foxn4 being expressed mainly by early V2 cells,
or late p2 progenitor cells. Interestingly, by 27hpf similar numbers of cells in rows 4 and 5
express foxn4, with an occasional cell in row 6 expressing this marker (Fig. 12D, I). By
30hpf expression of foxn4 persists mainly in row 5, but there are also similar number of
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cells labeled by foxn4 in rows 4 and row 6 (Fig. 12E, I). This shows that the dorsoventral
position at which foxn4 is expressed does indeed move dorsal over time.
I also compared the total number of foxn4-expressing cells at different stages (Fig.
12J). Although there is a slight trend towards an increase in the total number of cells, the
only statistically significant difference was between 22hpf and 30hpf (Appendix Table 2,
bolded value). However, the differences between 20hpf and 30hpf, and between 22hpf and
27hpf are approaching the significance threshold of p=0.05 (p=0.069 for 20hpf vs 30hpf,
and p=0.063 for 22hpf vs 27hpf, see Appendix Table 1). This suggests that the number of
foxn4-expressing cells may increase slightly in zebrafish spinal cord over these time points,
but it is a very subtle trend. Since the difference is so subtle and I only counted cells in 4
embryos at each stage, it is possible that examining a larger number of embryos would
result in more of these differences becoming statistically significant.
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Also, I observed that foxn4 is often present in cells that are either very large,
compared to their neighboring cells, or by pairs of neighboring cells, as shown in (Fig. 12FH). This suggests that foxn4 is expressed by cells that are undergoing division, or have just
divided and both sister cells are still expressing foxn4. This is consistent with data from the
previous zebrafish study (Kimura et al., 2008 supplementary material), which observed
foxn4 in Tg(vsx1:GFP)-expressing cells, often in pairs of neighboring cells that both
expressed vsx1 at 18hpf.
Since foxn4 is expressed soon after cell division, it is possible that it is already
expressed by late stage progenitor cells. In order to investigate whether foxn4 is expressed
in the p2/V2 region, and also to determine whether it is expressed in progenitor cells, in
post-mitotic cells, or in both populations, I performed double in situ hybridizations with
molecular markers that mark different dorsal-ventral progenitor domains. First, I tested
whether the dorso-ventral position of foxn4 coincides with V0 progenitor markers, dbx1b
and dbx2. While dbx1a is expressed solely by V0 progenitor cells, dbx2 has a wider
expression domain, which includes the p0 and p1 and part of the dp6 progenitor domains
(see England et al., 2011). As shown in Figs 14A and 14B, foxn4 is expressed more ventrally
than these markers.
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Therefore, I used markers of p2 progenitor cells nkx6.1, and nkx6.2 to test whether
foxn4 is expressed by V2 cells. nkx6.1 is expressed by p2 cells and also by more ventrally
located pMN cells and p3 cells, while nkx6.2 is expressed by all those cells but also more
dorsally located p1 cells (see England et al., 2011). In addition to being expressed in
progenitor cells, at least nkx6.1 is also thought to persist in a subset of very early V2
interneurons (Cheesman et al., 2004; Kimura et al., 2006). As shown in Fig. 14C, many
nkx6.1-expressing cells do not express foxn4. However, there is a slight overlap between
the dorso-ventral position of nkx6.1 and foxn4. This prompted me to examine single
confocal microscope focal planes and investigate whether any of the foxn4-expressing cells
also express nkx6.1. I found that several cells co-expressed both markers, an example of
which is shown in panel 10C’. Similarly, foxn4-expressing cells overlap with the dorsoventral position of nkx6.2, as shown in panel 10D. Even though many progenitor nkx6.2expressing cells do not express foxn4, some foxn4-cells express nkx6.2, as shown in single
confocal section panel 10D’. This suggests that foxn4 is expressed by very late p2
progenitor cells, and/or by very early post-mitotic V2 cells.
To further test whether foxn4 is expressed by early V2 cells, particularly early V2b
cells I performed double in situ hybridization experiments with gata2a. gata2a is expressed
before gata3 in V2b cells in zebrafish (Batista et al., 2008), and it is also expressed early on
by Tg(vsx1:GFP) cells (Kimura et al., 2008), suggesting that it might be expressed initially
by all early V2 cells, as it is in amniotes (Peng et al., 2007) before it resolves into just being
expressed by V2b cells. I found that all of the foxn4-expressing cells co-express gata2a,
although there are many more gata2a-positive cells that do not express foxn4 (Fig. 14E).
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This is consistent with foxn4 being expressed only in more recently-born V2b cells and
gata2a single-expressing cells down-regulating foxn4.
To summarize, my results show that foxn4 is expressed in very early V2 cells that
express gata2a, nk6.1 and nkx6.2. It also can not be ruled out that foxn4 may also be
expressed by very late p2 cells, since nkx6.1 and nkx6.2 are expressed by p2 progenitor
cells. However, foxn4 is not expressed by post-mitotic, gata3-expressing inhibitory V2b
cells, or any other inhibitory cells in zebrafish spinal cord at 24hpf. Expression of foxn4 is
located more dorsally over time, suggesting that position at which V2 cells form changes
over time. However, the gene appears to be expressed only transiently by maturing V2
cells.

3.1.1.5 GABAergic cells
Since V2b and KA cells are GABAergic, as discussed in the introduction, I decided to
also use expression of gad genes (which are expressed by GABAergic cells; Higashijima et
al., 2004) as a method of examining both of these cell populations. However, there are also
other GABAergic cells in zebrafish spinal cord, including V1 cells that are generally found
slightly dorsal to V2 cells, but that probably also partly overlap with the V2 domain (Batista
and Lewis, 2008; England et al., 2011). According to my cell count data, at 24hpf gads are
expressed by numbers of cells that are very comparable to the number of cells that express
gata2a/gata3/tal1 in rows 1-5, with the differences between the average number of
labeled cells never being larger than 2 cells in each of those rows (Fig. 15; Table 7). Even in
row 6, the number of GABAergic cells seems to be larger than that of V2b markers, but only
slightly. As expected, there are additional sporadic GABAergic cells present in rows 7 and 8,
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where V2b cells are not found. However, these are only few (average of 1.5 cells in row 7,
and 3.5 cells in row 8), and likely reflect more dorsally located cells that are beginning to
acquire a GABAergic phenotype (many of the dorsal inhibitory cells in zebrafish spinal cord
are glycinergic (Higashijima et al., 2004a). Overall, I conclude that gads are a good marker
for estimating the number of V2b and KA cells at 24hpf, and that V2b and KA cells can be
easily distinguished at this stage from other GABAergic cell populations based on the
dorsoventral location of the cells. More importantly though, use of this marker in
experiments on mutant embryos discussed later will also help me to assess whether KA
and V2b cells have lost their GABAergic phenotype, which is a key functional aspect of both
of these cell types.
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Figure 15. Number of GABAergic cells in wild-type embryos at 24hpf. Graph shows average number of cells in each row
labeled by in situ hybridization for different genes, as indicated by colors. GABAergic cells are labeled by mixture of gads
probes, and the numbers are shown in comparison to most established KA and V2b markers (gata3, gata2a, tal1). Only very
few additional GABAergic cells are present at 24hpf in the zebrafish spinal cord. This data is a compilation of all the genotyped
wild-type embryo cell counts from incrosses of heterozygous mutants (from at least 2-3 separate experiments). Lines above
the bars indicate the expected positions of KA”, KA’ and V2b cells in the zebrafish spinal cord based on current knowledge.
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3.1.2 Transgenic lines that could potentially label V2a cells.
V2b cells are formed by a division of one p2 cell into a V2a cell and a V2b cell
(Batista et al., 2008; Kimura et al., 2008). Some genes are expressed by both V2 cell types
early in differentiation (e.g. lhx3, vsx1; gata2a; Batista et al., 2008; Kimura et al., 2008). I
was, therefore, interested in whether the new markers of V2b cells that I had identified
(sox1a, sox1b, foxn4) are also expressed by V2a cells. I hoped to perform double labeling
experiments with a transgenic line that labels V2a cells, Tg(vsx1:GFP) (Kimura et al., 2006)
to test this. In addition, since V2a/V2b cells form from a single division, I was hoping to
establish whether mutations in genes expressed in V2b cells (analyses discussed later in
thesis) might result in V2a cells forming at the expense of V2b cells. For these purposes, I
was hoping to use the Tg(vsx1:GFP) line (Kimura et al., 2008). To my surprise, my first
experiments at 24hpf (when many V2a cells are already mature) did not reveal many cells
labeled in the spinal cord by this transgenic line. To test whether this was the result of a
delay in GFP expression I examined this line at 27hpf, 30hpf, 36hpf and 48hpf.
As shown in Fig. 16A, at 27hpf I could see only a background-like haze and only 1-2
cells in the anterior of the embryo on the compound microscope. At 30hpf I could see many
more cells (see also Kimura et al., 2006). However, the background haziness did not allow
me to clearly see cells and their axons on the compound microscope (Fig. 16B), and a
similar effect was observed at 36hpf on the compound microscope (Fig. 16C). The
experiment on embryos at 48hpf did not work, most likely because it is harder to
permeabilize the embryos at this stage, and I was not able to see the GFP in the spinal cord
(Fig. 16D). Therefore, I examined the embryos where the results appeared most promising
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(30hpf and 36hpf) on the confocal microscope to see whether I could see cells with better
resolution. As shown in Fig. 16E, at 30hpf even the confocal microscope did not let me see
cell axons very clearly (likely due to the surrounding haze), but I was able to better see cell
somas. At 36hpf the cell soma was completely visible (Fig. 16F), and the largely reduced
haze at that stage enabled me to examine the axons of Tg(vsx2:GFP) cells. However, the
number of cells that are labeled at that stage made it very difficult to distinguish between
individual cells and/or follow individual axons. These limitations would make it very
difficult to perform double labels, count cells or examine axon phenotypes in mutant
embryos.
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Figure 16. Assessment of Tg(vsx2:GFP) zebrafish line. Lateral views of spinal cord of
transgenic Tg(vsx2:GFP) embryos following GFP immunohistochemistry at 27hpf (A),
30hpf (B, E), 36hpf (C, F) and 48hpf (D). Anterior left, dorsal up. (A-D) were taken using a
compound microscope. (E and F) show pictures of embryos from the same experiment
taken using a confocal microscope. Scale bar: 50μm
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Other alternatives for labeling V2a cells are two other transgenic lines,
Tg(vsx2:RFP), and Tg(vsx2:Kaede) (Kimura et al., 2006). These lines were made in a similar
way to Tg(vsx2:GFP), but as they are the result of separate BAC insertions, they might have
slightly different expression patterns. I was hoping that at the earlier stages (27hpf, 30hpf,
36hpf), the haziness seen in Tg(vsx2:GFP) would be reduced and I would be able to see cells
more clearly, in numbers that would allow for easier counts and/or analyzing axons.
Unfortunately, this is not the case (Fig. 17), although these embryos were analyzed only on
the compound microscope. At 27hpf Tg(vsx2:Kaede)-labeled cells are slightly more visible
(Fig. 17A, compare to Fig. 16A) but they still have a ‘halo’ around their cell bodies, and the
cell axons are not clearly visible. Tg(vsx2:RFP) cells look similar but are even dimmer at
27hpf, as shown in Fig. 17D. The haze is still present at 30hpf in Tg(vsx2:Kaede). Even
though more cells seem to be labeled at this stage (Fig. 17B), I still could not see cell axons
in those embryos. In Tg(vsx2:RFP) at 30hpf, the cells begin to be brighter and more cells are
labeled, but the haze makes it possible to see only a few clear cell body shapes and none of
the axons (Fig. 17E). At 36hpf the Tg(vsx2:Kaede)-labeled cells have largely reduced
background (Fig. 17C), and many more cells are visible. This looks more suitable for
experiments, as compared to Tg(vsx2:GFP) pictures from the compound microscope
(Fig. 16C). The Tg(vsx2:RFP) line shows many cells at 36hpf (Fig. 17F), but since the cells
are much dimmer and more difficult to see, even at this stage this line seems the least
suitable for experiments.
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Figure 17. Assessment of Tg(vsx2:Kaede) and Tg(vsx2:RFP) zebrafish lines. Lateral views of spinal cords of
transgenic Tg(vsx2:Kaede) and Tg(vsx2:RFP) embryos following RFP or Kaede immunohistochemistry. Anterior left,
dorsal up. (A-C) show Tg(vsx2:Kaede) embryos at 27hpf (A), 30hpf (B), 36hpf (C). (D-F) show Tg(vsx2:RFP) embryos at
27hpf (D), 30hpf (E) and 36hpf (F). All photographs were taken using a compound microscope. Scale bar: 50μm
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Overall, I conclude that the Tg(vsx2:Kaede) line might be the best out of the three
lines for examining V2a cells, and the likely best stages to investigate would be between
30hpf and 36hpf. However, at those stages cells might be difficult to count, and it is still not
clear whether all of the V2a cells are labeled. The Tg(vsx2:GFP) line could potentially be
used between 30hpf and 36hpf depending on nature of experiments, but it is probably less
clear than the Tg(vsx2:Kaede) line. The Tg(vsx2:RFP) line seems least likely to clearly show
V2a cells due to both the background and how dim the cells are, making it even more
difficult to distinguish cells from the surrounding background. However, at 24hpf those
lines do not label sufficient number of V2a cells to perform double-staining, or to assess the
phenotype caused by the mutation in the gene. None of the lines seemed sufficiently
suitable for my experiments and I did not pursue using these lines any further.

3.2 Roles of gata2a, tal1 and gata3 transcription factor genes in
development of zebrafish spinal cord
3.2.1 Roles of gata2a, tal1 and gata3 in V2b and KA cell specification
As mentioned several times previously, gata2, tal1 and gata3 are all expressed in
post-mitotic V2b and KA cells in zebrafish spinal cord at 24hpf (Batista et al., 2008; this
thesis). To test whether any of these transcription factor genes are required for correct
specification of these cells, I examined the expression of different V2b and/or KA marker
genes in mutants for each of these genes. In each case, I performed in situ hybridization in
embryos from an incross of two heterozygous parents and then determined the number
and location of labeled cells in the region of the spinal cord adjacent to somites 6-10.
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3.2.1.1 gata2a
As discussed in the introduction, the gata2a mutant used in this study should result
in a truncated protein that lacks both of the functional zinc finger domains (Fig. 4A; Zhu et
al., 2011). Therefore, it is highly likely that gata2um27 is a null mutant allele. Based on
results from a previous study in zebrafish using morpholinos designed to knock down
gata2a (Yang et al., 2010), we would expect KA” cells not to form in gata2a mutants, and
KA’ cells to form normally. The effects of loss of Gata2a function on zebrafish V2b cells,
however, were unknown before my study.
In gata2a mutants, the number of cells expressing gata3, tal1, sox1a, and gads seems
to be severely reduced in the row directly above the notochord where KA” cells are located
(Figs 18 and 19) but there is no statistically significant change in the number of cells
expressing most of these markers in more dorsal rows. More specifically, gata3 and tal1
expression is only altered in row 1, where on average only about 1 cell remains in the
mutants (Figs 18A, 18I, 18C, 18K, 19A, and 19E). In addition, sox1a and gad expressions are
lost in row 1 (about 1 sox1a-expressing cell remains and about 3 gad-expressing cells), and
also significantly decreased in row 2 (Figs 18D, 18L, 18G, 18O, 19C and 19D). These results
are consistent with the prediction that gata2a is required for KA” cells to form properly
and they also suggest that gata2a may be required for the correct expression of some genes
in KA’ cells.
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Figure 18.
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Figure 18. Expression of V2b and/or KA markers in gata2aum27 mutant and sibling
embryos at 24hpf. Lateral views of zebrafish spinal cords at 24hpf. (A-H) show expression
of indicated genes in wild-type sibling embryos, and (I-P) show expression in mutant
embryos. In most cases (tal1, sox1a, sox1b, tal2, gads, foxn4) embryos shown here were
genotyped as wild-type or mutant. Occasional photographs (gata3, gata2a) are of embryos
that were not genotyped. In these cases, pictures are representative of the phenotype that
was observed in genotyped wild-type and mutant embryos and these phenotypes were
observed in appropriate Mendelian ratios in the photographed experiment. Embryos were
always genotyped if there was no obvious phenotype. All panels show the merged view of
several planes from one side of the spinal cord from the compound microscope. Scale bar:
50μm.
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Figure 19.
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Figure 19.Number of cells labeled in the gata2aum27 mutant and sibling embryos at
24hpf. Graphs show average number of cells expressing indicated gene in the spinal cord
region adjacent to somites 6-10. Cell counts were performed on genotyped mutant and
wild-type embryos, apart from one case (gata2a) where the cell count of mutant embryos
is compared to a mixture of heterozygous mutant and wild-type embryos at 24hpf. At least
four embryos were counted in each case. Cell counts from rows 4and above are shown as
‘4+’. Statistically significant (p<0.05) differences as assessed by Student’s t-test are
indicated by brackets and stars (* p<0.05, **p<0.01, ***p<0.001). Error bars indicate SEM.
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To my surprise however, tal2 expression in the KA” domain is unchanged in mutant
embryos (Figs 18F, 18N and 19F). My cell counts show that there is only a small, not
statistically significant decrease in the number of tal2-expressing cells in row 1 where KA”
cells are found (Fig. 19F). This very small difference is in sharp contrast to the loss of other
markers discussed above. These results also contrast with findings from gata2a
morpholino knockdown studies that showed loss of tal2 expression in row 1 (Yang et al.,
2010).
Similarly, the number of cells expressing sox1b in this domain remains unchanged
(Figs 18E, 18M and 19G) and, there is no obvious sox1b expression phenotype in gata2a
mutant embryos (Fig. 19G). My cell counts show that the numbers of cells labeled with
sox1b do not differ significantly in any row. Given that sox1b is expressed by KA” cells, as I
previously demonstrated with the Tg(gata1:GFP) co-expression experiments in Fig. 10B,
this result is also surprising. It shows that Gata2a function is dispensable for expression of
sox1b in either KA or V2b cells. It also suggests that sox1a and sox1b are regulated
differently in KA” cells.
In addition, I found no change in the number of foxn4-expressing cells in mutant and
wild-type embryos (Figs 18H, P and 19H), despite the fact that gata2a and foxn4 are coexpressed in the spinal cord (Fig. 14). This suggests that Foxn4 might be upstream of
Gata2a in those cells – or that these two transcription factors act independently of each
other.
Taken together, my data suggest that either KA” cells still form in the absence of
gata2a, but the cells lose expression of some of the markers normally expressed by those
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cells (i.e. gata3, tal1 and sox1a), as well as their GABAergic phenotype, or that KA” cells
become a different type of cell that does not express gata3, tal1 or sox1a but still expresses
tal2 and sox1b.
I also examined at the expression of gata2a in gata2a mutants (Figs 18B, 18J and
19B). Because of time constraints, in this experiment I did not genotype sibling embryos
but just identified them by their phenotype (this is the only marker that I did this for with
this mutant). Therefore, while the mutant cell counts from this experiment are genotyped
mutant embryos, the ‘sibling’ cell counts are a mixture of wild-type and heterozygous
mutant embryos. As shown in Fig. 19B, I saw a decrease in number of gata2a-expressing
cells in all rows, compared with sibling embryos. Also, the expression is much weaker in all
remaining cells (Figs 18B and 18J). This could be due to nonsense-mediated decay of the
RNA, where the RNA molecule within the cell is detected as erroneous and targeted for
degradation. However, if this is the case, it is surprising that while expression of gata2a is
almost completely lost in KA” and KA’ cells, expression in V2b cells is diminished but
persists in many cells. All of the above cell counts in gata2a wild-type and mutant embryos
are summarized in Table 9.
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Table 9. Summary of the phenotype observed in gata2aum27 mutant embryos and
their siblings. Values represent average numbers of cells expressed in each row of the
spinal cord for any given marker. First value corresponds to genotyped mutant embryos,
and second value represents number of cells in genotyped wild-type embryos, apart from
gata2 expressing cells, where values are an average from heterozygote and wild-type
embryos. Values of rows 1-8 show cell numbers in individual spinal cord rows. Row ‘4+’
represents values from rows 4-8 grouped together, and ‘2+’ represents values from rows 28 grouped together. Total number of cells from rows 1-8 is shown in the last row, but no
colors were used in this case. In other cases, colors indicate whether the differences are
statistically significant. Red and grey colors show no statistically significant difference
between wild-type and mutant cell counts using Student’s t-test. Also, grey color indicates
values where very few cells were present in either wild-type or mutant embryos (less than
2 cells). Other colors denote a statistically significant difference (p ≤0.05) between the
numbers of cells in wild-type and mutant embryos. Dark green = cells almost completely
lost in mutants (less than 15% cells left in mutants), light green = cells significantly reduced
(less than 33% cells left in mutants), blue = cells reduced (more than 33% cells left but
statistically significant difference between mutant and wild-type). p-values that approach
0.05 significance cut-off are indicated in brackets.
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Table 9.
gata2a mutant
Row/Marker
1
2
3
4
5
6
7
8

gata3

gata2a

tal1

sox1a

sox1b

tal2

gads

✗

SR

✗

✗

✔

✔ (NS, p =0.06)

SR

1.2/20.75

4.75/20

0.5/21.25

1.2/21.8

21/22.5

19/21.6

3.25/21.25

✔

✗

✔

SR

✔

✔

R

8.4/9.75

0.5/6

4/6.25

2.6/9.8

11.25/10.75

7.4/8.8

5.25/11

✔

R

✔

✔

✔

✔

✔

14.8/15

3.25/12

10.25/12.75

15.6/13.8

13.25/10.5

11.2/9.6

15/13.75

R

✔

✔ (NS,p =0.054)

✔

✔

✔

✔

9.8/12.75

12.25/14.6

14.0/11.75

12.4/10.4

10.25/10.25

5.8/4.4

9/11.75

✔

R

✔

✔ (NS, p =0.08)

✔

✔

✔

5/5.5

3.25/7.6

9.0/9.5

11.0/9.0

6.25/7.5

2.8/3.4

4.5/6.75

−

−

R

✔

✔

−

✔

0.8/1.25

0.25/1.6

1/3.5

4.0/3.6

1.75/2.5

0.6/0.4

2.5/1.75

−

✔

1.0/0.8

2/0.75

0

0

− (NS, p =0.06)
0

0/2
SR

0

0

0

0

0

0

1.75/3

4+

R

R

✔

✔ (NS,p =0.055)

✔

✔

✔

TOGETHER

15.6/19.5

15.75/23.8

24/24.75

28.4/23.8

20.25/21

9.2/8.2

17.75/25.25

2+

R

R

✔ (NS, p =0.01)

✔

✔

✔

✔

TOGETHER

38.8/44.25

19.5/41.8

38.25/43.75

46.6/47.4

44.75/42.25

27.8/26.6

38/50

40/65

24.25/61.8

38.75/65

47.8/69.2

46.8/48.2

41.25/71.75

R

R

R

R

✔

R

TOTAL

65.75/64.75
✔
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In addition, I examined whether the gata2a mutation causes a phenotype in heterozygous
embryos. In order to test this, I examined expression of gads in genotyped heterozygous
embryos and compared them to genotyped wild-types. I chose to examine expression of
gads because they label the largest number of cells, including all KA and V2b cells, and
these genes have a pronounced and obvious expression phenotype in homozygous
mutants. No statistically significant difference was found between heterozygous gata2um27
carriers and wild-type embryos (Fig. 20D), suggesting that there is no heterozygous
phenotype caused by this mutation in spinal cord.
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Figure 20. Heterozygous mutants have no phenotype. No heterozygous mutant
phenotype was found in tal1t21384, gata2aum27 or gata3sa0234 mutants. Graphs show number
of cells that express the gene indicated, as assessed by in situ hybridization. Embryos were
identified as heterozygous carriers of mutations in tal1t21384 (A-C), gata2aum27 (D), or
gata3sa0234 (E) and compared with genotyped wild-type siblings. Values show average of
cell counts from at least 4 embryos in each case. Error bars represent SEM. No significant
differences were found with Student’s t-test (p>0.05 in all cases).
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3.2.1.2 tal1
As described in the introduction, the tal1 mutant used in this study results in a
protein truncation, which removes the entire helix-loop-helix DNA binding domain (Fig.
4B; Busssman et al 2007). Homozygous mutants also lack blood circulation, and have heart
edema at 48hpf (Bussmann et al., 2007). Given the loss of functional domains and the
severe phenotype in homozygous mutant embryos, it is likely that the tal1 mutant used in
this study is a null mutant. I used the blood phenotype to identify mutant embryos in in situ
hybridizations with genes expressed in blood where the blood phenotype is obvious (tal1),
but also genotyped those embryos afterwards for cell counting. The heart edema
phenotype was visible too late for my analysis, so I genotyped embryos expressing genes
not expressed in blood, to identify mutants. Before this work, the role of tal1 in zebrafish
spinal cord development had not been investigated, even though we know from previously
published studies that tal1 is expressed in V2b and KA cells at 24hpf in zebrafish (Batista et
al., 2008).
My studies show that expression of gata3, gata2a, sox1a, sox1b, tal2 and gads in tal1
mutants is unchanged in row 1 where KA” cells are located, but is severely reduced in rows
2 and 3, where KA’ cells are found (Figs 21A-B, 21D-I, 21K-O and 22A-D, 22F, 22G).
However, the degree to which expression in those rows is reduced varies between different
markers. To resolve whether remaining cells are medial and belong to the KA’ population,
or lateral and are more likely to be V2b cells, I recounted a subset of genotyped embryos
looking at the medial/lateral position of cells. The cells that remain in rows 2 and 3 in
mutant embryos are located laterally, suggesting that they belong to V2b population, and
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are not KA’ cells (Fig. 23, Table 10). Therefore, expression of all of these genes is lost in KA’
cells in tal1 mutants. This data is also summarized in Table 11, in which a lack of medially
located cells in mutant embryos is indicated by ‘(0m)’. In rows 4 and above, no significant
difference was found in the number of cells expressing gata3 or gata2a (Fig. 22A and 22B,
respectively). In contrast, expression of sox1a was slightly reduced, and the number of
GABAergic cells was reduced to an even larger extent (Fig. 22C and 22D, respectively).
Interestingly, expression of sox1b and tal2 was almost completely abolished in rows 4 and
above in tal1 mutants (Fig. 22F and 22G, respectively).

119

Figure 21.
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Figure 21. Expression of V2b and/or KA markers in the tal1t21384 mutant and sibling
embryos at 24hpf. Lateral views of zebrafish spinal cords at 24hpf. (A-H) show expression
of indicated genes in wild-type sibling embryos, and (I-P) show expression in mutant
embryos. In some cases (gata2a, tal1, foxn4) embryos shown here were genotyped as wildtype or mutant. Other photographs (gata3, sox1a, sox1b, tal2, gads) are of embryos that
were not genotyped. In these cases, pictures are representative of the phenotype that was
observed in genotyped wild-type and mutant embryos and these phenotypes were
observed in appropriate Mendelian ratios in the photographed experiment. Embryos were
always genotyped if there was no obvious phenotype. All panels show the merged view of
several planes from one side of the spinal cord from the compound microscope. Scale bar:
50μm
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Figure 22.
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Figure 22. Number of cells labeled in the tal1t21384 mutant and sibling embryos at
24hpf. Graphs show average number of cells expressing indicated gene in the spinal cord
region adjacent to somites 6-10. Cell counts were performed on genotyped mutant and
wild-type embryos at 24hpf, and at least four embryos were counted in each case. Cell
counts from rows 4 are shown as ‘4+’. Statistically significant (p<0.05) differences as
assessed by Student’s t-test are indicated by brackets and stars (* p<0.05, **p<0.01,
***p<0.001). Error bars indicate SEM.
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Figure 23.
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Figure 23. Number of cells labeled in the tal1t21384 mutant and sibling embryos at
24hpf with distinction between lateral and medial position of the cells. Graphs show
the average number of cells expressing indicated genes in the spinal cord region adjacent to
somites 6-10. Cell counts were performed noting the medial/lateral position of labeled
cells. These counts are independent of the previous cell counts that did not address
medial/lateral position of the cells. Whenever possible, embryos from the previous cell
count were included. If this was not possible, additional embryos were genotyped. For scl
expression, only sibling (mixture of genotyped heterozygous mutant and wild-type)
embryos were available for cell counts, as indicated in the graph. Cell counts from rows 4
and above were gathered together and are shown as ‘4+’. At least four embryos were
counted in each case.
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Table 10. Lateral/medial cells counts in tal1t21384 mutant embryos and their siblings.
Values represent average numbers of cells expressed in each row of the spinal cord for any
given marker. Columns in yellow color show mutant values, and no color shows wild-type
(or sibling, in a case of tal1 marker) values. First value in each cell represents number of
medial cells, and second value represents total number of cells in a specific row. Number of
embryos counted is indicated at the bottom of each column.
Row
number

gata3
(tal1MUT)

gata3
(tal1WT)

gata2a
(tal1MUT)

gata2a
(tal1WT)

tal1
(tal1MUT)

tal1
(tal1SIB)

sox1a
(tal1MUT)

sox1a
(tal1WT)

1

19

21.25

20.25

19.5

17.2

17.75

19.75

20.25

2

0/1.67

5.75/7

0/0.25

8.25/9.85

0

5.25/7.5

0.5/1.25

8.25/8.25

3

0/2.33

7.75/15

0/7

6.75/14.55

0.4/3.4

6.75/13.5

0/4.5

6.75/12

4

0/9.33

2/11

0/12

2/12.6

0/8.45

0/10.25

0/9

2/10.5

5

0/5.67

0/5.5

0/4.75

0/4.6

0/1.5

0/3

0/5

0/6.25

6

0

0/1.5

0/0.25

0/0.6

0

0

0/1.25

0/2

7

0

0

0

0

0

0/0.5

0

0/0.5

8

0

0

0

0

0

0

0

0

n
values

n=3

n=4

n=4

n=4

n=5

n=4

n=4

n=4

Row
number

sox1b
(tal1MUT)

sox1b
(tal1WT)

tal2
(tal1MUT)

tal2
(tal1WT)

gads
(tal1MUT)

gads
(tal1WT)

1

20.33

20.25

18.75

20.5

21

21.5

2

0

7.75/11.75

0

8.75/10.75

0/0.25

10/12

3

0/2

9.25/12.25

0

7.25/10.75

0/0.25

7/13.75

4

0/1.67

0.5/6.5

0

1.5/7.75

0/2

1/10.75

5

0

0/5

0

0/3.75

0/6.75

0/8

6

0

0/1.25

0

0/0.5

0/0.75

0/7

7

0

0/0.5

0

0.5/0.5

0/0.5

0/2

8

0

0

0

0

0/2.25

0/3

n
values

n=3

n=4

n=4

n=4

n=4

n=4
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Table 11. Summary of the phenotype observed in tal1t21384 mutant embryos and their
siblings. Values represent average numbers of cells expressed in each row of the spinal
cord for any given marker. First value corresponds to genotyped mutant embryos, and
second value represents number of cells in genotyped wild-type embryos. Values of rows 18 show cell numbers in individual spinal cord rows. Row ‘4+’ represents values from rows
4-8 grouped together. Total number of cells from rows 1-8 is shown in the last row, but no
colors were used in this case. In other cases, colors indicate whether the differences are
statistically significant. Red and grey colors show no statistically significant difference
between wild-type and mutant cell counts using Student’s t-test. Also, grey color indicates
values where very few cells were present in either wild-type or mutant embryos (less than
2 cells). Other colors denote a statistically significant difference (p ≤0.05) between the
numbers of cells in wild-type and mutant embryos. Dark green = cells almost completely
lost in mutants (less than 15% cells left in mutants), light green = cells significantly reduced
(less than 33% cells left in mutants), blue = cells reduced (more than 33% cells left but
statistically significant difference between mutant and wild-type). p-values that approach
0.05 significance cut-off are indicated in brackets.
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To determine whether expression of tal2 is delayed in V2b cells, or whether cells
initially express tal2 but then quickly lose expression in mutants, I examined expression of
tal2 at 22hpf and at 27hpf. In both cases, the phenotype was similar to 24hpf, with only the
most ventral row of cells retaining tal2 expression in tal1 mutants (Fig. 24). I did not count
the cells in embryos of these stages, but it seems that at 22hpf, 24hpf, and 27hpf the tal1
mutation abolishes tal2 expression in cells dorsal to KA” cells.
Also, I was intrigued by the very pronounced decrease in the number of GABAergic
cells in rows 4 and above. Since there are other GABAergic cells in the zebrafish spinal cord
that express gads, it was surprising that very few cells persisted in tal1 mutants.
Importantly, the remaining cells express gads only very weakly in all rows dorsal to row 1.
One possible explanation is that cells initially express gads, but expression is then downregulated either because cells are changing their fates or becoming sick. To test this, I
examined expression of gads at 22hpf (Fig. 24A, B). No cells dorsal to KA” cells express gads
at 22hpf in tal1 mutant. Another explanation could be that V2b cells are delayed in
becoming GABAergic, which I tested by investigating expression at 27hpf (Fig. 24C, D).
Even though a few sporadic cells express gads at 27hpf, the expression is still weaker than
in KA” cells and the cells are not positioned in the usual row pattern (Fig. 24C, D). This
suggests that these cells are not V2b cells but are instead more dorsal GABAergic cells. In
conclusion, V2b cells lose their GABAergic phenotype and expression of sox1b and tal2, but
expression of other markers persists in absence of Tal1.
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Figure 24.
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Figure 24. Expression of gads and tal2 in tal1t21384 mutant and sibling embryos at 22hpf and 27hpf. Lateral views of
zebrafish spinal cord at indicated stages. Anterior left, dorsal up. Expression of gads in tal1t21384 sibling embryo at 22hpf (A),
tal1t21384 sibling embryo at 24hpf (B), tal1t21384 sibling embryo at 27hpf (C) and tal1t21384 mutant embryo at 27hpf (D).
Expression of tal2 in tal1t21384 sibling embryo at 22hpf (E), tal1t21384 mutant embryo at 22hpf (F), tal1t21384 sibling embryo at
27hpf (G) and tal1t21384 mutant embryo at 27hpf (H). In all cases pictures are representative of the phenotype that was
observed in appropriate Mendelian ratios in the photographed experiment. Scale bar: 50μm
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I also examined expression of tal1 in tal1 mutants (Figs 20E, 21E, 22E). I initially
found mutants based on their obvious blood phenotype, but confirmed the genotype before
counting cells. I observed an expression pattern similar to that seen for other genes.
Expression is unchanged in KA” cells, reduced in rows 2 and 3 where KA’ cells are found,
and only slightly reduced in cells of rows 4 and above where most V2bs are located (Fig.
21C, 21K and 22E). This suggests that tal1 is not required for its own regulation in KA” cells
and V2b cells, and that there is no significant RNA-mediated decay of the tal1 mutant RNA
in zebrafish spinal cord.
Expression of foxn4 remains unchanged in tal1 mutants. There is no statistically
significant difference in the number of cells in any of the rows that express foxn4, or in the
total number of cells that express foxn4 (Figs. 20H and 21H). This suggests that tal1 is not
upstream of foxn4 in the pathway that leads to formation of V2b cells.
I also examined whether the tal1 mutation has a heterozygous phenotype. Given
that the phenotype in V2b cells is different for different genes in tal1 mutants, I examined
genes that had the most dramatic phenotype in both KA’ and V2b cells (sox1b, tal2 and
gads), as I reasoned that if there was a heterozygous phenotype it was most likely to be
detected with one or more of these genes. However, none of these genes had an expression
phenotype in heterozygous tal1 mutation carriers (Figs. 20A, 20B and 20C). This suggests
that the tal1t21384 mutant does not cause a heterozygous phenotype in zebrafish spinal cord.
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3.2.1.3 gata3
The gata3 mutant, as discussed in the introduction, has not been published and was
kindly provided by Dr. Steven Harvey in Derek Stemple’s lab at the Wellcome Trust Sanger
Institute, UK. This mutant is also likely to be a null allele because the deletion/insertion
change in the gene sequence results in a premature stop codon before both of the zinc
finger domains (Fig. 4C).
The phenotypes that I observed in gata3 mutant embryos resemble those seen in
tal1 mutants for KA cells, but there are some notable differences between the two mutants
with respect to V2b cells. However, as shown in Fig. 25 and my cell counts in Fig. 26, the
lack of gata3 does not affect the formation of KA” cells, as assessed by expression of all of
genes expressed by KA” cells that I investigated in this study. This result is consistent with
observations made in morpholino-injected embryos (Yang et al., 2010), and this aspect of
the phenotype is similar to the phenotype observed in tal1 mutant embryos described
earlier.
The pattern of KA’-specific gene expression in gata3 mutants is also similar to tal1
mutants in several aspects. In gata3 mutants, KA’ cells in row 2 are lost, as assayed by all of
the genes used (Figs 25, 26 and 27). In row 3, there is a reduction in the number of cells
expressing all of the genes, but still many cells express tal1 and gata2a, and a smaller
number of cells express gads. When I recounted cells based on their medial/lateral
position, I saw that the cells that remain in row 3 are all lateral (Fig. 27, Table 12). Also, an
average of one cell remained labeled in row 3 by tal2, sox1a and sox1b (Fig. 27, Tables 12
and 13). In these cases, instead of re-counting cells in those embryos based on the
lateral/medial position, I checked the location of these occasional cells in row 3. The
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remaining cells in row 3 were always laterally located, and this is indicated by ‘0m’ in
Table 13.
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Figure 25.
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Figure 25. Expression of V2b and/or KA markers in the gata3sa0234 mutant and
sibling embryos at 24hpf. Lateral views of zebrafish spinal cords at 24hpf. (A-H) show
expression of indicated genes in wild-type sibling embryos, and (I-P) show expression in
mutant embryos. In most cases (gata3, tal1, sox1a, sox1b, foxn4) embryos shown here were
genotyped as wild-type or mutant. Occasional photographs (gata2a, tal2, gads) are of
embryos that were not genotyped. In these cases, pictures are representative of the
phenotype that was observed in genotyped wild-type and mutant embryos and these
phenotypes were observed in appropriate Mendelian ratios in the photographed
experiment. Embryos were always genotyped if there was no obvious phenotype. All panels
show the merged view of several planes from one side of the spinal cord from the
compound microscope. Scale bar: 50μm
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Figure 26.
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Figure 26. Number of cells labeled in the gata3sa0234 mutant and sibling embryos at
24hpf. Graphs show average number of cells expressing indicated gene in the spinal cord
region adjacent to somites 6-10. Cell counts were performed on genotyped mutant and
wild-type embryos, apart from one case (of gata3) where the cell count of mutant embryos
is compared to a mixture of heterozygous mutant and wild-type embryos (indicated as
‘sibling’) at 24hpf. At least four embryos were counted in each case. Cell counts from rows 4
are shown as ‘4+’. Statistically significant (p<0.05) differences as assessed by Student’s ttest are indicated by brackets and stars (* p<0.05, **p<0.01, ***p<0.001). Error bars
indicate SEM.
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Figure 27. Number of cells labeled in the gata3sa0234 mutant and sibling embryos at
24hpf with distinction between lateral and medial position of the cells. Graphs show
average number of cells expressing indicated genes in the spinal cord region adjacent to
somites 6-10. Cell counts were performed noting the medial/lateral position of labeled
cells. These counts are independent of the previous cell counts that did not address
medial/lateral position of the cells. Whenever possible, embryos from the previous cell
count were included. If this was not possible, additional embryos were genotyped. Cell
counts from rows 4 and above were gathered together and are shown as ‘4+’. Cells in at
least four embryos were counted in each case.
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The phenotype of V2b cells in gata3 mutants is less clear. The number of cells that
are in rows 4 and above labeled by gata2a and tal1 is partially reduced (Fig. 26A, 26F).
Only around 2 cells less express gata2a in those rows (reduction from average of 19.2 to 17
cells), which suggests that gata3 might slightly affect gata2a expression in cells of rows 4
and above. tal1-expressing cells display a larger reduction of around half the cells (from
average of 22 to 13.25 cells) in mutants compared to wild-type embryos, suggesting that
gata3 is required for expression of tal1 in at least a subset of V2b cells of rows 4 and above,
or that it is required for tal1 expression to be maintained in V2b cells.
In addition, results differ between expression of sox1a and sox1b in cells located in
row 4 and above. The number of sox1a-expressing cells in those rows in mutant embryos
was unchanged, but only around a half of cells still express sox1b (Fig. 26C). This suggests
that tal1 is required for expression of sox1b in some V2b cells or it is required for
maintenance of sox1b expression in those cells, but that tal1 is not required for sox1a
expression in V2b cells. This result also suggests that sox1a and sox1b genes are regulated
differently in zebrafish spinal cord. However, it should also be noted that the numbers of
cells in those rows differ greatly in wild-type siblings from both experiments. As shown
later in this results chapter (in section 3.2.3), sox1a-labeled cells coming from gata3 incross
are among the highest number out of all three mutant crosses investigated, whereas sox1blabeled cells coming from gata3 incross are among the lowest. This could partly be due to
very small differences in the developmental staging of embryos and/or in how well the
staining worked in each case. This results in a difference of almost 10 cells on average
labeled in wild-type embryos with sox1a versus sox1b RNA probes. This indicates that
careful conclusions should be made when comparing results from different experiments.
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However, within an experiment mutant embryos are always compared with wild-type
siblings with identical experimental treatment, so these results should still be helpful in
understanding the phenotypic change in mutants.
Interestingly, expression of both tal2 and gads in cells in row 4 and above remains
unchanged in gata3 mutants (Fig. 26). This is in striking contrast with the phenotype
observed earlier in tal1 mutants in this domain, where all the cells of row 4 and above were
lost in the mutant embryos (Figs. 21-24). Since tal2 likely represents only a subset of V2b
cells, this suggests that gata3 is not required for tal2 expression in a sub-population of V2b
cells. Given that the GABAergic phenotype also remains unchanged, it appears that gata3 is
not required for V2b cells to acquire their neurotransmitter phenotype.
Expression of foxn4 remains unchanged in the gata3 mutant embryos (Figs 25H,
25P and 26G). This suggests that either Foxn4 is upstream of Gata3, which would be
consistent with the fact that I did not observe any co-expression of foxn4 and gata3 or that
the two genes act independently of each other in V2b cells.
I also performed an in situ hybridization for gata3 in gata3 mutants. In a manner
similar to assessing expression of gata2a in gata2a mutants, I just identified the embryos
by their phenotype (this is the only marker that I did this for with this mutant). Therefore,
while the mutant cell counts from this experiment are genotyped mutant embryos, the
‘sibling’ cell counts are a mixture of wild-type and heterozygous mutant embryos. (i.e.
denoted ‘siblings’). Interestingly, mutant embryos show a weaker expression of gata3 in
V2b cells and KA” cells, but the number of those cells is still similar to the number of cells
labeled in sibling embryos (Fig. 25A 25I and Fig. 26A). However, there are no cells
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expressing gata3 in the locations where KA’ cells are normally found in rows 2 and 3,
which is consistent with expression of other markers. This suggests that gata3 is required
for correct expression of gata3 in KA’ cells, and may be required for normal levels of
expression in KA” and V2b cells (or there could be some nonsense mediated decay of the
gata3 transcript).
As was the case for other mutants, I also tested whether there is a heterozygous
phenotype for this gata3 mutant allele. Since the phenotype in homozygous mutant
embryos was most obvious in KA’ cells, with only slight changes in V2b cells, I decided to
look at expression of gads in genotyped heterozygous gata3 mutation carriers. Again, no
statistically significant phenotypic difference was found between heterozygous mutants
and wild-type embryos (Fig. 20E). This suggests that the gata3sa0234 mutation does not have
a heterozygous phenotype in zebrafish spinal cord.
Overall, these results show that gata3 is not required for correct formation of KA”
cells, but is required for correct formation of KA’ cells, which is in agreement with previous
descriptions of gata3 morpholino knock-down phenotypes (Yang et al., 2010). The
mutation in gata3 appears to have only a partial effect on expression of markers in the V2b
domain. Slight, statistically significant reductions were found in expression of gata2a and
sox1b, while larger reductions of around half of the cells were observed for tal1. No
statistically significant difference between expression patterns in V2b cells of mutant
embryos compared to wild-type was found in the expression of gata3, sox1a, tal2, foxn4, or
gad. Also, gata3 appears to be expressed more weakly in mutant embryos but in a similar
number of KA” and V2b cells compared to the sibling embryos. Taken together this
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suggests that gata3 is required for the formation of KA’ cells and for expression of a small
subset of genes in V2b cells. While the KA” and KA’ phenotype in gata3 mutants is
comparable to that in tal1 mutants, the V2b phenotypes are different as in tal1 mutants
V2b cells are no longer GABAergic and they also have a more dramatic loss of expression of
several other genes, most markedly tal2 and sox1b (Fig. 26F, 26G). The lateral/medial
position of cells in each row is shown in Table 12, and all above results are also
summarized in Table 13.
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Table 12. Lateral/medial cells counts in gata3sa0234 mutant embryos and their siblings. Values represent average
numbers of cells expressed in each row of the spinal cord for any given marker. Columns in yellow color show mutant values,
and no color shows wild-type values. First value in each cell represents number of medial cells, and second value represents
total number of cells in a specific row. Number of embryos counted is indicated at the bottom of each column.
Row
number

gata2a
(gata3MUT)

gata2a
(gata3WT)

tal1
(gata3MUT)

tal1
(gata3WT)

gads
(gata3MUT)

gads
(gata3WT)

1

21.33

20.33

20.5

20.5

22

21

2

0/0

8.33/9.33

0

7.75/8.75

4.75/7.5

8.33/8.33

3

0/8.67

7.67/14.33

0/4.75

6.75/12

5.75/12

6.67/14

4

0/12.33

3.33/14.33

0/9.5

1.75/11.5

0.25/10.25

0/14.67

5

0/4.66

0/6

0/2.75

0/6.5

1.25/7.25

0/6.67

6

0/0.67

0/0.33

0/0.5

0/0.75

0/2.75

0/3

7

0

0

0

0

0/0.25

0/0

8

0

0

0

0

0/1.25

0/2

n values

n=3

n=3

n=4

n=4

n=4

n=3
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Table 13. Summary of the phenotype observed in gata3sa0234 mutant embryos and
their siblings. Values represent average numbers of cells expressed in each row of the
spinal cord for any given marker. First value corresponds to genotyped mutant embryos,
and second value represents number of cells in genotyped wild-type embryos, apart from
gata3 expressing cells, where values are an average from heterozygote and wild-type
embryos. Values of rows 1-8 show cell numbers in individual spinal cord rows. Row ‘4+’
represents values from rows 4-8 grouped together. Total number of cells from rows 1-8 is
shown in the last row, but no colors were used in this case. In other cases, colors indicate
whether the differences are statistically significant. Red and grey colors show no
statistically significant difference between wild-type and mutant cell counts using Student’s
t-test. Also, grey color indicates values where very few cells were present in either wildtype or mutant embryos (less than 2 cells). Other colors denote a statistically significant
difference (p ≤0.05) between the numbers of cells in wild-type and mutant embryos. Dark
green = cells almost completely lost in mutants (less than 15% cells left in mutants), light
green = cells significantly reduced (less than 33% cells left in mutants), blue = cells reduced
(more than 33% cells left but statistically significant difference between mutant and wildtype), yellow=statistically significant increase between mutant and wild-type. p-values that
approach 0.05 significance cut-off are indicated in brackets.
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Table 13.

gata3 mutant
ROW/Marker
1
2
3

4

gata3
✔
20.5/20
✗
0/5.5
✗
0/11.75
✔
10.5/12

gata2a
✔
21.75/21
✗
0/10.16
R
9.5/13.33

tal1
✔
20.5/20.75
✗
0/10.25
R
5/12.25

sox1a
✔
20.83/20.6
✗
0/7.6
✗
0.17/11.4

sox1b
✔
21.4/21.25
✗
0/5.5
✗
0.2/14.25

tal2
✔
21/20
✗
0/10
✗
0.25/10

gads
✔
20.25/21.25
✗
0/8.25
✗
1.75/13.5

(0m)

(0m)

(0m)

(0m)

(0m)

(0m)

✔
12.25/13.17

R
9.0/13

R
11/11.8

✔
7.8/9.75

✔ (NS, p =0.07)
9.0/7.0

R
11.25/15.25

✔ (NS, p =0.06)
3.75/6.75

INC
12/8.6

R
2/5

R
1.50/4

✔
8.5/7

−
0/0.33

SR
0.5/2.25

R
0.6/2

−
0.25/0

R
1/2.75

0

0

✔
5.5/4.8
−
0.17/0.2

0

0

0
✔
17/19.17
✔
26.33/28.33
R
48.25/63.67

0
R
13.25/22
R
17.5/25
R
38.75/65.25

0
✔
28.67/25.4
not
established
R
49.83/65

0
R
10.4/16.75
not
established
R
32/57.75

0
✔
10.75/11
not
established
R
31/52.5

0
✔
1.75/1.25
R
22.5/26.5
R
24.25/31.67
R
44.5/69.5

(0m)

5

✔
5.25/5.75

✔
4.75/5.67
(0m)

6

✔
1.25/2.5

7
8
4+
TOGETHER
Presumed
V2b cells
TOTAL

✔
17.5/20.25
not
established
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3.2.2 There is no obvious developmental delay in gata2a, gata3 or tal1
mutants
Sometimes mutations can cause an overall delay in development. Given that KA and
V2b cells form gradually over time, differences in the developmental stage of embryos
could result in different numbers of KA and V2b cells being present. Therefore, to exclude
the possibility that some of the phenotypes described above could be the result of a
developmental delay specifically in mutant embryos, I examined the position of lateral line
primordium in identified wild-type and mutant embryos. The lateral line primordium is a
structure that moves along the embryonic trunk at both sides of the embryo at a well
characterized pace (Kimmel et al., 1992), and its position is one of the most precise ways to
assess developmental stage of zebrafish embryos between 24 and 30hpf. Conveniently, one
of the probes that I used as a marker of V2b and KA cells, sox1a, also labels the lateral line
primordium (Fig. 28A). When I examined the position of this structure on both sides of
spinal cord, I saw no statistically significant difference between the stages of wild-type and
mutant embryos in either gata2a, tal1 or gata3 mutant lines (Fig. 28B, 28C and 28D,
respectively). This shows that mutations in those genes do not cause a developmental delay
in zebrafish embryos.
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Figure 28. Position of lateral line primordium in wild-type and mutant zebrafish embryos at 24hpf. (A) sox1a
expression in 24hpf zebrafish trunk with arrow indicating lateral line primordium. Anterior left, dorsal up. The dots in the
upper half of the embryo are spinal cord cells. (B-D) Graphs representing position of lateral line primordium in genotyped
wild-type and mutant embryos from incrosses of gata2aum27 (B), tal1t21384 (C) or gata3sa0234 (D) heterozygous parents. The
average was calculated using single values that represent position of primordium on each side of the embryo. At least 4
embryos were analyzed in each case, resulting in at least 8 single values used for calculations. Error bars represent SEM.
Scale bar = 50μm
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3.2.3 Comparison of cell count numbers of wild-type embryos from
different experiments
All of my interpretation of results from mutant embryos assumes that the number of
cells labeled by certain RNA probes is consistent between different in situ hybridization
experiments. To test this, I assessed the reproducibility of my in situ hybridization
experiments by comparing the number of cells labeled with each marker gene used in wildtype sibling embryos from the different experiments described above (Figs 29, 30).
For gata3-labeled cells, I compared the expression pattern in genotyped wild-type
embryos from both an incross of heterozygous tal1 mutants and an incross of heterozygous
gata2a mutants (Fig. 29A). I found no statistically significant differences between the
overall number of cells labeled or the number of cells labeled that were located specifically
in row 1 (p= 1, Appendix Table 2), row 2 (p=0.099, Appendix Table 2) or row 3 (p=0.423,
Appendix Table 2). However, in row 4, there was a statistically significant difference
between number of cells labeled in both experiments (average of 10 cells labeled in tal1
incross experiment, and 12.75 cells in gata2a incross experiment, p=0.048). This is likely to
be because it becomes more difficult to accurate assign cells to a particular row, in more
dorsally located positions. Cell counts are more difficult to perform consistently when cells
are further away from the notochord, partly because of the cuboidal shape of cells. Cells are
not always arranged in clear/neat rows, especially in more dorsal positions where their
dorso-ventral position depends on more ventrally located cells. Consistent with this
hypothesis – if I compare the number of cells in row 4 and above (identified as ‘4+’ in
figures), these numbers (19 for wild-type embryos from the tal1 mutant incross, and 19.5
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for wild-type embryos from the gata2a incross) are not statistically significantly different
(Fig. 29E; p=0.94, Appendix Table 2).
In a similar way, I compared the number of gata2a-labeled cells in genotyped wildtype embryos from gata3 and tal1 incross experiments. In rows 1-5, no significant
difference was found between experiments, although in row 1 the p value was approaching
significance (Fig. 29B, p=0.053, Appendix Table 2). In row 6, there is a statistically
significant difference between gata2a-expressing cells in both experiments (p=0.017;
Appendix Table 2). Again, when the values from rows 4 and above are gathered together,
no significant difference can be found between wild-type embryos from both experiments
(Fig. 28F), which is consistent with hypothesis presented earlier that slight differences in
cell counts in these more dorsal rows reflect a difficulty with precisely identifying rows far
away from notochord. Taken together, these results indicate that similar numbers of both
KA cells and V2b cells are labeled in both experiments.
For tal1 I compared expression in genotyped wild-type embryos from gata2a, gata3
and tal1 incrosses of heterozygous parents. Pairwise comparison with Student’s t-test
showed no significant differences between average values in rows 1-3, but the gata2a
versus gata3 incross comparison for row 2 approached significance (p=0.055; Appendix
Table 2). Small significant differences were found between various experiments in rows 4,
5 and 6 (Fig. 29C; Appendix Table 2). In row 4 the difference in the number of cells labeled
in tal1 wild-type siblings versus gata3 wild-type siblings were statistically significantly
different (p=0.12, Appendix Table 2). Also, in row 5 there were statistically significant
differences found. gata2a wild-type siblings had significantly more cells expressing tal1 in
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row 5 (average of 10.25 cells, Fig. 29C), than in gata3 wild-type siblings (average of 6.75
cells, p=0.01), or tal1 wild-type siblings (average of 4.75 cells, p=0.07). Also, in row 6
significant differences were found between all three of the pairwise comparisons
(Appendix Table 2). In addition, my comparison of cell counts from row 4 and above shows
that the number of cells in tal1 wild-type siblings is significantly lower than in the other
two experiments (16.5 cells in the tal1 incross, versus 25.75 cells in gata2a incross
(p=0.09) and 22 cells in gata3 incross (p=0.006) (Fig. 29G, Appendix Table 2). Since cells
are usually specified from the ventral to dorsal, with older cells located more dorsally, this
suggests to me that potentially the embryos from the tal1 incross experiment might have
been slightly younger than in the other two experiments. This hypothesis would be
supported by the fact that the numbers of more dorsal (rows 5 and 6), as well as to a
smaller extent the number of KA” cells labeled by tal1 is smaller in these wild-type siblings.
Analysis of tal2-labeled wild-type mutants shows a similar trend. The only
statistically significant difference that could be found in the cell counts by row from three
individual experiments was in row 6, where tal1 wild-type siblings have more cells labeled
than gata3 wild-type siblings (Fig. 29D). However, when the values from row 4 and above
were combined, there was no statistically significant difference between any of the
experiments (Fig. 29H, Appendix Table 2).
Therefore, given that the differences within individual cell populations do not differ
to a large extent, and that I am comparing embryos of the same stage within each
experiment (by comparing mutants to their wild-type siblings from the same cross), I
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believe that we can still draw conclusions about Tal1 function from the tal1 mutant
experiments.
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Figure 29.
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Figure 29. Expression of gata3, gata2a, scl and tal2 in wild-type embryos from
different experiments. Graphs show average number of cells that express indicated genes
in a 5 somite length of spinal cord adjacent to somites 6-10. Counts are for both sides of the
spinal cord and at least 4 embryos were counted in each case. Cells were counted in
individual rows along the dorsal-ventral axis with row 1 being the most ventral row, which
is located just above the notochord. Embryos are from incrosses of tal1t21384, gata2aum27
and gata3sa0234 heterozygous mutants and were either genotyped (wild-type), or assessed
by the clearly visible phenotype in approx. 25% of embryos (sibling). (A-D) show cell
counts in each individual row. (E-H) show the same values for rows 1, 2 and 3, with values
from row 4 and above grouped together. Statistically significant (p<0.05) differences as
assessed by Student’s t-test are indicated by brackets and stars (* p<0.05, **p<0.01,
***p<0.001). Error bars represent SEM.
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I also compared sox1a expression in genotyped wild-type embryos from incrosses of
heterozygous parents of all three mutants. In rows 1, 2, 3 and 4, no significant differences
were found between the wild-type expression in all three experiments (Fig. 30A, Appendix
Table 2). However, small significant differences could be seen in number of cells labeled in
rows 5 and 6 (Fig. 30A). In row 5, less cells were stained in tal1 wild-type siblings than in
gata2a wild-type siblings (p=0.046), although none of the other pairwise comparisons
were statistically significant. In row 6, less cells are labeled in tal1 wild-type siblings, with
statistically significant differences between these embryos and both gata2a (p=0.027) and
gata3 wild-type siblings (Fig. 30A; p=0.021; Appendix Table 2). In row 7, no statistically
significant difference was detected, most likely due to the fact that very few cells are
labeled in this row in any of the experiments. The lower number of cells in dorsal rows
labeled with sox1a in tal1 wild-type siblings is also seen when the values are combined
from rows 4 and above (Fig. 30E). It appears that tal1 wild-type siblings have less cells than
both gata2a and gata3 wild-type siblings, but a statistically significant difference could be
detected only between tal1 wild-type siblings and gata3 wild-type siblings in this case
(Fig. 30E, Appendix Table 2). This suggests that the tal1 embryos might have been slightly
younger and/or the probe did not stain as well in this particular tal1 experiment as in the
other experiments.
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Similarly, no differences are observed between expression of sox1b in wild-type
sibling embryos that come from incrosses of all three mutants in individual rows 1-4 (Fig.
30B, Appendix Table 2). However, there is a small variation in cell counts in rows 5, and 7,
with no statistically significant difference in the number of cells of row 6. gata2a wild-type
siblings appear to have most cells labeled in row 5, with statistically significant differences
between gata2a wild-type siblings and both tal1 (p=0.045), and gata3 wild-type siblings
(p=0.031) (Fig. 30B, Appendix Table 2). However, in row 7, the tal1 wild-type siblings have
most cells labeled, with statistically significant differences only between tal1 wild-type
siblings and gata3 wild-type siblings (Fig. 30B; p=0.040; Appendix Table 2). When the
values from row 4 and above are combined, no statistically significant difference can be
found between the number of cells labeled in either of the experiments (Fig. 30F). Again,
the differences in individual rows most likely occurred due to difficulties identifying the
exact position of cells far away from the notochord in the individual embryos.
The number of GABAergic cells also differs only within occasional individual rows
between all three experiments. In rows 1-3, and in row 5 there is no statistically significant
difference between numbers of cells labeled by gads in wild-type sibling embryos from
either experiment (Fig. 30C). However, in row 4, the least cells are labeled in tal1 wild-type
siblings, with a statistically significant difference between this experiment and the gata3
wild-type siblings (Fig. 30C). At the same time, in row 6 the tal1 wild-type siblings appear
to have the most cells labeled with gads, with statistically significant differences found
between this experiment and both gata2a (p=0.007), and gata3 wild-type siblings
(p=0.016). No statistically significant difference was detected between the more dorsal
rows. The difference in individual row counts between the tal1 wild-type siblings and other
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experiments is not apparent when cells from row 4 and above are combined, as no
statistically significant difference was detected in either comparison (Fig. 30G, Appendix
Table 2).
In case of cell counts performed on wild-type embryos labeled with foxn4 in
experiments from all three mutant lines, the difference is visible only in row 3 out of all
rows labeled (Fig. 30D, Appendix Table 2). In row 3 of tal1 wild-type siblings, the number
of cells is statistically significantly lower than in gata3 wild-type siblings (Fig. 30D).
Understandably, the same trend is visible when cells from row 4 and above are pooled
together (Fig. 30H). However, foxn4 appears to label only one cell population (most likely
early V2b, sometimes probably just after division) that might not be consistently
positioned within one specific row, but is found in rows 3-5. Therefore, I decided that a
comparison that would better reflect the actual phenotype would be to compare the total
number of cells. In this case, there is no significant difference between the number of foxn4labeled cells in wild-type sibling embryos from either of the experiments.
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Figure 30.
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Figure 30. Expression of sox1a, sox1b, gads and foxn4 in wild-type embryos from
different experiments. Graphs show average number of cells that express indicated genes
in a 5 somite length of spinal cord adjacent to somites 6-10. Counts are for both sides of the
spinal cord and at least 4 embryos were counted in each case. Cells were counted in
individual rows along the dorsal-ventral axis with row 1 being the most ventral row, which
is located just above the notochord. Embryos are from incrosses of tal1t21384, gata2aum27
and gata3sa0234 heterozygous mutants and were either genotyped (wild-type), or assessed
by the clearly visible phenotype in approx. 25% of embryos (sibling). (A-D) show cell
counts in each individual row. (E-H) show the same values for rows 1, 2 and 3, with values
from row 4 and above grouped together. Statistically significant (p<0.05) differences as
assessed by Student’s t-test are indicated by brackets and stars (* p<0.05, **p<0.01,
***p<0.001). Error bars represent SEM.
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3.3 Other potential markers of V2b and/or KA cells
Several additional candidate genes that might be expressed in V2b and/or KA cells
were identified via either literature searches and/or from another project in the lab that
investigated the expression profiles of various zebrafish spinal cord cell types via
microarray. In parallel to my examination of gata3, gata2a and tal1 mutants, I also
examined the expression of some of these genes in the hope of finding genes that label
specifically V2b, KA’ or KA” cells, since most transcription factors described to date are
expressed by all three of these cell types. I performed GFP immunohistochemistry and in
situ hybridization with these genes in the Tg(gata1:GFP) line that labels KA cells and a
subpopulation of V2b cells to investigate whether those candidate genes are expressed by
either V2b or KA cells. As shown in Fig. 31, several markers had a partly overlapping
expression with Tg(gata1:GFP) cells.
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Figure 31.
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Figure 31. Genes that are candidates for being expressed by V2b and/or KA cells in
zebrafish spinal cord. Lateral views of 24h spinal cords of Tg(gata1:GFP) embryos with
GFP expression in green and insm1a (A), mnx1 (B), her6 (C), crb1 (D) and sp8a (E) mRNA
expression in red. Each panel represents a merge of multiple projections from one side of
the spinal cord followed by a merged image of both green and red channels. White stars
indicate cells that are double-labeled. Panels in A’, B’, C’ and D’ show single confocal plane
of the area marked with white box in panels A, B, C and D, respectively. Scale bar: 50μm
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insm1a was initially identified from the microarray screen by another student in the
lab (Paul Campbell). My double labels show that this gene is expressed by a subset of
Tg(gata1:GFP) cells (Fig. 31A). The cells that express both insm1a and Tg(gata1:GFP) are
located at positions that correspond to all three populations: KA”, KA’ and V2b cells.
Interestingly, these co-labeled cells are sporadic, and overall this gene does not seem to be
expressed by all members of any one population. However, because of the significant
background in those embryos, it is difficult for me to confidently determine the precise
number of co-expressing cells.
mnx1 was also identified by another student in lab (Paul Campbell) from the
microarray screen. It does not appear to be expressed by Tg(gata1:GFP) KA” cells
(Fig. 31B). However, there are a small number of more dorsal cells (3 cells that I could
identify across both sides of the spinal cord of embryo in Fig. 31B) that are co-labeled by
both Tg(gata1:GFP) and mnx1. Those cells could potentially be V2b or KA’ cells. This would
be consistent with the literature that shows that some mnx1-expressing cells have a V2blike morphology and are GABAergic at 24hpf (Seredick et al., 2012). Interestingly though, in
my experiment I could see Tg(gata1:GFP)-positive cells with a V2b morphology that did not
express mnx1, which indicates that perhaps only some V2b cells express mnx1. This marker
is also expressed in primary motoneurons, together with other members of the mnx family
(Seredick et al., 2012). Therefore, despite the fact that the mnx1 appears to be expressed by
some V2b cells, it is not a V2b-specific marker.
I identified her6 from the microarray project during my rotation in the lab as a
marker that might be expressed by inhibitory neurons. As shown in Fig. 31C, her6 appears
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to be expressed by some KA cells, but also by many more cells in the ventral rows where
KA cells are located. The ventral expression of her6 appears to be restricted to rows ventral
to the position of V2b cells, and none of the GFP-positive cells with V2b-like morphology
co-expressed her6. However, this gene seems to be also expressed in cells located in the
dorsal spinal cord (Fig. 31C). Interestingly, when Alex Nichitean investigated the
expression pattern of this gene in mindbomb mutants in which Notch signaling is
inactivated, the expression of her6 was largely abolished. This suggests that her6 is
expressed by cells that depend on Notch signaling for their formation. This group includes
KA cells, which is consistent with her6 being expressed by KA cells. Therefore, her6 may be
expressed by a subset of KA cells, but is not a KA-specific marker due to the more extensive
ventral her6-expressing domain and the dorsal expression domain.
crb1 (crumbs family member 1, photoreceptor morphogenesis associated) was also
identified by myself during my rotation from the microarray screen as a marker potentially
expressed in V2b or KA cells. As opposed to all other genes investigated in this thesis, crb1
does not encode for a transcription factor but for a transmembrane protein. Interestingly, it
appears to be expressed by KA cells, as it is co-expressed with Tg(gata1:GFP) (Fig. 31D).
Also, it appears that crb1 might be expressed by additional cells in row 1, which suggests
that it might be expressed by other cells in the lateral floor plate region, perhaps p3 or V3
populations. In row 2, all of the Tg(gata1:GFP) cells appear to co-express crb1, which
suggests that all or most of the KA’ cells express this gene. None of the cells located more
dorsally to this region were found to express crb1. This is perhaps one of the most exciting
results, as it suggests that only KA cells and not V2b cells express crb1. However, this
marker is not KA-specific because of the additional crb1-expressing cells in the first row
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above notochord. Hopefully, future experiments will reveal the identity of those cells and
possibly the role of crb1 in KA cells.
sp8a was also identified from the microarray screen as a gene upregulated in
inhibitory (versus excitatory) cells of zebrafish spinal cord. However, it does not appear to
be expressed by any of the Tg(gata1:GFP) cells (Fig. 31E) although, interestingly, it is
expressed by cells that are roughly in the KA’ and/or V2b position. It is likely that not all
V2b cells are labeled by this transgenic line based on my other results, and sp8a could be
potentially expressed by non-GFP positive V2b cells. However, since none of the sp8alabeled cells co-label with Tg(gata1:GFP), it is also likely that this gene is not expressed by
either V2b or KA cells.
Overall, I identified several genes that are expressed by KA’, KA” and/or V2b cells in
zebrafish spinal cord (as summarized in Table 14). crb1 and her6 are expressed by either a
subset or all of both of the KA cell populations. insm1a may be expressed by a subset of all
three populations, as well as other cells, but this result needs to be repeated with a
stronger probe before a final conclusion can be made. mnx1 may be expressed by some V2b
cells, but this result needs to be confirmed at a later stage when there are more
Tg(gata1:GFP) cells with a V2b morphology, or by co-labeling with a known V2b marker. In
all of these cases, the genes are also expressed by additional cell populations and are,
therefore, not exclusive to KA”, KA’ and/or V2b cells. I also showed that sp8a is not
expressed by KA or V2b cells.
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Table 14. Summary of conclusions about novel candidate genes that may be
expressed by V2b and/or KA cells. This table shows the general conclusions that may
be drawn from experiments that establish the expression pattern of candidate genes at
24hpf in zebrafish embryos. The conclusions are simplifications based on the
experiments presented in this thesis and also supported by published literature, as
discussed in text. Evidence that comes from this thesis is referenced to the respective
figures in the last column.
Gene
name

Expression profile
V2 domain
KA domain

Comments

Reference
figure

foxn4

Subset of early
V2b cells

Absent

-

11-14

sox1a

Likely most V2b
cells

All KA cells

May be in a few
additional cells

9-10

sox1b

Likely most V2b
cells

All KA cells

May be in a few
additional cells

9-10

insm1a

Some V2b cells

Some KA
cells

Also in many
additional cells

31

mnx1

A few V2b cells

Absent

Also in motoneurons

31

her6

Absent

Most KA cells

Also in some dorsal
cells, and in additional
cells in KA domain

31

sp8a

Absent

Absent

-

31

crb1

Absent

All KA cells

Likely in some other
cells in KA D-V
position

31
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4. Discussion
The primary goal of this study was to better understand the molecular pathways
that establish GABAergic V2b and KA cells in zebrafish spinal cord. Previous reports
showed that formation of many inhibitory GABAergic spinal cord cells depends on the
PAX2 transcription factor in both mouse (Pillai et al., 2007), and zebrafish (Batista and
Lewis, 2008). Interestingly, V2b cells in mouse, and both V2b and KA cells in zebrafish, are
the only GABAergic spinal cord cells that do not express Pax2 (Pillai et al., 2007; Batista and
Lewis, 2008). As would be expected, in the absence of PAX2 and other highly related PAX
transcription factors those ventrally located neurons retain their GABAergic phenotype
(Pillai et al., 2007; Batista and Lewis, 2008). This indicates that another, pax2-independent
mechanism must specify the GABAergic phenotype of those cells. Furthermore, evidence
from knock-down studies in zebrafish indicates that there is a difference in how mature KA’
and KA” form – expression of at least some genes in KA” cells requires gata2a and not
gata3, and KA’ cells require gata3 but not gata2a for their correct specification (Yang et al.,
2010). This is a very interesting result, but morpholino experiments can sometimes cause
non-specific phenotypes due to off-target effects (Eisen and Smith, 2008; Shulte-Merker
and Steiner, 2014). Therefore, it was important to confirm this result in mutant fish. Also,
this result raised the possibility that transcription factor genes expressed by zebrafish KA”,
KA’ and V2b cells might play distinct roles in formation of those cells. In this thesis I
investigate whether tal1, gata2a, or gata3 are required for V2b or KA specification by
examining single mutations in these genes. I also investigated whether other transcription
factors are expressed by V2b and/or KA cells. In this discussion, first, I will discuss my

167
analyses of sox1a, sox1b and foxn4 expression in wild-type embryos. Then, I will describe
my analyses of KA”, KA’ and V2b cells in tal1, gata2a and gata3 mutants. Finally, I will
briefly describe my more preliminary results on other potential markers expressed by V2b
and/or KA cells. For reference, the expression patterns of each gene in wild-type embryos
are gathered together in Fig. 32.
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Figure 32. Expression patterns of V2b and/or KA genes in wild-type embryos at 24hpf. Graph shows average number of
cells in each row labeled by in situ hybridization for different genes (represented by different colors). This data is a
compilation of all the genotyped wild-type embryo cell counts from incrosses of heterozygous mutants (from at least 2-3
separate experiments). Values in this figure are a combination of values from earlier figures that show expression patterns of
these genes presented in the results section. Lines above the bars indicate the expected positions of KA”, KA’ and V2b cells in
the zebrafish spinal cord based on current knowledge.
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4.1 sox1a and sox1b are expressed by V2b and KA cells
As explained in the introduction, sox1a and sox1b are zebrafish orthologs of mouse
Sox1. There are two zebrafish sox1 genes because of the additional whole genome
duplication event that occurred in teleosts (Amores et al., 1998; Taylor et al., 2003;
Glasauer and Neuhauss, 2014). In amniotes, Sox1 is broadly expressed in the chicken spinal
cord (Okuda et al., 2006) and in mouse spinal cord progenitor cells (Pevny et al., 1998) and
post-mitotic V2c cells (Panayi et al., 2010). In zebrafish, sox1a and sox1b expression had
been observed mostly in the retina and brain, but it was reported that it was not detected
in the spinal cord at any stage examined (12 and 21 somite, and 25hpf) (Okuda et al.,
2006). However, I think the authors may have missed expression of sox1a and sox1b in the
spinal cord, as I can see weak expression in their photographed embryos at 25hpf (Okuda
et al., 2006). Also, direct data submission to the zebrafish expression database by the
Thisse lab shows sox1a expression in spinal cord at 24hpf (Thisse et al., 2004; ZFIN.org). In
this thesis, I confirm that both sox1a and sox1b are expressed at 24hpf in zebrafish spinal
cord. In addition, another student in the lab (Alex Nichitean) detected spinal cord
expression of sox1a at 20hpf, 22hpf and 27hpf (data not shown).
V2b, KA’ and KA” cells in zebrafish all express tal1, gata2a and gata3, and are
GABAergic (Batista et al., 2008; Yang et al., 2010; Bernhardt et al., 1992). All of these cells
are also labeled by Tg(gata1:GFP), even though they don’t express gata1 (Detrich et al,
2004) suggesting that this transgene promoter lacks either a spinal cord repressor
element, or acts as an enhancer trap (Batista et al., 2008). Based on my results, I propose
that both V2b and KA cells also express sox1a and sox1b, as both of those transcription
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factors are co-expressed with GFP in Tg(gata1:GFP) embryos (see Fig. 10). However, at 24h
the Tg(gata1:GFP) line only labels a small number of the V2bs in my experiments (Fig. 10).
This suggests that either not all of the V2bs are labeled by Tg(gata1:GFP), or that the
expression of the transgene is delayed in most V2b cells. As a result, it is hard to determine
whether the sox1a- and sox1b-positive cells that do not co-express GFP are also V2b cells or
might be an additional cell type. However, all of the Tg(gata1:GFP) cells express sox1a and
sox1b, which suggests that both of those transcription factors are expressed by all KA cells,
and at least the subset of V2bs that was labeled by the transgenic line (Fig. 10 and Table 8).
In mouse, Sox1 is expressed in V2b cells but also in V2c cells that no longer express
the V2b marker gata3 (Panayi et al., 2010). I was not able to establish whether V2c cells
also exist in zebrafish. Given that both sox1a and sox1b are expressed in a few more cells
than gata3, gata2a and tal1, especially in row 6 and 7, it is possible that these more dorsal
cells are V2c cells, although they could also be a different cell type (especially given their
more dorsal location). The overall similarity of sox1a and sox1b expression to that of other
V2b markers, and the fact that in mouse Sox1 is transiently expressed by V2b cells (Panayi
et al., 2010) suggests that sox1a and sox1b are expressed by V2b cells. In addition, in all
three of the tal1/gata2a/gata3 mutants, expression of at least one of the sox genes is
altered in a manner similar to that of other V2b and KA markers, consistent with these
genes being expressed by KA and V2b cells in zebrafish. Double in situ hybridization
experiments between sox1a/sox1b and other V2b cell markers (e.g. tal1, gata2a or gata3)
could confirm whether sox1a/b are only expressed in V2b cells, or whether they also are
expressed by additional cells. To see whether V2c cells exist in zebrafish however,
transgenic lines that would allow for lineage tracing would be needed. This would allow for
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identifying cells that once were V2b cells (e.g. expressed gata3), but later express only
sox1a and/or sox1b (become a new subpopulation, V2c). Since degradation time of GFP is
quite long after protein is fully folded, use of traditional lines (e.g. Tg(gata1:GFP) would not
suffice, as it would be difficult to establish whether cells are still V2b cells or already
became V2c cells. However, a transgenic line (e.g. Tg(gata3:eGFP)) line could be made to
trace the origin of the sox1a/sox1b-expressing cells to cells that once expressed gata3. Such
lineage tracing lines are used in mouse and are also available in zebrafish (Hans et al.,
2009). However, currently a line that specifically enables tracing of V2b/V2c fate is not
available.
In contrast to V2b cells, KA cells are consistently labeled by the Tg(gata1:GFP) line:
the number of GFP-positive cells is equivalent to the number of KA cells in the first two to
three rows of the spinal cord. The co-expression of both sox1a and sox1b in these GFPpositive cells shows that KA cells express both of those transcription factor genes.
Currently there is no evidence from other organisms that indicates expression of sox1a and
sox1b in cells that contact cerebrospinal fluid (cerebrospinal fluid contacting neurons (CSFcNs) in amniotes; KA cells in zebrafish). It is possible that the Sox1-expressing cells in
mouse might be CSF-cNs. More detailed examination by either co-labeling with a CSF-cN
specific marker such as pkd2l1 (Djenoune et al., 2014), or looking at the morphology of the
cells that express Sox1 could establish whether expression of Sox1 in CSF-cNs is conserved
in zebrafish and amniotes.
In zebrafish, there are temporal and spatial differences in the expression of sox1
genes in many tissues (Okuda et al., 2006). For example, in retina sox1a is expressed a

172
number of hours before sox1b is expressed (Okuda et al., 2006). In addition, sox1b is
expressed only in the forebrain, whereas sox1a is expressed in both forebrain and
hindbrain (Okuda et al., 2006). Therefore, despite the fact that those genes are very closely
related and both show high similarity at a sequence level to human and mouse SOX1
(Okuda et al., 2006), their expression and functions in specific cell types might differ. The
phenotypes of zebrafish single mutants analyzed in this study support the idea that sox1a
and sox1b are regulated differently, which might also suggest distinct roles for these genes
in the development of V2b and KA cells. In KA” cells in gata2a mutants, I observed that only
sox1b is lost, while sox1a expression is unaffected. In contrast, sox1b expression is lost in
V2b cells in tal1 mutants, while sox1a expression in those cells is only slightly reduced.
Similarly, in V2b cells in gata3 mutants, around half of the cells lose sox1b expression, while
no significant change is observed in expression of sox1a. This suggests that sox1b may be
downstream of tal1 and gata3 in V2b cells, and sox1a downstream of gata2a in KA” cells.
Different functions and/or regulation of orthologous genes is often a consequence of
additional whole genome duplication events such as the one that occurred at the base of
the teleost lineage (Glasauer and Neuhauss, 2014). A study that investigated changes in
non-coding elements (CNEs) surrounding all of the soxB genes (to which sox1a and sox1b
belong) in the pufferfish showed that about half of the CNEs were split apart after the
genome duplication event, suggesting that subfunctionalization may have occurred for
those genes (Woolfe and Elgar, 2007). For example, subfunctionalization during evolution
occurred in the functions of co-orthologs sox9a and sox9b, where the craniofacial and
pectoral fin phenotypes of single mutants are different from each other but are additive in
double mutants (Yan et al., 2005). Therefore, it is possible that sox1a and sox1b in zebrafish
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have subdivided more ancestral functions. Alternatively, it is possible that both sox1a and
sox1b genes have retained similar functions in zebrafish, but their expression is regulated
differently. In case of another zebrafish sox ortholog pair, sox11a and sox11b, the sequence
of their enhancers has evolved to varying degrees, but the sequence of the genes has
remained similar, and as a result expression of the genes is regulated differently, but the
resulting proteins have similar functions (Navralitova et al., 2010). Given the difference
between expression of sox1a and sox1b in response to loss of gata2a, gata3 and tal1, it is
likely that sox1a and sox1b genes are regulated differently. To test whether they have
different functions, mutants of sox1a and sox1b would be needed, which are not available at
this time.

4.2 foxn4 is expressed by early V2 cells
foxn4, as explained in the introduction, is probably expressed by zebrafish V2 cells
relatively early, as shown by co-expression of foxn4 and vsx1 mRNA in the Tg(vsx1:GFP) line
at 18hpf (Kimura et al., 2006). It is interesting, however, that Tg(vsx1:GFP) labeled V2a cells
so early, as in my experiments I could not clearly see spinal cord cells at 24hpf, and only
sporadic cells were labeled at 27hpf. Also, my double in situ hybridization labeling shows
that foxn4 is co-expressed with gata2a, with all the cells that are foxn4-positive expressing
also gata2a. However, there are many cells that are not foxn4-positive that express gata2a.
This means that either only a subset of gata2a-expressing V2b cells express foxn4, or that
most likely foxn4 is expressed early in V2b cells and then downregulated. In this case, the
foxn4-negative, gata2a-positive cells would represent more mature V2b cells. Double ISH
co-labeling with some of the p2 progenitor/very early V2 cell markers nkx6.1 and nkx6.2 is
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consistent with this hypothesis, as many foxn4 cells still express both of those markers.
Therefore, I postulate that foxn4 is expressed early by V2b (and V2a) cells, but its
expression is transient and quickly downregulated as the cells progress to more mature
stages.
As discussed in the introduction, in mouse, Foxn4 is expressed in cells that are
common precursors of both V2a and V2b cells, while in chicken there is a significant
overlap between expression of Foxn4 and Gata2-expressing V2b cells, but no overlap with
Vsx2-expressing V2a cells (delBarrio et al., 2007). In both mouse and chicken Foxn4 plays a
crucial role in specification of V2b cell fate (Fig. 3; Li et al., 2005; delBarrio et al., 2007;
Misra et al., 2014). Foxn4 is both required for Tal1 expression in mouse and sufficient to
induce Tal1 expression in chicken, while loss of Tal1 has no effect on expression of Foxn4 in
mouse (delBarrio et al., 2007). Also, Foxn4 is sufficient to induce Gata2 and Gata3
expression in chicken embryos, with Gata2 expression observed before Tal1 and Gata3
expressions (delBarrio et al., 2007). Also, the number of Vsx2-expressing V2a cells
decreases in chicken after forced expression of Foxn4 (delBarrio et al., 2007). In mouse,
Foxn4 has recently been shown to be responsible for establishing and maintaining the
Delta-Notch signaling that is crucial for development of V2a/V2b cells (Misra et al., 2014).
This suggests that in amniotes, Foxn4 is upstream of Tal1, Gata2 and Gata3 during V2b cell
differentiation, which is in agreement with my observations in zebrafish.
Currently there is no zebrafish foxn4 null mutant available that would help to
confirm whether foxn4 is upstream of other V2b genes. However, I investigated whether
foxn4 expression is altered by absence of tal1 gata2a, or gata3. The number of foxn4-
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expressing cells in each of the three mutants does not change. This supports the idea that
foxn4 is upstream of tal1, gata2a, and gata3 during V2b formation. Also, previous research
that attempted to investigate the role of foxn4 in V2b development of zebrafish shows that
overexpression of full-length transcript in embryos results in roughly a 25% increase in the
number of GABAergic V2b cells, and a similar decrease in the number of Tg(Vsx2:GFP) V2a
cells (Li Lin, 2008 Master’s Thesis). This would further support the idea that foxn4 is
responsible for the specification of V2b versus V2a cell fate in both zebrafish and amniotes.
In addition, my results indicate that the dorsoventral position at which V2b cells are
born might change over time. Alternatively, mature V2b cells might migrate in a similar
way to V2a cells in zebrafish (Kimura et al., 2006). If foxn4 is expressed only transiently and
early in differentiation of V2 cells in zebrafish, as it is in amniotes (del Barrio et al., 2007;
Misra et al., 2014), my results would suggest that the dorsoventral position at which V2b
cells form changes over time (Fig. 12), as more dorsal cells express foxn4 at later stages. At
the same time, V2b cells at 24hpf are found in the same rows but also slightly more dorsally
than foxn4-expressing cells at and/or before 24hpf, which would suggest that cells might
migrate slightly dorsally to their final positions, after expressing foxn4. Also, the total
number of cells that express foxn4 changes only slightly, with about 15-17 cells on average
expressing foxn4 at any of the stages between 20hpf-30hpf that I examined. Since foxn4 is
expressed only in a subset of cells that express V2b markers, but V2b cells are present in all
rows where foxn4 is expressed, I think foxn4 may be transiently expressed in forming V2b
cells. Also, I think that young V2 cells that express foxn4 are born more dorsally, but later
might also migrate slightly more dorsally before becoming fully mature. Given that some
V2 cells are ventral to foxn4-expressing cells at 24hpf (Fig. 12; Fig. 32; Table 7), I propose
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that these cells could be older V2b cells born from early foxn4-expressing cells that had
already migrated but do not continue to move to even more dorsal positions. This would be
partly consistent with observations of Kimura and colleagues which show that more dorsal
V2a cells are older than ventral V2a cells (Kimura et al., 2006). As described earlier, the tool
used by this team was Tg(vsx1:Kaede) zebrafish line that labels vsx1-expressing cells and
enables conversion of the Kaede chromophore from green to red at specific times (Kimura
et al., 2006). vsx1 labels V2a cells, but is expressed relatively early in V2 differentiation,
together with foxn4 and gata2a (Kimura et al., 2006). Since red (older) cells were found
more dorsally, the result was interpreted that V2a cells are born ventrally and then migrate
dorsally (Kimura et al., 2006). In addition my results suggest that the position of early V2
cells that express foxn4 becomes more dorsal. It is possible that in previous experiments
even some of the Tg(vsx1:Kaede) cells were being born more dorsally (Kimura et al, 2006),
but then after conversion of chromophore they migrated even further to their final
positions. Even though my interpretation of the results differs from the one presented in
the paper describing V2a migration (Kimura et al., 2006), both scenarios are possible given
the available data, and my results support the hypothesis that at least part of the migration
of V2 cells occurs before the cells become fully differentiated.
Finally, my results suggest that V2b cells are still forming at 30hpf, based on the
premise that foxn4 is expressed by early V2 cells. The similarity in the total number of
foxn4-expressing cells suggests that the V2 cells differentiate in similar numbers at 20hpf,
22hpf, 24 hpf, 27hpf and 30hpf. The slight increase in total numbers of cells labeled by
foxn4 at later stages might suggest that even more V2 cells form at later stages, as
compared to earlier stages. This would be in agreement with the evidence for
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differentiation of V2a cells at later stages, as vsx2 (also known as vsx2, another V2a marker)
mRNA can be detected as late as 48hpf (Kimura et al., 2006). Also, vsx2 expression at late
stages (e.g. 32hpf) is found relatively dorsally to that of earlier stages (Kimura et al., 2006).
Since V2a and V2b cells are born simultaneously by the Notch-signaling-mediated lateral
inhibition mechanism (Kimura et al., 2008; Batista et al., 2008), it is likely that V2b cells are
also born at stages past 24hpf. Alternatively, it is possible that at stages other than 24hpf
cells other than V2 cells express foxn4 in zebrafish, but currently there is no evidence that
would support this. Previous study of foxn4 expression in zebrafish mentions that ‘no
staining in neural tube is seen after neuronal differentiation is completed’ (Danilova et al.,
2004), it is unclear however what the authors meant by this, and even though later stages
were investigated, no spinal cord photographs past 22hpf are provided. Perhaps,
investigation of expression pattern at even later stages and/or double ISH experiments
with V2b and/or other spinal cord cell markers at later stages could resolve which cells
express foxn4 past 24hpf.

4.3 Regulatory network that leads to formation of KA” cells
As described in the introduction, KA” and KA’ cells, contact the central canal and are
important for regulation of swimming behaviors in zebrafish (Wyart et al., 2009). Both of
these cell types express tal1, gata2a, gata3 (Batista et al., 2008), as well as tal2 (Pinheiro et
al., 2004) and sox1a and sox1b (this thesis) and are GABAergic (Bernhardt et al., 1992).
Previous knockdown studies in zebrafish suggested that KA” cells depend on gata2a but
not on gata3 for their correct specification (Yang et al., 2010). Also, the GABAergic

178
phenotype of KA” cells may require tal2, but tal2 is not required for expression of other KA”
markers such as gata3 or gata2a (Yang et al., 2010).
Interestingly, gata3 seems to be expressed more weakly in KA” cells of wild-type
embryos than in more dorsally located cells (Neave et al., 1995; Figs 6A, 18A, 21A, 25A in
this thesis), which might potentially reflect its function in KA” cells. However, no similar
difference between levels of expression in different types of cells was observed for tal1 or
gata2a.
My results using single mutants show that tal1 and gata3 are not required for
correct formation of KA” cells, but gata2a is required for expression of most KA” markers.
The KA” phenotype in gata3 mutants is consistent with the morpholino knock-down
phenotypes described above, but the gata2a mutant phenotype differs in certain aspects
(Yang et al., 2010). My data show that gata2a is required for the correct expression of the
majority of KA” markers since tal1, gata3, sox1a, as well as the GABAergic phenotype of the
cells are all lost in row 1 of gata2a mutant zebrafish. Interestingly though, both tal2 and
sox1b expression are retained in gata2a mutant embryos.
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Figure 33. Schematic representation of possible genetic hierarchies in KA”, KA’ and
V2b cells. Schematics show the potential genetic hierarchies that regulate development of
KA” cells (A), KA’ cells (B), and V2b cells (C), based on results presented in this thesis.
Arrows indicate genes that appear to be downstream of each other. Black color represents
interactions with strong supporting evidence, and grey arrows represent potential
interactions that are less strongly supported. Further investigation will be necessary to
test the latter and reveal remaining interactions.

180
The fact that expression of tal2 is retained in KA’’ cells in gata2a mutants is in sharp
contrast to previous knockdown studies, where tal2 was lost in row 1 in gata2a morphants
(Yang et al., 2010). Yang et al., 2010 propose that tal2 is downstream of gata2a in KA” cells,
as gata2a morpholino injections abolished expression of tal2 in these cells, but tal2
morpholino injections did not affect expression of gata2a in KA” cells.
The differences between my results and the results of Yang and colleagues could
have several explanations. First, it is possible that the morpholino injections exhibited offtarget effects that are additional to abolishment of gata2a function, and that the effect is,
therefore, not seen in gata2a mutants. We know that many morpholinos are prone to
exhibiting such off-target effects, as the amount of morpholino injected is often in
overwhelming excess of target RNA that is available for binding (Bedell et al., 2011;
Shulte-Merker and Steiner, 2014). Given the difficulty in distinguishing the effects of offtarget binding phenotype from the phenotype of knocking down the target mRNA function,
it is strongly recommended that the mutant phenotype takes precedence over a
morpholino-based phenotype (Schulte-Merker and Steiner, 2014). In case of tal2 marker,
the phenotype of tal2 expression in KA” cells caused by knocking down gata2a with
morpholinos is not validated by my observations in the gata2a mutant.
In addition, we know that tal2 is expressed in KA” cells, but that also a subset of
tal2-expressing cells co-expresses nkx2.2b, indicating that tal2 is also expressed in
progenitor p3 cells (Schafer et al., 2007). It is possible that if KA” cells do not form in
gata2a mutant embryos, those cells might be still ‘locked’ in their very late p3 state from
which the KA” form. In that case, the cells would express the tal2 marker, but not have a
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mature KA” identity. In this case the tal2-expressing cells in gata2a mutants could be very
early KA” cells, that do not express other transcription factors normally expressed by these
cells. This scenario would mean that, contrary to the mechanism proposed by Yang et al.,
2010, tal2 is either upstream of gata2a in formation of KA” cells, or its expression is
independent of gata2a.
tal2 is also expressed by V3 cells in zebrafish that express sim1a (Schafer et al.,
2007), and by Sim1-expressing V3 cells in mouse (Zhang et al., 2008). However, since V3
cells do not form until later stages of development (Schafer et al., 2007), the lack of change
in tal2 expression at 24hpf is unlikely to be related to V3 cells. It would be interesting to
test whether a mutation in gata2a would cause KA” cells to change into V3 cells by
examining expression of sim1a. Previous studies suggest that at 48hpf morpholino knockdown of gata2a or of gata3 does not affect vglut2.1 or sim1a expression, however most of
these results were ‘data not shown’ (Yang et al., 2010) and I was not that convinced by the
data that was shown. The researchers do not show the effect of gata3 morpholino
injections, and in gata2a-morpholino injected embryos only vglut2.1 result is shown, which
looks to me from photographs like it might be expressed more strongly and/or by more
KA” cells (Yang et al., 2010, Supplementary Materials Fig. 2).
A similar mechanism to that proposed above could also explain the retention of
sox1b expression in gata2a mutants. If sox1b is also expressed early in KA’’ cell formation in
p3 cells, it might be still expressed in the absence of gata2a. In this case, I would
hypothesize that sox1a, in contrast, is expressed only later in KA” cells and not in p3 cells,
as this could explain why gata2a mutants lose expression of sox1a but not sox1b in KA”
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cells. Alternatively, it is possible that the regulation of these sox1a genes differs in KA” cells,
and only one copy of Sox1 ortholog (sox1a) is regulated by gata2a in specification of KA”
cells. It would be interesting to see whether abolishment of sox1b (but not of sox1a) results
in abolishment of KA” formation, to test whether sox1b is upstream of gata2a or acts
independently of it. However, as mentioned before, currently there are no mutant strains of
sox1a/b are available and only knockdown experiments would be possible.
Finally, it is possible that the loss of Gata2a function in our mutant is not complete
and that even though the DNA-binding function is lost, the transcription factor still exerts
part of its function by for example binding to other transcription factors. Given that the
phenotype seen seems specific to KA” cells and, aside from tal2 marker expression,
resembles the morpholino- based studies, I think it is more likely that the mutant we used
is a null allele and the phenotype is the consequence of complete loss of gata2a.
Taken together, based on the results obtained in this study I propose that gata2a is
required for the correct formation of mature KA” cells and their GABAergic phenotype.
Gata2 is upstream of tal1, gata3, and sox1a, and in the absence of Gata2 function KA” cells
do not properly differentiate as functional inhibitory cells. However, gata2a is either
downstream of tal2 and sox1b, or those markers participate in an alternative, gata2aindependent pathway in formation of KA” cells.

4.4 Regulatory network that leads to formation of KA’ cells
As discussed earlier, KA’ cells are primarily found in row 2 in zebrafish spinal cord,
but can also occasionally be found in row 3 where, if located medially, they still access the
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central canal with their sensory tuft (Dr. Claire Wyart, personal communication; Djenoune
et al., 2014). KA’ cells differ from KA” cells in their dorsoventral position and origin, as they
are born from the same progenitor domain as motoneurons (pMN progenitor domain)
(Park et al., 2004). Just like KA’’ cells KA’ cells express gata2a, gata3 and tal1 (Batista et al.,
2008), tal2 (Pinheiro et al., 2004; Schafer et al., 2007) as well as sox1a and sox1b (this
thesis), and the cells are GABAergic (Bernhardt et al., 1992).
Loss of Gata2a does not have an effect on the expression of the majority of KA’ cells
in zebrafish spinal cord, which is consistent with previous morpholino knockdown results
(Yange et al., 2010). Interestingly, my cell counts show, however, that there is a small loss
in the number of GABAergic cells in row 2 of gata2a mutants, compared to their wild-type
siblings (Fig. 19). This suggests that perhaps not all of the KA’ cells are able to become
GABAergic in the absence of Gata2a. However, this result is slightly different from the
previous knockdown study, which showed that KA’ cells are still GABAergic after injections
with gata2a morpholino (Yang et al., 2010). However, since the reduction in KA’ cells that
express gads that I observed in gata2a mutants is relatively small, it could have been easily
missed by the team of Yang and colleagues as they didn’t count cells (Yang et al., 2010).
Also, since only about half of the GABAergic cells are affected in gata2a mutants, future
work should probably repeat this experiment to confirm that this phenotype is not due to
subtle differences in embryo stages. I took great care during the staging and fixing
processes of my experiments to make sure that embryos were always at 24hpf, however it
is possible that subtle variabilities in stage may have sometimes occurred due to small
changes in the temperature of the incubator and/or other variables.
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However, similar phenotypic changes in KA’ cells of gata2a mutant was found with
sox1a marker. Since the expression of sox1a is almost completely abolished in row 2 of
gata2a mutants, it suggests that gata2a is required for correct expression of both sox1a and
GABAergic phenotypes in KA’ cells. Given that sox1b expression remains unaffected in the
KA’ cells, it again suggests that those two co-orthologs are differently regulated in specific
cell types of the zebrafish spinal cord.
While gata2a is required for sox1a expression and potentially the GABAergic
phenotype of KA’ cells, it most likely acts downstream of tal1 and gata3 in these cells, since
gata2a expression is abolished in KA’ cells in both tal1 and gata3 mutants. Loss of tal1,
causes loss of all markers of KA’ cells (Figs. 21-24), placing it near the top of the genetic
hierarchy that leads to formation of KA’ cells. In addition to counting cells in each
dorsal/ventral spinal cord row, I repeated my cell counts to distinguish between lateral
V2b cells and medial KA’ cells in row 3. These analyses showed that in tal1 mutants only
very sporadic cells could be found that might be a KA’ cell. Similarly, loss of gata3 leads to
the abolishment of all examined markers that label KA’ cells: no medially located cells in
row 2 or 3 express any KA’ markers (Fig. 33). This is consistent with morpholino
knockdown results, which show that abolishment of gata3 results in loss of tal2 and
GABAergic markers in KA’ cells (Yang et al., 2010). Based on those published results, and
on the loss of expression of additional markers in KA’ cells in the gata3 mutants, it appears
that gata3 is required for the specification of the global cell fate of KA’ cells. In addition, my
results show that tal1 is required for the specification of the global cell fate of KA’ cells,
which is the first time that tal1 has been shown to be required for KA/ CSF-cN specification
in any vertebrate.

185
Interestingly loss of tal1 also results in loss of tal1 expression in KA’ cells but not in
other cells, suggesting that most likely KA’ cells are lost. A similar observation was made in
gata3 mutants in which gata3 expression seems to be reduced in KA’ cells. However, in
gata3 mutant all the other cells also expressed gata3 much more weakly when compared
to the sibling embryos, which might indicate that gata3 RNA is subject to nonsense
mediated decay in gata3 mutants. Since expression of both tal1 and gata3 as well as all
other KA’ markers are lost in KA’ cells of both single mutants, both tal1 and gata3 are
required on their own for correct formation of KA’ cells. It would be interesting to see
whether those cells die, or whether KA’ cells become other cells in absence of tal1 and
gata3. Since, as mentioned before, KA’ cells form from the same progenitor domain as
motoneurons do (Park et al., 2004), it would be interesting to see whether number of cells
that express motoneuron markers (e.g. islet1/2) increases in tal1 and gata3 mutants.
It would be also interesting to see whether tal1 and gata3 act together in
specification of KA’ cells by forming a larger complex, or whether they act independently of
each other to specify KA’ cells. Studies that involve investigation of protein-protein
interactions, such as co-immunoprecipitation experiments, would be needed to answer this
question directly.
It is also possible that a larger complex that includes Gata3 and Tal1 forms in KA’
cells, given that in other tissues similar complexes form. For example during blood
development, TAL1 and GATA proteins (e.g. GATA-1), are known to form complexes. TAL1
has an ability to bind to E-boxes (consensus sequence CANNTG) (Church et al., 1985), the
boxes are however sometimes positioned in a way that also requires both TAL1 and GATA
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protein binding to DNA for transcriptional activity (Tripic et al., 2009). In those cases,
binding of both TAL1 and GATA proteins together enables formation of a larger complex
that may include nuclear non-DNA binding proteins (e.g. lmo2), and only then downstream
genes can be expressed (Wadman et al., 1997). Also, sometimes TAL1 is required for
transcriptional activity but acts as a cofactor, and does not need to directly bind to DNA.
For example, TAL1 acts together with GATA3 (and LMO) in T-cell acute lymphoblastic
leukemia, where the full complex binds to DNA through the GATA site, and TAL1 must be
present in the GATA3-LMO-TAL1 complex for full transcriptional activity to take place (Ho
et al., 1998). Also, GATA protein binding has a large influence on binding specificity and
mode of action of TAL1 (repression/activation of target gene expression), and the binding
of GATAs appears to regulate the ability of TAL1 to activate or repress transcription
depending on the cell type in mouse cell cultures (Tripic et al., 2009; Wu et al., 2014). In
fact, binding of GATA proteins appears to be a stronger determinant of specific TAL1
binding than even the presence of E-boxes to which TAL1 binds in mouse blood cell
cultures (Ono et al., 1998; Wu et al., 2014). It is therefore possible that in zebrafish spinal
cord Gata3 and Tal1 act together in specification of KA’ cells, especially since my results
show largely similar phenotypes in KA’ cells resulting from either loss of tal1 or gata3.
However, it is not possible to conclude based on my results whether Tal1 acts as a co-factor
for Gata3 transcription factors, or whether they bind to DNA independently. Given that
both DNA-binding domains are truncated in the mutants, both scenarios are possible and
could result in a similar phenotype. More mechanistic studies, such as experiments
involving ChIP analysis would enable to better understand this process in KA’s of zebrafish.
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Overall, my results are in agreement with the knockdown experiments that suggest
that abolishment of gata3 in zebrafish embryos leads to the loss of KA’ cells (Yang et al,
2010). My research confirms this as all of the genes I examined are lost in KA’ cells in gata3
mutant embryos. Similarly, my results confirm that gata2a is dispensable for KA’
specification, with two major exceptions. First, GABAergic specification, which was
unaffected in morpholino-injected embryos (Yang et al., 2010), is abolished in about half of
the row 2 cells in gata2a mutants (Fig. 19). Also, the expression of sox1a is reduced in
gata2a mutants. These two results, suggest some aspects of KA’ differentiation might be
affected by loss of gata2a. In addition, loss of tal1 leads to abolishment of KA’ cells in all
cases, which is a phenotype not described by any previous studies. I conclude that tal1 and
gata3 are required for correct KA’ specification, while gata2a is dispensable for formation
of KA’s but might be required for the expression of sox1a and the KA’ GABAergic
phenotype.

4.5 Regulatory network that leads to formation of V2b cells
To determine the functions of tal1, gata2a and gata3 in V2b cell specification I
examined expression of genes expressed by these cells in the single mutants for each of
these genes. V2b cells are most extensively studied of the three cell types I investigated
during this thesis. As mentioned before, they express Tal1, Gata2 and Gata3 in amniotes
(Karunaratne et al., 2002; Peng et al., 2007; delBarrio et al., 2007) and in zebrafish (Batista
et al., 2008; Kimura et al., 2008). Tal1 is expressed in amniotes soon after the beginning of
V2b differentiation, after a progenitor cell differentiates into a V2a and V2b cell and the V2a
cell downregulates Gata2 (Smith et al., 2002; Muroyama et al., 2005). In mouse ventricular
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zone of the spinal cord, all of the cells that express Tal1 express Gata2, with some cells
present that express only Gata2 (Peng et al., 2007). Gata3 in amniotes is expressed by the
most mature V2b cells, and is an established marker of V2b cells, marking most laterally
located post-mitotic inhibitory V2b neurons (Smith et al., 2002, Karunaratne et al., 2002, Li
et al., 2005, Muroyama et al., 20005). In zebrafish V2b cells, tal1 and gata2a begin to be
expressed between 16-somite stage and 18-somite stage, while gata3 is expressed later
(after 18-somite stage), but at 24hpf the cells express all three of those markers (Batista et
al., 2008).
In this thesis, as discussed above – I also show that sox1a and sox1b are expressed
by at least some V2b cells although they may also be expressed by additional cells. Also, I
confirm that tal2 is expressed in a subset of V2b cells. Therefore, in addition to gata2a,
gata3 and tal1 I also examined expression of sox1a, sox1b and tal2 in potential V2b cells in
each of the three single mutants.
The changes in expression of known V2b markers (i.e. tal1, gata2a and gata3
markers) in each of the three mutants are always relatively small, with no more than half of
the cells being lost in the V2b domain. This suggests that redundancy may exist between
these transcription factors. Interestingly, my results also show that the expression of some
genes is lost whereas others are retained in V2b cells in mutant embryos, which suggests
that neither tal1, gata2a nor gata3 are required for global V2b specification. My single
mutant results allow me to draw some conclusions about V2b development but do not fully
explain the genetic hierarchy between tal1, gata2a and gata3 in these cells.
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In V2b cells in gata2a mutants, the only phenotypes observed are small changes in
GABAergic phenotype, as well as in gata3 expression. Given however that only an average
of about 3 cells lost expression of either gads or gata3, these differences may not be very
meaningful. For example, gata2a mutants show slightly more GABAergic cells in row 3 as
compared to the wild-type, which might mean that overall number of V2b cells stays the
same and the small differences are due to errors in determining the cell row that a cell is
present in. It is however possible that the loss of a few cells might reflect a genuine
regulation of gata3 and/or gads by gata2a, although in this case the effect is subtle. I
counted cells in only 4 embryos in this particular case, so perhaps looking at more embryos
or repeating this experiment could re-confirm the conclusion of this result. No significant
change was found in expression of other markers (tal2, sox1a, sox1b, tal1 and foxn4) in the
V2b domain of gata2a mutant.
These results are in sharp contrast to amniotic spinal cord, where Gata2 is required
for specification of both V2a and V2b cells, as at early stage of mouse embryonic
development (E10.5) both Vsx2 and Gata3 are attenuated in mouse Gata2 mutant (Fig.3,
Zhou et al., 2000; Francius et al., 2014). However, later stage studies in mouse mutant are
not possible due to early lethality of embryos right around E10 (Zhou et al., 2000).
However, conditional knockout of gata2a results in co-expression of both Vsx2 and Gata3
markers by the same cells at a later stage, showing that gata2a plays an important role in
the correct decision between V2a and V2b fate (Francius et al., 2014). Interestingly, cells
still express Gata3 and Vsx2 in the conditional mice in what appears to be larger numbers
than in null Gata2 mutant, but unfortunately the comparison of those numbers is not
provided (Francius et al., 2014). It is possible that at least some of the mutant phenotype
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observed in mouse is related to disruptions and/or slight delay in overall mutant
development, which does not happen in the conditional knockout mouse. Nevertheless, it
seems that in absence of Gata2 V2b cells do not form correctly in mouse (Zhou et al., 2000;
Francius et al., 2014). It cannot be ruled out that gata2a plays a similar role in zebrafish,
and that even though number cells that express V2b markers does not change, those cells
might in addition express V2a markers.
Also, my data suggests that loss of tal1 results in slightly reduced gata3 expression,
but gata2a expression is not significantly affected in V2b cells. This indicates that tal1 may
be partly required for gata3 expression or maintenance. Since the gata3 mutation also
results in a loss of about half of tal1-expressing cells, it is possible that a regulatory
feedback loop might exist between those genes. In addition, it is also possible that both
Tal1 and Gata3 operate together in a complex that maintains expression of their own genes,
as discussed later.
This is again in sharp contrast to the mechanism showed in mouse, where nervetissue specific loss of Tal1 results in attenuation of Gata2, and complete loss of Gata3
expression (Muroyama et al., 2005). Also, in chicken, Tal1 is sufficient to induce GATA3
expression, while causing attenuation of V2a marker VSX2 (Muroyama et al., 2005; Peng et
al., 2007). My results suggest that tal1 on its own is not required for gata2a expression,
while gata3 may only partly depend on tal1 in zebrafish V2b cells. It is however interesting
that in the manner similar to mouse described above, I also see a more drastic change in
the expression of gata3 than in gata2a expression in tal1 mutant. This suggests that tal1
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might be important for maintenance of at least gata3 expression, in which case
experiments at a later stage would show a more prominent change in phenotype.
Interestingly, mutation in tal1 results in an almost complete loss of sox1b expression
in V2b cells. At the same time, V2b cells still express sox1a. This suggests that tal1 is
upstream of sox1b but not of sox1a in V2b cells. This is another case where sox1a and sox1b
are regulated differently in specific cell populations. Also, in tal1 mutants, tal2 expression is
completely abolished in the few cells that would normally belong to the V2b domain at
24hpf, but also earlier at 22hpf and later at 27hpf. In addition, the GABAergic phenotype is
lost in most cells dorsal to row 4. Since there are cells that are GABAergic dorsally to row 4
that don’t belong to the V2b population (e.g. V1 cells, where tal1 is not normally
expressed), it is likely that some of those remaining cells are not V2bs. However, as also I
explained in the results section, the remaining expression of gads is generally weaker in
any cells that are not KA”s, which might be a result of embryos being generally a little
sicker and/or the other cells not forming correctly in absence of other cells that would
normally be in the spinal cord. Since KA” cells still express gads normally, as discussed
before, it is however unlikely that the tal1 mutant embryos are sick, unless those cells
would form early enough not to be affected. Overall, it appears that tal1 is required for
expression of sox1b and tal2, and for correct specification of GABAergic phenotype in the
V2b cells.
This is interesting, since Tal1 (otherwise known as Scl) and Tal2 are closely related,
and at least Tal1 is known to form transcriptional complexes with GATA proteins that
specify of many cell types, most notably blood (Bockamp et al., 1994; Tripic et al., 2009).
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However, in developing mouse midbrain, a conditional knockout of Tal1 does not affect the
expression of Tal2 (and other markers of GABAergic neurons of that region, including
Gata2 and Gata3) (Achim et al, 2013). However, knockout of Tal2 abolishes expression of
Tal1 and reduces Gata2, Gata3, expression and the GABAergic marker Gad1 (Achim et al.,
2013). The double Tal1/Tal2 knockout does not have a more severe effect on Gata2/3, but
completely abolishes the GABAergic phenotype of those cells. This suggests that at least in
some GABAergic midbrain cells, Tal2 is responsible for expression of Tal1, and that both of
those transcription factors are required for correct specification of GABAergic midbrain
cells (Achim et al., 2013). It is possible that Tal2 and Tal1 play similarly complementary
roles in specification of the GABAergic phenotype of V2b cells in spinal cord, but their
dependence on each other is reversed. My results indicate that at least in V2b cells, tal1
(tal1) regulates expression of tal2. This might mean that the loss of the GABAergic
phenotype in those cells is due to lack of both tal1/tal1 and therefore tal2, or tal1 might be
solely responsible for the change in GABAergic phenotype. Experiments that involve
abolishment of tal2 would be necessary to distinguish between those possibilities.
Overall, it seems that in absence of tal1 V2b cells still form, but lose expression of
some genes and their GABAergic phenotype. It is possible that sox1b and tal2 belong to the
pathway that specifies the GABAergic phenotype of V2 cells, as their expression in these
cells is also lost in tal1 mutants. This result is in contract to gata2a and gata3 mutants
where most V2b cells are still GABAergic. This suggests that Tal1 but not Gata2a or Gata3 is
required for the GABAergic phenotype of V2b cells.
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My results suggest that gata3 is also not required for expression of most V2b
markers. However, subtle changes can be observed in expression of some of the V2b
markers. Most strikingly, the number of tal1-expressing cells decreases by half in gata3
mutant embryos (Fig. 26). This is the most drastic change in expression pattern observed
in V2b cells in gata3 mutants, and it suggests that gata3 regulates expression of tal1 in V2b
cells to some extent. The fact that tal1 expression is not completely lost could be explained
by either compensation for lack of gata3 by another transcription factor (which could
include Tal1 autoregulation or Gata2a), or it is possible that gata3 is only required for the
maintenance of tal1 expression in V2b cells and that more cells would lose tal1 expression
at later stages. gata2a expression is also affected in gata3 mutants, but to a much smaller
extent (only about 3 cells are lost, which is a statistically significant difference). This might
mean that some aspect of gata2a expression is regulated by gata3 in V2b cells, although it
may also be just biological noise in my experiments.
Interestingly, overexpression experiments in chicken suggest that GATA3 is
sufficient to induce expression of GATA2 (Karunaratne et al., 2002). Also, both Gata2 and
Gata3 have 5’ regulatory sequences that can bind other GATA-family proteins (Karunaratne
et al., 2002). Despite the fact that Gata3 has so far been considered to be the most terminal
V2b marker in amniotes, it is possible that Gata3 regulates some aspects of Tal1 and Gata2
expression in V2b cells. Investigation of the expression of tal1 and gata2a at later stages in
gata3 mutant could resolve whether gata3 would be required for maintenance of tal1
and/or gata2a expression.
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Interestingly, gata3 mutants also lose about one-third of sox1b-expressing cells in
rows 4 and above, while no change in sox1a expression is observed. In addition, both of
those markers are lost in row 3 cells, where many cells are V2bs. This suggests that at least
some V2b cells that express sox1b are lost in the gata3 mutant. If V2c cells exist in
zebrafish, it is also possible that some of the lost cells correspond to V2c cells. However, it
should also be noted that many more sox1a-expressing cells were observed than sox1b
expressing cells in wild-type embryos from gata3 incross. Also, since about half of the tal1expressing cells and some of the sox1b-positive cells are lost in gata3 mutants, but almost
all sox1b-expressing cells are lost in tal1 mutants in V2b domain, it is possible that sox1b
expression is lost because tal1 not being present in the cells. In addition, I observed that
some GABAergic cells are lost in V2b domains in gata3 mutants, and even more GABAergic
cells were lost in tal1 mutants. If tal1 is required for GABAergic phenotype of V2b cells, and
gata3 is required for correct tal1 expression in at least a subset of V2b cells, loss of
GABAergic phenotype in V2b cells in gata3 mutants might be mediated by loss of tal1.
Therefore, one possible interpretation of my results would suggest that gata3 is required
for at least some aspect of tal1 expression, and loss of tal1 leads to loss of sox1b and
GABAergic phenotype of V2b cells.
Overall, I propose here that the mechanism of V2b specification in zebrafish differs
from the mechanism in amniotes. Most notably, none of the genes tal1, gata2a or gata3 are
required for correct expression of tal1, gata2a or gata3 or global specification of V2b cells
on their own. Instead, I propose that in V2b domain of zebrafish spinal cord at 24hpf, tal1 is
required for correct expression of sox1b, tal2 and the GABAergic phenotype of the V2b
cells. Also, gata2a might be required for maintenance of gata3 expression to a small extent,
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and gata3 is required for the correct expression (or maintenance of) about a half of tal1
and sox1b expression in V2b cells. This is summarized in the schematic (Fig. 33C).
In conclusion, my mutant analyses have provided novel insights into the regulatory
network that specifies V2b and KA cells. Further research on double mutants, performed by
Dr. Banerjee in the Lewis lab, will hopefully help us to even better understand the
interactions between tal1, gata2a and gata3 and their roles in specification of these cells.

4.7 Other candidate genes that may be expressed by V2b
and/or KA cells
The final aspect of this thesis that I will discuss is my analyses of other candidate
genes that I thought might be expressed by V2b or KA cells. I will discuss my results for
each of these genes in turn.

4.7.1 crb1
crb1 (crumbs family member 1, photoreceptor morphogenesis associated) encodes a
transmembrane protein that is a member of the Crumbs family. crb1 was first identified in
the apical membranes of fly epithelial cells, and recognized as an essential regulator of the
epithelial cell polarity (Tepass et al., 1990). Proteins of the Crumbs family are known to
exert their function by assembly of a larger Crumbs complex (Crb) to their intracellular
domain, and by binding to other ligands via extracellular domain (Le Bivic, 2011; Pocha
and Knust, 2013). Crb inhibits Notch signaling in the fly (Herranz et al, 2006) and during
neurogenesis in zebrafish (Ohata et al., 2011). This is exciting, as KA (and V2b
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specification) in zebrafish and mammals depends on Notch signaling. Expression and
function of key Crumbs proteins, including Crb1, is well conserved between mammals and
zebrafish, although in some cases differences exist (Le Bivic, 2011; Bulgakova and Knust,
2009).
In zebrafish, expression of crb1 has been identified in the developing brain and
retina (Omori and Malicki, 2006). Crb1 can be first detected in developing brain at 24hpf,
with expression in the retina detected only after 48hpf (Omori and Malicki, 2006). Despite
experiments being performed at the same developmental stage as my experiments, no
expression was detected in the spinal cord (Omori and Malicki, 2006). Here, I show for the
first time that crb1 is expressed in the zebrafish spinal cord at 24hpf and identify a subset
of crb1-expressing cells as KA” and KA’ cells. My results show that expression of crb1 is
restricted to the most ventral part of the zebrafish spinal cord, and that at 24hpf crb1 is
expressed by all KA” cells and by at least a subset of KA’ cells. This is also exciting, as the
crb1 appears to be one of the very few genes that are expressed solely by KA cells (and not
V2b cells) in zebrafish spinal cord.
In mammals, Crb1 is expressed in mouse developing brain, neural tube, and
developing and adult retina cells (den Hollander at al., 2002). In mouse retina, Crb1 is
essential for correct polarity and adhesion of specialized photoreceptors (Pellikka et al.,
2002) and glia cells (van de Pavert et al., 2007). Also, in humans mutations in the CRB1 are
associated with multiple eye dystrophies (den Hollander et al., 2004). Interestingly, in the
mouse developing neural tube expression of Crb1 coincides with expression of Nkx2.2, with
a slightly broader expression of Nkx2.2 than of Crb1 at E10.5 (den Hollander et al., 2002).
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This was interpreted as Crb1 being expressed by mouse V3 cells (den Hollander et al.,
2002). My results suggest that in zebrafish, V3 (or their progenitor cells) might also
express crb1, as cells located between the Tg(gata1:GFP) KA’’ cells in the p3/V3 domain
express this gene. However, no expression of Crb1 was so far identified in cerebrospinal
fluid contacting neurons (CSF-cNs) of mammals that correspond to zebrafish KA cells. If the
expression of this gene is conserved between amniotes and zebrafish, my results suggest
that this gene could potentially be expressed by mammalian CSF-cNs. Further functional
analysis of this gene is also readily possible, as currently there are several zebrafish mutant
strains available, and mouse mutants also exist. Given that this gene is expressed by KA
cells it would also be interesting to see whether its expression is affected by mutations in
tal1, gata2a or gata3.

4.7.2 insm1a
insm1a (insulinoma associated 1a) is a zebrafish ortholog of mammalian Insm1. In
mammals, Insm1 encodes a transcription factor with five zinc finger domains, and the
protein appears to be highly conserved between humans, mammals, zebrafish, frog and C.
elegans (Lan and Breslin, 2009). INSM1 was first identified via screening human genetic
libraries as a gene associated with the occurrence of insulinoma (Goto et al., 1992). Since
then, it was shown to be expressed mainly by the nervous and endocrine tissues (Lan and
Breslin, 2009), and in humans has been associated with at least 35 different types of
neuroendocrine cancer, including lung, renal, pancreatic carcinomas, as well as
neuroblastoma and retinoblastoma (Lan and Breslin, 2009). Previous research efforts have
concentrated mostly on elucidating the role of Insm1 in development of neuroendocrine

198
cells of the brain and other body tissues, and the function in the spinal cord has not yet
been analyzed (Lan and Breslin, 2009, Jia et al., 2015).
In developing mouse, Insm1 is expressed in the endocrine cells of pancreas, the
central and peripheral nervous system, as well as in olfactory epithelium, and it appears to
be a pan-neuronal marker of developing neurons in the brain (Farkas et al., 2008;
Osipovich et al., 2014). In the mouse olfactory epithelium, deletion of Insm1a results in
formation of fewer neurogenic basal progenitors and more apical cells that give rise to
additional progenitors (Rosenbaum et al., 2011).
Similarly, loss of function experiments show an increase in number of apical
progenitor cells in mouse cortex and other neuronal structures and loss of neurons,
whereas gain-of-function experiments show that cell cycle progression is inhibited upon
forced insm1a expression (Farkas et al., 2008). However, INSM1 is expressed by not only
progenitors, but also nascent cells in mouse and human embryonic spinal cords (Duggan et
al., 2008; Jacob et al., 2009). However INSM1 is only transiently expressed by post-mitotic
neurons, and is not detected in fully differentiated neurons of either mouse or human CNS
(Duggan et al., 2008). In addition, in mouse hindbrain, Insm1 acts upstream of Gata2 and is
required for correct specification of the serotonergic neurotransmitter phenotype of cells
(Jacob et al., 2009).
Insm1a has two orthologs in zebrafish that arose during the whole genome
duplication event in the teleost lineage - insm1a and insm1b. In this thesis, I only
investigated expression of insm1a. insm1a and insm1b are both expressed in similar
structures in the zebrafish, but differences can be found between their expression patterns
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(Lukowski et al., 2006). At 24hpf, both co-orthologs insm1a and insm1b are expressed in
the various structures of the brain including diencephalon and hindbrain, presumptive
pancreas tissue and both are expressed by spinal cord cells (Lukowski et al. 2006). In the
spinal cord, expression pattern of insm1b is broader than expression of insm1a. insm1a
expression is restricted to ventral neurons of the spinal cord, whereas insm1b is expressed
in three distinctive stripes across the dorsoventral axis (Lukowski et al., 2006). At this
stage, both co-orthologs appear to be expressed specifically by neurons as their expression
overlaps with the post-mitotic neuronal marker elavl3, but the expression of insm1b
appears to be stronger in the cranial neurons than in the spinal cord (Lukowski et al.,
2006). Later in development, expression of only insm1a can be detected in zebrafish retina,
where it appears to be transiently expressed between the 24hpf and 72hpf stages
(Lukowski et al., 2006) and expressed much later in adult zebrafish photoreceptor cells
(Morris et al., 2011). Knockdown studies have shown that insm1a is required for correct
development of photoreceptor cells in the zebrafish retina (Forbes-Osborne et al., 2012),
but no spinal cord phenotype was reported. Interestingly, insm1a appears to be negatively
regulated by Notch signaling (Forbes-Osborne et al., 2012), and the spinal cord KA and V2b
cells I investigate in this thesis also depend on Notch signaling for their formation (Batista
et al., 2008). It would be interesting to see whether expression of the insm1a in spinal cord
also depends on Notch signaling, for example with use of Notch-deficient mindbomb
mutant.
My results show that insm1a is expressed in the zebrafish spinal cord in a pattern
consisted with previously described expression (Lukowski et al., 2006). My analyses
suggest that at least some of the insm1a-expressing cells are V2b and/or KA cells, as they

200
co-label with Tg(gata1:GFP)-positive cells. In future, labeling with markers of other cells
would be needed to establish the identity of the remaining Tg(gata1:GFP)-negative insm1apositive cells. Since some V2b and KA cells express insm1a though, it would also be
interesting to see whether this gene is affected by mutations in tal1, gata2a or gata3.

4.7.3 her6
her6 (hairy-related 6), a zebrafish ortholog of mouse Hes1, encodes for a bHLH
transcription factor of the hairy-related Hes/Her family. These proteins often act as
transcriptional repressors of neurogenesis and other processes (Kageyama et al., 2007).
Hes1 appears to be required for the correct formation of neurons from radial glia in the
mouse brain, and for formation of optic vesicles (Hatakeyama et al., 2004).
The action of Her/Hes proteins often depends on Notch signaling (Kageyama et al.,
2007). For example, in mouse, Hes1 is expressed in various structures of the brain, where
its expression can be either Notch-independent or Notch-dependent (Kageyama et al.,
2007). This is interesting, because as discussed above KA and V2b cell formation in
zebrafish also depends on Notch signaling. In zebrafish brain, her6 expression in the brain
appears to depend on Notch signaling, as in the diencephalon and hindbrain of mindbomb
(mib) mutants, her6 expression is reduced (Cunliffe, 2004), but the spinal cord expression
in this mutant was not described.
Expression of her6 has been described in several zebrafish tissues, but spinal cord
expression has not yet been described. Her6 expression in zebrafish can already be
detected at 70% epiboly, with a segmental pattern of expression in the prospective
forebrain, hindbrain, and the midline becoming clear near the tailbud stage (Pasini et al.,
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2001). Later during development, her6 is expressed in rhombomeres of the hindbrain, with
the expression varying between specific rhombomere segments dependent on the stage
(Pasini et al., 2001). Also, during somitogenesis, her6 can be found in the notochord,
somites, and in the pre-somatic mesoderm (Pasini et al., 2001), where it is required for the
expression of the cyclic genes that are involved in somite formation (Pasini et al., 2004).
Also, in the zebrafish thalamus her6 appears to be required but not sufficient for the
GABAergic phenotype of the neurons, and the cells adopt a glutamatergic phenotype in
absence of her6 (Scholpp et al., 2009). In contrast, ectopic GABAergic cells form after forced
expression of her6 via a heatshock mechanism, although this is thought to be achieved via
resulting repression of neurog1 by her6 (Scholpp et al., 2009).
During my rotation project, I showed that her6 is also expressed in zebrafish spinal
cord. Also, another rotation student, Alex Nichitean, showed that her6 expression depends
on Notch signaling in the spinal cord, as the expression of her6 in mib mutants is
significantly reduced (data not shown). Since the expression of her6 appears to be located
in domains where KA” and KA’ cells would be found, I further investigated whether this
gene is expressed in these cells using double labels. In this thesis I show that her6 co-labels
with Tg(gata1:GFP) positive KA cells, demonstrating that her6 is a novel marker of KA cells.
This is exciting, as her6 appears to be the one of the very few transcription factors that are
expressed by KAs but not by the V2bs. Further experiments will hopefully reveal whether
her6 acts downstream of either tal1, gata2a or gata3 in KA formation.
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4.7.4 mnx1
mnx1 (motor neuron and pancreas homeobox 1; also known as Hb9) encodes for a
transcription factor with a homeobox-binding domain. Expression of human MNX1 was
first described in pancreas and lymphatic tissues (Najfeld et al., 1992; Harrison et al.,
1994). Mutations in this gene were later associated with Currarino syndrome (Ross et al.,
1998), in which erroneous secondary neurulation is thought to lead to a series of
malformations around the sacral area. More recently, mutations in MNX1 were also found
in association with neonatal diabetes cases (Bonnefond et al., 2013; Flanagan et al., 2014).
In mouse, Mnx1 is required for correct specification of pancreatic β-cells and production of
insulin (Harrison et al., 1999; Pan et al., 2015).
Expression of this gene in the spinal cord was first described in frog, and was
localized to motoneurons (Saha et al., 1997). Since then, studies have shown that Mnx1 is
required for correct formation of motoneurons in both mouse and zebrafish (Tannabe et
al., 1998; Arber et al., 1999; Seredick et al., 2012), and sufficient for specification of somatic
motoneurons in chicken (Tannabe et al., 1998). Expression of Mnx1 in amniote spinal cord
depends on Sonic hedgehog (Shh) signaling (Tannabe et al., 1998). Also, in mouse Mnx1 is
expressed by excitatory (glutamatergic) interneurons which are involved in locomotor
networks (Kwan et al., 2009; Hinckley et al., 2010).
In zebrafish spinal cord, mnx1 is expressed by both post-mitotic motoneurons and
by V2b cells (Seredick et al., 2012). It is first expressed by V2b cells at 16hpf, but its
expression persists until at least 24hpf (Seredick et al., 2012). However, mnx1 alone is not
required for formation of primary motoneurons or V2b cells zebrafish (Seredick et al.,

203
2012). Instead, knockdown analysis showed that mnx1 together with other mnx genes
(mnx2a and mnx2b) are required for correct formation of a specific subtype of
motoneurons (MiP) (Seredick et al., 2012). In absence of Mnx proteins, MiPs form V2a
interneuron-like characteristics (Seredick et al., 2012).
Since mnx1 is expressed by zebrafish V2b cells (Seredick et al., 2012), I was
interested whether it might also be expressed by KA cells. The experiments in zebrafish
show that mnx1 is not co-expressed with V2a marker vsx2 or with glutamatergic
neurotransmitter markers, and that it is expressed by GABAergic cells (Seredick et al.,
2012). Since KA cells are also GABAergic, I was interested to see whether some of those
cells express mnx1. I hypothesized that especially KA’ cells might express this gene, as both
KA’ cells and motoneurons form from the same progenitor domain (Park et al., 2004).
Alternatively, it would also be exciting if mnx1 was expressed by V2b cells but not KA cells,
as all genes identified so far as being expressed by V2b cells are also expressed by KA cells.
Therefore, mnx1 could potentially be a V2b-specific marker that distinguishes between
those cell types. However, my experiments show that only very few Tg(gata1:GFP)-positive
cells co-localize with mnx1, which could potentially be KA’ or V2b cells. Also, my results
indicate that only some V2b cells express mnx1, as some cells with V2b-like morphology
were observed that did not express mnx1. Given that mnx1 is not expressed by all V2b cells,
and is also expressed by other cell types, I conclude that this gene is not a good V2b-specific
marker.
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4.7.5 sp8a
sp8a (sp8 transcription factor a; formerly known as sp8) is a zebrafish ortholog of
mammalian Sp8(specificity protein 8) gene. Homologous buttonhead (btd) gene was first
identified in Drosophila, (Wimmer et al., 1993), and in this species it is responsible for early
neurogenesis (Younossi-Hartenstein et al., 1997) and growth of appendages (Estella et al.,
2003). More recently, Drosophila btd was found to maintain the early progenitor state of
intermediate progenitor cells and prevent their differentiation into more mature neurons
(Xie et al., 2014). Also, in frog (X. tropicalis), sp8 controls development of the inner ear
(Chung et al., 2014).
In mouse, Sp8 is expressed in apical ectodermal ridge (AER), where it is required for
dorsoventral patterning of the forming limb bud (Bell et al., 2003; Kawakami et al., 2004;
Haro et al., 2014). In addition, in mouse brain Sp8 is required for correct formation of
GABAergic neurons of the olfactory bulb (Waclaw et al., 2006). Also, expression of Sp8 was
detected in amniote spinal cord, where it was located to the ventral domain (Bell et al.,
2003; Kawakami et al., 2004). Interestingly, in mouse spinal cord expression of Sp8 was
further localized to a subset of Lhx3-expressing V2 cells, En1-expressing V1 cells and Olig2
expressing motoneuron progenitor (pMN) cells (Li et al., 2014). Notably, none of the Sp8expressing cells co-expressed Gata3 V2b marker (Li et al., 2014), which is consistent with
my finding in zebrafish that sp8a is most likely not expressed by V2b cells. Further analysis
in amniotes reveals that Sp8 and Nkx2.2 co-repress each other, and that Sp8 acts together
with Pax6 to establish the pMN/p3 boundary (Li et al., 2014).
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In zebrafish, sp8a is present in the AER (Norton et al., 2005) and in regenerating tail
fins (Stoick-Cooper et al., 2007). Also, expression in was described in the anterior neural
tube, with especially strong staining in the midbrain/hindbrain boundary (Correa et al.,
2005). However, spinal cord expression in zebrafish was documented for the first time by
the Lewis lab in a the direct data submission to ZFIN database (England et al., 2014). In this
thesis, I show that sp8a does not co-localize with Tg(gata1:GFP) cells, which shows that this
gene is not expressed by KA and most likely by V2b cells. Since it appears to be expressed
approximately in a similar dorsoventral position to Tg(gata1:GFP), it is possible that this
gene is expressed by earlier V2, V1 cells and/or by pMN cells, as it is in mouse. Further
analysis (e.g. by double in situ hybridization with markers of those cell types) could reveal
whether sp8a expression in spinal cord is conserved between zebrafish and amniotes.

4.8 Conclusions
In this thesis I show that sox1a and sox1b, orthologs of mammalian Sox1, are
expressed by V2b and KA cells in zebrafish spinal cord. My results also suggest that
expression of sox1a and sox1b is regulated differently in KA”, KA’ and V2b cells.
Also, I show that foxn4 is expressed by early V2 cells that express gata2a, and that
the position of foxn4- expressing cells becomes more dorsal over time, but the total number
of cells that express foxn4 does not drastically increase.
In addition, I demonstrate the importance of gata2a, tal1 and gata3 for developing
V2b and KA cells. My results indicate that gata2a is required for correct specification of KA”
cells (either their global cell fate or expression of vast majority of markers), and that both
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tal1 and gata3 are required for correct specification of global cell fate of KA’ cells. In
addition, tal1 is required for the GABAergic phenotype and expression of tal2 and sox1b in
V2b cells, but not for expression of many other genes normally expressed by these cells. My
results also indicate that in zebrafish neither gata2a nor gata3 are required for correct
specification of the V2b GABAergic phenotype or the global cell fate of these cells. Finally, I
identify potential novel markers of KA and V2b cells: crb1 and her6 are expressed by KA
and not by V2b cells, insm1a is expressed by a few members of both KA or V2b populations,
mnx1 may be expressed by very few V2b and/or KA’ cells. All of those markers are also
expressed by additional cells, and are, therefore, not specific to one population. However,
her6 and crb1 could be good markers to distinguish KA cells from V2b cells. I also show that
sp8a is not expressed by either V2b and/or KA cells at 24hpf in zebrafish.

4.9 Future work
Future work building on this research should answer remaining questions about
V2b and KA development. For example, even though I show in this thesis that sox1a and
sox1b are expressed by KA and at least some V2b cells, I was unable to show whether they
are expressed by all V2b cells in zebrafish. Also, it remains to be investigated whether these
genes are always co-expressed by the same cells, and whether either of them is expressed
by additional cell populations in the zebrafish spinal cord. Hopefully, future double in situ
hybridization experiments will answer these questions. In addition, I was not able to test
whether V2c cells exist in zebrafish, and further experiments (as discussed in this thesis)
would be needed to investigate this. Since sox1a and sox1b appear to be regulated
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differently in KA”, KA’ and V2b cells, it would be also exciting in future to investigate
whether those genes play different roles in specification of these cell types.
It would also be interesting to investigate whether the transcription factors Tal1,
Gata2 and/or Gata3 act together in specifying KA and/or V2b cells. To this end,
investigation of double mutants in these genes are currently being carried by Dr. Santanu
Banerjee in the Lewis lab. Since my results show that gata2a is required for expression of
most KA” markers (but not tal2 and sox1b), it would be interesting to see whether
abolishment of either tal1 and/or gata3 in addition to gata2a results in a loss of tal2 or
sox1b expression in KA’’ cells. Also, since my work shows that only tal1 is required for the
correct specification of the GABAergic phenotype of V2b cells, it would be particularly
interesting to see whether double mutant combinations of tal1, gata2a and gata3 affect this
and/or other aspects of V2b cell development.
I also hope that the novel markers that I identified for KA but not V2b cells (her6,
crb1) will help with investigations of the mechanisms that specify KA cells. For a long time,
more detailed investigations of KA cells in zebrafish have been hindered by a lack of
molecular markers that are expressed specifically by these cells. However, a gene encoding
for calcium-permeable polycystic kidney disease 2-like 1 (PKD2L1) channel, first
discovered in heart, retina and kidney (Basora et al., 2002), has now been shown to be
expressed in CSF-cNs of both brain stem and spinal cord in postnatal P1-P4 (Huang et al.,
2006) and adult (Orts-Del'immagine et al., 2012) mouse. PKD2L1 is conserved across
vertebrates, and in the spinal cord it is specifically expressed by CSF-cNs in mouse and
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macaque and KA cells in zebrafish (Djenoune et al., 2014). In future, this KA-specific
marker may also enable additional investigation of specification of KA cells in zebrafish.
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Appendix Tables:
Table 1. p-values of Student’s t-test comparison of cell counts of foxn4-labeled cells in wild-type embryos at 4 different
developmental stages. Values correspond to Fig. 12. 4 embryos were counted in each case. Statistically significant differences
(p<0.05) are indicated in bold. All statistical tests were performed with Student’s t-test.

Developmental stage
(in hours post-fertilization)

p-value
(Student's t-test)

20vs22
20vs24
20vs27
20vs30
22vs24
22vs27
22vs30
24vs27
24vs30
27vs30
In bold: p<0.05

0.700
0.093
0.172
0.063
0.100
0.069
0.042
0.386
1.000
0.266
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Table 2. p-values from pairwise comparisons of wild-type embryos from incrosses of tal1t21384, gata2aum27 and gata3sa0234
heterozygous mutants. Values correspond to Figs 29 and 30. Statistically significant differences (p<0.05) are indicated in bold and
are on the pink background. Values that approach significance threshold (p<0.065) are italicized and are on the light blue
background. All statistical tests were performed with Student’s t-test.
Wild-types from
incross of:
mutant 1

mutant 2

gata2a

tal1

gata3

tal1

tal1

gata2a

Row number

Marker
1

2

3

4

5

6

7

8

TOTAL

4+

gata3

1.000

0.100

0.423

0.048

0.175

0.129

N/A

N/A

0.212

0.672

gata2

0.053

0.228

0.181

0.390

0.673

0.017

N/A

N/A

0.540

0.759

0.086

0.183

0.488

0.279

0.011

0.018

0.058

N/A

0.012

0.009

scl

tal1

gata3

0.156

0.211

0.256

0.013

0.172

0.005

0.058

N/A

0.021

0.006

gata2a

gata3

0.488

0.055

0.552

0.095

0.033

0.147

N/A

N/A

0.907

0.178

tal1

gata2a

0.169

0.116

0.178

0.939

0.046

0.027

0.428

N/A

0.000

0.059

tal1

gata3

0.739

0.581

0.518

0.338

0.131

0.021

0.428

N/A

0.029

0.017

gata2a

gata3

0.098

0.086

0.071

0.178

0.765

0.229

0.067

N/A

0.067

0.375

tal1

gata2a

0.076

0.271

0.142

0.152

0.045

1.000

0.148

N/A

0.221

0.300

sox1a

sox1b

tal1

gata3

0.362

0.127

0.519

0.539

0.418

0.360

0.041

N/A

0.439

0.349

gata2a

gata3

0.429

0.052

0.051

0.740

0.031

0.541

0.215

N/A

0.116

0.078

tal1

gata2a

0.449

0.620

0.967

0.173

0.584

0.133

N/A

N/A

0.260

0.159

tal1

gata3

0.783

0.567

0.587

0.218

1.000

0.043

N/A

N/A

0.360

0.842

gata2a

gata3

0.659

0.138

0.561

0.052

0.558

0.178

N/A

N/A

0.096

0.165

tal1

gata2a

0.837

0.277

1.000

0.409

0.348

0.007

1.000

1.000

0.065

0.088

tal2

gads

tal1

gata3

0.878

0.055

0.811

0.010

0.455

0.016

0.161

0.188

0.048

0.124

gata2a

gata3

1.000

0.193

0.904

0.041

0.751

0.311

0.066

0.322

0.726

0.562

tal1

gata2a

N/A

N/A

0.355

0.051

0.951

N/A

N/A

N/A

0.209

0.080

tal1

gata3

N/A

N/A

0.008

0.088

0.532

N/A

N/A

N/A

0.507

0.060

gata2a

gata3

N/A

N/A

0.242

0.795

0.460

N/A

N/A

N/A

0.079

0.060

foxn4
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